Mechanism of catalysis and inhibition of Bacillus cereus class B #beta#-lactamase by Bounaga, Sakina
University of Huddersfield Repository
Bounaga, Sakina
Mechanism of catalysis and inhibition of Bacillus cereus class B #beta#-lactamase
Original Citation
Bounaga, Sakina (1999) Mechanism of catalysis and inhibition of Bacillus cereus class B #beta#-
lactamase. Doctoral thesis, University of Huddersfield.
This version is available at http://eprints.hud.ac.uk/4732/
The University Repository is a digital collection of the research output of the
University, available on Open Access. Copyright and Moral Rights for the items
on this site are retained by the individual author and/or other copyright owners.
Users may access full items free of charge; copies of full text items generally
can be reproduced, displayed or performed and given to third parties in any
format or medium for personal research or study, educational or not-for-profit
purposes without prior permission or charge, provided:
• The authors, title and full bibliographic details is credited in any copy;
• A hyperlink and/or URL is included for the original metadata page; and
• The content is not changed in any way.
For more information, including our policy and submission procedure, please
contact the Repository Team at: E.mailbox@hud.ac.uk.
http://eprints.hud.ac.uk/
MECHANISM OF CATALYSIS AND 
INHIBITION OF BACILLUS CEREUS CLASS B 
P-LACTAMASE 
By 
Sakina Bounaga 
March 1999 
A thesis submitted to the University of Huddersfield in partial 
fulfilment of the requirements for the degree of Doctor of Philosophy 
The Department of C4emical and Biological Sciences 
The University of Huddersfield 
Queensgate 
Huddersfield HD I 3DH 
Abstract 
Bacillus cereus class B P-lactamase (P-lactamase U) is a bacterial metalloprotein which requires 
zinc ions for its activity and catalyses the hydrolysis of the P-lactam amide bond of penicillins, and 
related antibiotics. The pH dependence of k,,, t/K,,, and kt for the P-lactamase II catalysed 
hydrolysis of cephaloridine, benzy1penicillin and cefuroxime has been investigated and indicates 
that there are at least three catalytically important groups in the enzyme active site, two of pK. 5.6 
± 0.2 and one of pK. 9.5 ± 0.2. Below pH 5 there is an inverse second order dependence of activity 
upon hydroniurn ion concentration, indicative of the requirement of two basic residues for catalysis. 
These are assigned to zinc-bound water and aspartate 90, both with pY, of 5.6 ± 0.2. The kinetic 
solvent isotope effects were investigated and found to be 1.3 ± 0.5 for kt/K. and 1.5 ± 0.1 for kt. 
The effect of added methanol on the enzyme reactivity was studied and showed no influence on k,,. t 
indicating that Asp90 does not act as a nucleophile to generate an anhydride intermediate. The 
enzyme activity, as measured by k,. t/&,,, was independent of zinc ion concentration from pH 6 to 
7, but was augmented by increasing zinc ion concentration below pH 5. Below pH 6 the enzyme 
activity was found to be third order in hydroniurn ion concentration and a decrease in the apparent 
p1r, value was observed with increasing zinc ion concentration. 
Several thiol compounds were synthesised and tested as Bacillus cereus P-lactamase H inhibitors. 
The kinetics and mechanism of inhibition of P-lactarnase II by thiol, N(2- 
mercaptoethyl)phenylacetamide (1), were investigated. The pH dependence of Ki shows similar pH 
inflections to those observed in the catalysed hydrolysis of substrates. The inhibitory effect of N- 
carbobenzoxy-cysteinyl amino acids was investigated and the effect of the dipeptide substituent 
and the stereochernistry at each centre was studied. It was found that the best inhibition was 
obtained with a hydrophobic side chain and that the D, D isomers exhibit the highest potency, with 
Ki"s in the pM region. 
The possible mechanisms of action for P-lactamase R are discussed and it is concluded that the 
zinc ion acts as a Lewis Acid to stabilise the dianionic form of the tetrahedral intermediate and to 
provide a hydroxide-ion bound nucleophile. When the enzyme binds one zinc ion, the carboxylate 
anion of Asp90 acts as a general base to form the dianion and also, presumably, as a general acid 
catalyst facilitating C-N bond fission. However, when the enzyme binds two zinc ions it is 
proposed that the water molecule bound to the second zinc ion acts as the general acid catalyst 
since Asp90 is a ligand of the second zinc ion. 
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1. Introduction 
1.1 General introduction 
It has been known for a long time that microorganisms produce substances capable 
'I of inhibiting the growth of other microorganisms in order to protect themselves 
These substances are known as antibiotics. Their discovery has had a major effect 
on the treatment of bacterial infections and played a important role in the 
development of human medicine. 
The majority of antimicrobial agents either modify or inhibit the synthesis of key 
substances in the bacteria: some antibiotics such as sulfonamides interfere with 
bacterial protein synthesis, others interfere with the synthesis of bacterial DNAý. 
The latter have proved to be very effective against bacteria, but they also carry a 
risk of toxicity for humans. 
1.2 The P-lactam antibiotics 
1.2.1 The P-lactam antibiotics 
Since the discovery by Fleming in 1929 of penicillin', by observing antibiosis 
between a Penicillium notatum mould and a culture of Staphylococcus aureus, the 
number of classes of P-lactam antibiotics continues to grow. They have been very 
effective, and hence, are widely used against pathogenic bacterial infections. 
The P-lactwn antibiotics represent a large family of compounds which can be 
classified into several groups according to their structure. They all have a common 
I 
structural similarity, a four membered lactam ring often fused to a secondary ring 
structure through the nitrogen and the adjacent tetrahedral carbon atom of the 
O-lactarn ring. The most familiar class contains the penicillins (1, Figure 1.1) 
(penams) with the O-lactarn fused to a thiazolidine ring and another important class 
consists of the cephalosporins (2, Figure 1.1) (cephems) with the D-lactam fused to 
a dihydrothiazine ring. There are many other classes of P-lactarn antibiotics which 
have been isolated from the fermentation broth of microbial cultures, and an even 
larger number have been synthesised in the laboratory. Among these are the 
cephamycins (3), oxacephems (4), penems (5), oxapenams (such as clavulanic acid 
(6)), carbapenems (such as thienamycin (7)), nocardicins (8) and monobactams (9) 
(Figure 1.1). 
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Figure 1.1 P-Lactam antibiotics 
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The bacteria] activity of these antibiotics is often attributed to the chemical 
reactivity of the P-lactam ring, but the molecular recognition between the antibiotic 
and its receptor target enzyme is equafly important. 
1.2.2 The mechanism of action of P-lactarn antibiotics 
P-Lactam antibiotics selectively interfere with the fonnation of the bacterial cell 
wall, inducing physiological effects, leading to the death of the bacterium. One of 
the main reasons for the low toxicity of these antibiotics to humans is that humans 
don't have a cell wall.. 
1.2.21 Bacterial cell wall structure and biosynthesis 
The bacterial cell wall consists of several layers'. Rigid and porous, it provides the 
shape and physical protection for the cell by preventing the swelling and the 
subsequent rupture of the bacterial cytoplasm as a consequence of high internal 
osmotic pressure. Its synthesis is a major function of the bacterial cell. 
Bacteria are divided into two classes according to their wall structure: Gram- 
positive and Gram-negative'. The cell envelope of the Gram-negative bacteria 
consists of three distinct layers: the cytoplasmic (inner) membrane, the 
peptidoglycan layer and an outer membrane which is selectively permeable. The 
cell walls of Grain-positive bacteria are less complex and contain a larger amount 
of peptidoglycan. They are much more permeable and therefore highly susceptible 
to P-lactam. antibiotics. 
3 
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The peptidoglycan (or murein) is a rigid structural frame which consists of parallel 
polysaccharide chains covalently cross-linked by short peptides (Figure 1.2). The 
glycan is a polymer of altemating N-acetylmuramic acid (NAM) and N- 
acetylglucosamine (NAG) units, connected by 0-1,4-glycosidic 'linkages. The 
composition of the peptide varies from bacteria to bacteria, although they 
commonly have the sequence L-alanyl-D-glutamyl-y-L-X-D-alanyl, in which L-X is 
most often an amino carrying residue such as lysine. 
77 NAG-NAM-NAG-NAM-NAG-NAM-NAG-NAM-NAH 
L-Ala L-Ala 
D-Glul-*, D, -Ala D-Gia 
L-X-NE6 D-Ala L-X-D-Ala 
L)---Ala L-X-Nq V-Ala L-X-NH, 
11-Ata D-Gb 13-AU D--Gl-u 
L-Ala L-Ala 
ý-NAG-NAM-NACY-NAM-NAG-NAM-NACY-NAM-NACr-I 
ML 
L 
NAM: N-acetylmurarric acid 
NAG-. N-acetylglucos 'ne 
X residue with a anino group such as LAysine 
transpeptidation 
both transpepticfase anctcarboxypep6cfase activity release D7-al'anine 
Figure 1.2 Schematic representation of the'cross-linking in peptidoglycan 
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The biosynthesis of the peptidoglycan consists of three major steps: first the 
synthesis of the precursors in the cytoplasm, which are exported through the 
membrane in the second step using a liposoluble carrier, in the third step they are 
assembled to form the peptidoglycan (firstly a transglycosylation reaction which 
elongates the glycan strands and then transpepticlation). 
The cross-linking process which occurs during the final step consists of two stages; 
carboxypeptidation followed by transpeptidation. It involves three enzyme 
activities: peptidoglycan transpeptidase, which catalyses the cross-linkage reaction; 
D-alanine carboxypeptidase, which hydrolyses the terminal D-alanine residue from 
the pentapeptide side chain and endopeptidase which hydrolyses the cross linkage 
between peptidess. 
The precursor of the- pentapeptide contains- one- additional D--alanine- residue 
exhibiting a D-alanyl-D-alanine C terminus. This polypeptide is a substrate for the 
transpeptidase and the carboxypeptidase. The latter regulates the extent to which 
the peptidoglycan is cross-linked by clipping off the terminal D-alanine without 
, fomiing, a cross-linV. Transpeptidase reacts with its peptide substrate to form an 
acyl enzyme intermediate, with the elimination of D-alanine and subsequent 
reaction with the free amino group of a second cross-bridge leads to the formation 
of a cross-fink and regeneration of the enzyme (Figure 1.2). 
P-Lactam antibiotics are known to inhibit aU three of the enzyme activities that 
occur in the tenninal stages of peptidoglycan biosynthesie. Their non toxicity 
5 
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towards humans is due to the lack of molecules similar to peptidoglycan 
precursors, and of D-amino acids in eukaryotic cells. 
1.2.2.2 Inhibition of cell wall synthesis 
In spite of the fact that P-lactarn antibiotics have long been employed in medicine 
and their mode of action emensively studieds, 9,10,11, the complete knowledge of 
their mechanism of action is still unknown. As most of the studies were performed 
with penicillins and cephalosporins, it is generally assumed that other P-lactarn 
antibiotics act similarly6. 
P-Lactam antibiotics react with a number of proteins situated at the outer surface 
of the plasma membrane. Studies have shown that there is no binding to 
intracytoplasmic componentslo. The mode of action of the P-lactarn antibiotics is 
generally considered to be one of two processes, either the activation of autolytic 
cell wall processes or the inhibition of peptidoglycan incorporation into the cell 
wall 12 . Two families of enzymes , recognise penicillins and other 
P-lactam 
antibiotics. The first family is known as the penicillin-binding proteins or PBPs 
which contains the DD-peptidases which are inactivated by the P-lactarns and play 
a major role in the late stage of the bacterial cell wall peptidoglycan synthesis. The 
second family contains the P-lactamases which hydrolyse the P-lactarn ring. 
The complexity of the reactions observed, is due to the variety of PBPs in the 
bacterial cell membrane. There are typically three to eight distinct PBPs found in 
any given organism, and are all situated on the bacterial plasma mernbranelo. They 
6 
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all appear to be serine active site enzymes and perform their catalytic cycle 
according to an acylation/deacylation pathway. Their physiological roles have been 
reviewed by Waxman and Strominger9. 
There are two general categories of PBPs: low molecular weight (40-50 kDa), 
13 
exhibiting DD-carboxypeptidase activity in vitro , which are relatively abundant 
and appear to be unnecessary for the cell viability; high molecular weight PBPs 
(60-140 kDa) which are minor components of the cell, but are essential to its 
viability. Some, such as Escherichia coli PBPs IA and IB, combine 
transglycosylase and transpeptidase activities in vitro. The high molecular weight 
PBPs are more sensitive than the low molecular weight PBPs to both penicillins 
and cephalosporinsý. 
Penicillins, are thought to exert their bacteriocidal effects by interfering with the 
synthesis of the bacterial cell wall through inhibition of the transpeptidase enzymes. 
The first stage of antibiotic activity is the binding of the P-lactarn to the PBP, 
whilst the second stage is the physiological effect on the cell, induced by the 
formation of the enzyme-inactivated complex, such as disruption of the cell growth 
cycle. 
Penicillin binds to and inactivates peptidoglycan transpeptidase or 
carboxypeptidase probably by virtue of its structural similarities to at least some of 
the possible conformations of the acyl-D-alanyl-D-alanine of nascent peptidoglycan 
strandsý 14 (Figure 1.3). Penicillins have been described as transition state analogues 
of X-D-alanyl-D-alanine. 
7 
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Figure 1.3 The transpeptidation reaction of N-acylated D-alanyl-D-alanine, 
catalysed by a transpeptidase serine enzyme, compared with the inhibition 
reaction with penicillin 
P-Lactam antibiotics are considered to be active site-directed acylating agents. 
First, they bind to the enzyme reversibly, then acylate the enzyme. The P-lactam 
remains attached to the acyl enzyme because the leaving amino group remains 
covalently attached to the carboxylic acid ester thus blocking access of the amino 
acceptor (Figure- L31. Thu acyl enzyme cannot therefore turnover and is 
inactivated. The catalytic pathway is described -in Figure 1.413. When the 
8 
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"substrate" is penicillin, the deacylation step (k3) is very slow, and the enzyme is 
immobilized as a very stable acyl enzyme complex. Cell death and lysis are known 
to be indirect consequences of the weakening of the peptidoglycans. When S is the 
physiological substrate (X-D-Ala-D-Ala), the values of k2 and k3 are high, leading 
to a high tumover rate. 
ki 
- 
k2 k3 
E+S - '-- ES EA E+P k-1 k-1 
Acylation 
H20 
Deacylation 
E= DD-peptidase 
S= P-lactam 
EA = acyl enzyme complex 
Figure 1.4 Catalytic pathway of the interaction between P-lactam and DD- 
peptidase 
There are two essential features for the recognition of the penicillin antibiotic at the 
active site: the carboxyl group in the 3 position of the 5 membered ring and the 0- 
lactam carbonyl functionsý , the rest of the molecule bears structural similaritY to 
the natural substrate and helps anchor the antibiotic to the active site. 
1.3 Bacterial resistance to antibiotics 
The extensive use of P-lactam antibiotics to fight bacterial infections has led to the 
emergence of resistant strains of pathogenic bacteria'. Bacteria have found 
different ways to overcome the deadly action of P-lactarn antibiotics. The 
mechanisms frequently observed are: 
9 
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* efflux or active excretion of the antibiotic out of the cell using pumps; 
e modification of the antibiotic target, such as modification of ribosomes, or 
modification of enzymes responsible for the cell wall synthesis (such as PBP 
mutations); 
9 enzymatic modification of the antibiotic making it inactive (such as the action 
of P-lactamases). 
v 
The production of P-lactamases represents the most widespread mechanism of 
bacterial resistance and poses a serious threat to the therapeutic action of the 
P-lactam antibiotics. They catalyse the hydrolysis of the P-lactam ring giving rise to 
biologically inactive products (Figure 1.5). 
RCONH s RCONH s 
N 
H20 
0 HNN 
0 
Co - 
ß-Lactamase o- 2 c02» 
Figure 1.5 Hydrolysis of P-lactam antibiotics by P-. 1actamase 
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1.4 The P-lactamases 
Fleming, as early as 1929, noticed that some groups of bacteria were not inhibited 
by penicillin. Later, the component responsible for this phenomenon was identified 
as an enzyme and named "penicillinase"16 , but are generally now 
known as 0- 
lactamase. 
The D-lactarnases appear to be produced only by bacteria and are widely 
distributed. About 200 enzymes have been discovered and characterised to date 17 . 
The P-lactamase encoding genes are often found on chromosomes, transposons 
and plasmids, the latter allowing them to spread from bacteria to bacteria of 
different genera. Some bacteria are able to produce P-lactamases only when 
exposed to P-lactam antibiotics and this induction allows the bacterium to regulate 
the production of the enzymes". 
The P-lactamases may have evolved from penicillin-sensitive enzymes of cell wall 
biosynthesis by deyeloping an efficient catalytic mechanism for hydrolysis of the 
penicilloyl-enzyme linkage (Figure 1.3, page 8). Ambler'9 acknowledged the 
structural similarity at the active site between class A P-lactamases and some DD- 
peptidases, although admits that there is little evidence for a common evolutionary 
origin of the two types of enzymes. The suggestion of a common ancestor is, 
however, supported by sitnilarities in the secondary and tertiary structures of these 
enzymesýo and by the fact that some PBPs exhibit a weak P-lactamase activity. The 
11 
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penicillin binding site in the transpeptidase is broadly similar to the penicillin 
9,14 hydrolysis site in the P-lactamases" . 
1.4.1 Description of P-lactamases 
P-Lactamase enzymes (P-lactarn hydrolase EC 3.5.2.6) can mechanistically be 
divided into two groups - serine active site enzymes, which belong to the same 
family as the PBPs2', and zinc enzymes, which require zinc ions for their activity. 
The serine enzymes are classified into three groups, A, C and D, on the basis of 
their primary structures. The class B P-lactamases represent the zinc dependent 
enzyme and, being the subject of this thesis, a detailed introduction to these 
enzymes is offered in Section 1.5. 
All four classes are produced by gram-negative bacteria, whereas gram-positive 
species only produce class A and B enzymes which are most often chromosome- 
encoded" 
1.4.2 Class A, C and D P-lactamases 
The class A, C and D P-lactamases operate by a mechanism similar to the basic 
initial steps observed for the DD-peptidases (Figure 1.4). They act on their 
substrate by serine attack on the P-lactam carbonyl carbon to form an acyl enzyme 
intermediate. However, in the case of P-lactam'ases this intermediate is relatively 
unstable because it is hydrolysed to regenerate the enzyme. The acylation step (k2) 
and deacylation step (k3) are generally quite large and the antibiotic is rapidly 
hydrolysed'5. The mechanism (Figure 1.6) is thought to involve a general base 
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deprotonating the serine residue as it attacks the carbonyl function of the P-lactam 
ring, forming a tetrahedral intermediate. A proton is then donated to the amine 
nitrogen leaving group to facilitate ring opening of the P-lactam. Deacylation may 
(424 then occur by reaction with water21,23 
00 
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Figure 1.6 Proposed mechanism of action of serine P-lactamaseS24 
Three conserved structural elements have been found to be involved in forming the 
active site5-l'. There is evidence of an "oxyanion We" in the active site, which is 
5,20,25 
responsible for stabilising the presumed tetrahedral oxyanion intermediate' 
Class A P-lactamase enzymes are found in both gram-positive (mainly 
chromosome-encoded) and gram-negative (mainly plasmid-encoded) bacteri2l 
Their properties and primary structure differ considerably and they therefore 
represent a very heterogeneous family2. They were first described as 
"penicillinases" for their ability to very efficiently hydrolyse penicillin. Some class 
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A P-lactamases can be considered as "perfect" enzymes with their best substrates 
having rates close to the diffusion controlled rate of encounter". The active-site 
serine was identified as Ser70. The catalytic properties of these enzymes have been 
discussed by Matagne el al . 
27. 
Class C P-lactamases seem to represent a more homogeneous group. They were 
first described as chromosomally determined cephalosporinases 16 because of a 
larger k., value for cephalosporins than for penicillins. It is now known that these 
enzymes have no particular marked preference and show very similar substrate 
profilesý'. Their structure is close to that of class A, but their sequence varies. 
Ser64 has been identified as being involved in the catalytic mechanism of these 
enzymes. The deacylation step is known to be the rate limiting step for class C P- 
lactamases (k2>>k3) (Figure 1.4)23. In water, containing methanol, the intermediate 
acyl enzyme can react with the alcohol to givethe methyl ester of the product and 
the rate increases with increasing methanol concentration(). 
Class D P-lactamases, also known as "oxacillinases" because of their ability to 
hydrolyse oxacillins, are very I different from the other serine P-lactamases2' 2'. They 
are always plasmid-encoded23 and their kinetics with some substrates are quite 
complee. Very little is known'ab'out these'enzymes and no tertiary structure is 
available yet. 
Different strategies have been adopted to fight the P-lactamase mediated resistance 
to P-lactam antibiotics, such as the synthesis of new P-lactams which are poor 
substrates for many P-lactamas'es" Another successful approach is the production 
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of mechanism-based inhibitors (e. g. clavulanic acid), also known as "suicide 
inhibitore'30. These are often P-lactams and inactivate the enzyme by acylating it 
but subsequently forming a stable covalent adduCt3l . The interactions between 
active site serine P-lactamases and mechanism-based inhibitors have been studied 
by Matagne el al . 
32 
. The potent inhibitor may be used in conjunction with good 
antibiotics even if they are susceptible to P-lactamase catalysed hydrolysis. 
Most class A and D, but not class C, O-lactarnases are inhibited by clavulanic 
acid2'. The incentive in pursuing the search for new inhibitors is driven by the 
emergence of some P-lactamases which are not inhibited by these inactivators. 
1.5 The Class B P-lactamases 
Class B P-lactamases are metallo-proteins which require a bivalent transition-metal 
ion for their activity, most often zinc. They catalyse the hydrolysis of a wide variety 
of antibiotics including carbapenems which generally escape the action of the active 
site serine enzymes. They are therefore often described as broad spectrum 0- 
lactamases", 3'. They are not inhibited, by clavulanic acid or other mechanisms 
based inhibitors of serine O-lactamases, but are inactivated by metal chelating 
agents such as EDTAý6 . The catalytic properties of some well characterised class B 
34 O-lactamases have been reviewed by Felici et aL 
For many years the only bacterium known to produce zinc P-lactamases was the 
non pathogenic species Bacillus cereusý 
1,39,40 
and! this. enzyme was therefore 
considered to be clinically unimportant. Later, these metallo-enzymes were found 
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to be produced by at least ten different bacteria", some of which are common 
clinical pathogenS36 responsible for nosocomial infections (e. g. Aeromonas 
hydrophild, Pseudomonas mallophilia (LI )37 , Bacteroidesftagilis). The clinical 
importance of these enzymes has now been re-evaluated, especially since mediated 
dissemination of a metaflo-o-lactamase plasmid gene has been observed 36 . 
Furthermore there are no clinically useful inhibitors avaflable. 
1.5.1 Class B Bacillus cereus P-lactamase 
The first metallo-o-lactamase to be identified was from Bacillus cereus3s. Crude 
extracellular extracts from B. cereus displayed penicillinase and cephalosporinase 
activities, the latter being lost on purification or after exposure to EDTA and other 
metal chelating agents. The activity was found to be restored upon addition of zinc 
sulfate *to the preparation 38 . Purification and fractionation by precipitation yielded 
two crystalline enzymes, P-lactarnase-I and P-lactamase II, with penicillinase and 
cephalosporinase activities respectivelý". The tenn cephalosporinase did not 
reflect the true nature of the substrate profile of this enzyme and was replaced by 
the description P-lactamase II by Kuwabara el aL'9. 
P-Lactamase II was found to be zinc dependent, heat stable and to have a wider 
range of activity than most of the P-lactamases previously described 38. The 
suggestion that the zinc was bound to the apoenzyme by one or more thiol groups 
was reported after it was found that several thiol reagents on D-lactamase 11 
inhibited the zinc activation of the enzym e40,41 . The presence of the sole cysteine 
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residue in P-lactamase II was described by Davies el al. 
42, 
who also determined the 
molecular weight of the molecule to be 22 kDa. 
The substitution of the zinc ion in P-lactamase II by other bivalent metal ions such 
as Co', Cd 2+, W+ gives metal-enzyme complexes which exhibit significant 0- 
lactarnase activity, the zinc enzyme being the most active, whilst Hg2+ and Ctý+ 
inactivate the enzyme'. Equilibrium dialysis and kinetic studieel indicated that the 
enzyme could bind two zinc ions, with the second zinc binding site being of lower 
affinity. 
Studies by 1H NMR spectroscopy and differential tritium exchange followed by 
tryptic digestion of the enzyme, revealed at least 5 histidine residues in the 
proteiný"44. Three of these histidines were found to serve as ligands to the zinc ion 
at the first site, occupation of which is essential for activity (dissociation constant 
about I VM), a fourth histidine is thought to act as a ligand for the second binding 
site (dissociation constant about 24 nNl)43,44 
Elucidation of the amino acid sequence of P-lactarnase II, showed that the enzyme 
consists of a simple polypeptide chain of 227. amino acids, with a molecular mass of 
25 kDa45, '6, " and not 22 kDa as previously reported 42 . The residues involved in the 
active site were found to be His86,, I-lis88 and lEs2lO, and the only cysteine 
residue to be located at the position 168. These results were in agreement with 
DNA sequencing experimente. 
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In a further investigationý9 using chemical modifications (inactivation of 0- 
lactamase II by water soluble carbodiimide in the presence of nucleophiles), it was 
suggested that the enzyme may contain an essential carboxylic acid involved in the 
catalytic mechanism, Glu37. The mechanism of action was thought to involve 
Glu37 acting as a general base deprotonating a water molecule, which would then 
attack the P-lactam ring. A pH dependence study of k.,,, /K. for the hydrolysis of 
benzylpenicillin by the C02+ P-lactamase 11 revealed two pK, values of 5.5 and 
9.050. These findings supported previous results from NMR studies of zinc 0- 
lactamase43. It was suggested later, that the pK. of 5.5 could be attributed to the 
zinc bound water, which could be acting as a nucleophilic group". 
This postulated mechanism was thought to be consistent with the data obtained 
from cryoenzymology studies and by rapid-scanning stopped flow techniques of the 
Co2' P-lactamase catalysed hydrolysis of substrates", which showed that catalysis 
proceeded by a branched Idnetic pathway with formation of non covalent enzyme- 
substrate complexes. The metal ion was found to be directly involved in catalysis. 
The mechanism of the non-enzyme catalysed hydrolysis of benzylpenicillin was 
studied by Page et aL 52,53,54 , where the metal ion was found to initially bind to the 
carboxylate group and the P-lactam nitrogen, stabilising the tetrahedral 
intermediate and enhancing the rate of C-N cleavage. However, direct co- 
ordination of the P-lactarn carbonyl oxygen to the metal ion was reported to be 
kinetically significant in the enzyme catalysed reactions'. 
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From X-ray-crystallographic studieS56 of Cd 2+ P-lactamase at 0.35 nm resolution, it 
was accepted that Glu37 was too far from the catalytic site to play the role 
proposed by Little el al . 
49 and it was suggested that Glu2l2, which was much 
closer, could be involved. Two other amino acids with carboxylic acid side chains 
were found to lie near the active site, AspS I and Asp90. It was later proved, by 
oligonucleotide mutagenesis that neither Glu37 nor Glu2l2 were essential for 
enzyme activity' 7, and site-directed mutagenesis studies" of Asp8l and Asp90 
strongly suggested that Asp90 plays an important role in catalysis, and could 
possibly act as a general base in the'hydrolytic mechanism. By analogy with 
59 - metallo-peptidase such as carboxypeptidase A, it was proposed that the 
mechanism of action involved the zinc bound water acting as a nucleophile, 
attacking the carbonyl group of the D-lactarn ring, with Asp90 acting as the general 
base deprotonating the water with subsequent donation of the proton to the 
nitrogen of the ring to cause cleavage (Figure 1.7). 
19 
Introduction 
N f --) I\ 
0 .0 
2+ 0 0 
H Asp 90 
NH, 
J-)D- 
2+ HOrO 
Asp 90 
Figure 1.7 Proposed mechanism of action of P-lactamase H" 
The 3-D structure of P-lactamase II was investigated by X-ray crystallography at 
2.5 MO resolution (300 K) and later at 1.85 M1 (100 K). 
9 0-1 
-. 
If 
0' '-Asp 90 
20 
Infroduclion 
Figure 1.8 Ribbon diagram of the molecular structure of P-lactamase 1162 
P-Lactamase 11 Is a0 sandwich structure (ccPO(x protein) with helices on each 
external face which represents a novel type of folding (Figure 1.8). The dimensions 
of the molecule are about 32 x 30 x 28 A. Two tightly packed O-sheets are 
encircled by five a-helices and the active site is located at the top of the structure 
between the two O-sheets. Four ligands (His86, His88, His149 and a water 
molecule or a hydroxyl ion) are bound to the zinc which displays a tetrahedral 
shape (Figure 1.9). 
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Figure 1.9 Schematic view of the metal site of P-lactamase 1163 
During the course of this work, it was reported that, at 100 W1, a second zinc lies 
at 3.74 A from the first zinc and is coordinated by lEs2 10, Asp90 and Cys 168. A 
carbonate ion seems to bind to the second zinc as a bidentate ligand making the 
geometry square bipyramidal. The binding of the second zinc which was not 
observed at room temperature was probably favoured at low temperatures6l. 
Comparisons between the zinc containing holoenzyme and the apoprotein (zinc- 
free enzyme) illustrate that in addition to its catalytic role the metal ion has a 
structural role'o. 
Also in this work, Orellano el al. 63 confinned that P-lactarnase II binds two zinc 
ions. The enzyme is fully active with one zinc, however they claimed that its 
activity is more efficient upon binding of the second zinc after studies of the 
dependence of the activity on the metal concentration. They suggest a mechanism 
of action similar to the mechanism, described later, of the Bacteroides ftagifis 
binuclear zinc P-lactamase, where the zincl-bound water acts as a nucleophile 
whilst the proton donor is another water molecule bound to zinc2. 
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Considering the ambiguity and the uncertainty surrounding the mechanism of 
action of this enzyme, further investigations are required-in order to more fully 
understand the catalytic mechanism which will assist in the design of effective 
inhibitors. 
1.5.2 Examples of other class B P-lactamases 
In addition to Bacillus cereus P-lactwnase II, class B P-lactarnases have been 
found to be produced by at least nine- other bacterial mrcesý5: Aeromonas 
hydrophila; Bacteroides ftagilis; Bacillus ficheniformis; Flavobacterium 
odoratum; Legionella gormaii; Pseudomonas aeruginosa; Pseudomonas cepacia; 
Serratia marcescens and Xanthomonas maltophilia, some of which are infectious 
to humans6. 
Although all class B P-lactamases ý share some significant - similarities in ý their 
sequences, they display structural differences which lead to different enzymological 
propertiesý'. 
Class B O-lactamases from' Bacteroidesftagilis and Aeromonas hydrophild are 
described below in order to compare their structural and catalytic properties with 
those of Bacillus cereus 0-lactamase II., 
1.5.2.1 Bacteroidesftagilis metallo-p-lacimnases 
Bacteroides ftagilis is" considered to be one of the most serious human 
pathogens6s. In 1986 Cuchural et al . 
65 isolated a zinc-p-lactamase ft e orn, two 
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Bacteroidesftagifis strains. This enzyme is responsible for the resistance of these 
bacteria to a wide variety of P-lactams including imipenern (a carbapenern) and 
cefoxitin (a cephamycin). This enzyme is inactivated by EDTA and other metal 
chelating agents and the activity is restored by addition of zinc ions. It is 
established that metallo-P-lactamases from this species are the most potent and 
display very large values of kt and kt/K. against a large number of substrateS34'66 . 
The primary sequence of Bacteroidesftagifis zinc-p-lactamase is quite similar to 
P-lactamase II from Bacillus cereus; however, the overall an-dno, acid identity is 
o/67 about 32 Co , with the most conserved sequence being the residues surrounding 
the zinc binding sites such as the three histidines and the cysteine residue". 
B. ftagilis metallo-P-lactamase tightly binds two zinc ions per molecule. They are 
both required in catalysis for maximum actiVitY69 . The dissociation constants of 
both metal binding site are thought to be lower than 10 [M. 
A recent X-ray crystallographic study of the crystal structure of the enzyme at 
1.85 A resolution7o revealed a four layer ctopa molecule, as observed for 
B. cereus P-lactamase II, with a binuclear zinc site situated at the edge of the 
00 sandwich. The first zinc ion which corresponds to the high affinity zinc site in 
B. cereus P-lactamase II is bound to four ligands (His99, Hisl0l, lEs162, Waterl) 
and displays a tetrahedral geometry. The second zinc ion located at 3.5 A from the 
first one, has atrigonal bipyramidal geometry and is bound to Asp103, Cysl8l, 
His223 and two molecules of water (Waterl, Water2) (Figure 1.10). The metal 
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coordination was corroborated by studies of the crystal structures of a Cd 
2+ bound 
enzyme and a Hg2+_soaked zinc-containing enzyme". The two zinc ions are 
thought to share Waterl, probably as a hydroxide ion, whose binding is modulated 
by its interaction with an aspartate (Asp103). 
Cysl8l 
162 
I-fis233 
Asp103 
ol z 
Water2 
Water 
IESIOI 
iqQQ 
Figure 1.10 Schematic view of the metal sites of Rfragifis metallo-p- 
lactamase63 
It has been suggested that the catalytic mechanism involves the shared hydroxide 
ion acting as a nucleophile attacýing the 
'carbonyl 
of the P-lactarn, ring while 
Water2 could supply a proton to the nitrogen of the cleaved P-lactaM63,71. 
However, recent studies on the orthorhombic crystal structure of the B. ftagilis 
metallo-P-lactamase reported by Carfi ef aL 7Z73 at 2.0 A resolution indicate that 
zincl is b ound to His82, His84,, Flis145 and zinc2 to Asp86, Cys164, His206 and 
one water molecule. The shared hydroxide is not found, but the difference between 
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these findings and the structure proposed by Concha et al . 
70 could come from 
different crystallisation conditions. 
1.5.2.2 A eromonas hydrophila metaII6-p-lactamases. 
As early as 1970, it was found that members of the genus Aeromonas (a Gram- 
negative bacteria), were able to produce up to three different P-lactamaseS74 . These 
bacteria are responsible for a range of infections of varying clinical severity in both 
adults and children 74 - Among the O-lactamases isolated form these strains 
is a class 
C cephalosporinase, a class D penicillinase and a class B P-lactamase, which are all 
chromosomally encoded. The production of these enzymes is usually inducible'4 
Aeromonas metallo-P-lactamase, unlike the other class B P-lactamases, displays a 
relatively specific substrate profile. It shows a poor activity against some penicillins 
and cephalosporins and behaves as a relatively specific carbapenemase 34 , with only 
two good substrates imipenern (a carbapenem) and ampicillin (a penicillin). 
A. hydrophila metallo-p-lactamase shows a significant degree of similarity with the 
other P-lactamases in some regions of its sequence. There are a least five regions 
of homology, three of them involving the ligand binding residues. From a molecular 
point of view this enzyme seems to be quite different from B. cereus and 
Bacteroidesftagilis metao-o-lactamases. Massida et al . 
75 suggest the presence of 
at least 2 distinct molecular subclasses within class B P-lactamase. 
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A. hydrophild metallo-p-lactarnase seems to be fully active with only one zinc ion 
per enzyme. Zinc concentration dependence studieS76 of this enzyme have shown 
that the enzyme binds a first zinc very tightly and that the binding of a second zinc 
noncompetitively inhibits the enzyme with a Ki of 46 pM at pH 6.5. The zinc ion is 
bound to three ligands, two histidine and one asparagine. Unlike the B. cereus and 
the B. ftagilis metaflo-o-lactamases, the first histidine is replaced by an asparagine 
and this difference could explain the rather specific substrate profile of these 
enzyme 
24. 
1.6 Zinc-metallo-proteases. -ý_ 
Class B P-lactarnases are members of the group of hydrolytic metallo-enzyme 
j77,78 
which includes carboxypeptidase Aý9 (CPA) and the angiotensin converting enzyme 
(ACE). 
Carboxypeptidase A was the first metallo-enzyme for which the high resolution 
structure and sequence were obtained79 and is also one of the most extensively 
studied, thus serving as a prototype for zinc-peptidases. CPA is a zinc digestive 
protease which is produced by fish and mammalian pancreas and catalyses the 
hydrolysis of C-terminal amino acid residues from peptides and proteins, with a 
preference for hydrophobic side chains such as phenylalanine. It also catalyses the 
hydrolysis of similarly configured esters. 
CPA is a mononuclear zinc enzyme, with a molecular weight of 34472 Da, 
composed of 307 arnmo acids". The zinc ion is bound to three ammo acids 
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residues (His69, Glu72, I-lisI96) and a water molecule79"O's'. The other important 
anýno acids present in the active site are Glu270, Tyr248 and Arg145, which are 
hydrogen bonded to the zinc bound water. 
Although extensively studied, the catalytic mechanism of CPA remains ambiguous, 
and different pathways have been proposed: 
Early works-"', " on the mechanism of action of the enzyme involved a 
nucleophilic pathway with Glu270 acting as nucleophile fonning an anhydride with 
the carbonyl of the scissile peptide bond (Figure 1.11 (1)). Although no covalent 
acylenzyme intermediate was detected by methanolysis experiments$3 and 
cryokinetics studieS84 , recent studies on the catalytic 
hydrolysis of specific ester 
substrates'5,86 and resolution of reaction intermediates by different spectroscopic 
techniqueSI7,89 , support the possibility of the anhydride pathway. 
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Figure 1.11 Proposed mechanisms of action of carboxypeptidase A86 
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Another proposed mechanism involves Glu270 acting as a general base9 and is 
thought to proceed through Glu270 assisting the attack of an external water 
molecule (Figure 1.11 (2)) or, more plausibly, a zinc bound water On both peptide 
and ester substrates? 0. Peptides and esters may be hydrolysed through different 
mechanisms, forming distinct metallo-intennediates", 9'. X-ray structural studies of 
enzyme-substrate and enzyme-inhibitor complexe? 2, '9 support the zinc bound 
water pathway. Figure 1.12 shows the catalytic pathway based on the mechanism 
proposed by Christianson et aV9. The zinc bound water molecule, assisted by 
Glu270 acting as a general base, attacks the substrate carbonyl, thereby fonning a 
tetrahedral intermediate. Glu270 donates a proton back to the nitrogen causing C- 
N bond fission and collapse of the intemediate. However, it is worth noting that 
the conversion of the tetrahedral intermediate to the products shown requires at 
least two proton transfer steps. 
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Figure 1.12 Zinc-bound water pathway in carboxypeptidase A mechanism 
At present it appears that both proposed mechanisms of catalysis are plausible and 
recent 'molecular dynamic simulations9' of the CPA-substrate complex do not rule 
out either. 
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1.7 Role of zinc ion in metallo-enzymes 
Zinc is a II B element, with a complete d-shell and two additional 4s electrons and 
therefore readily loses two electrons and chemically combines in the +2 oxidation 
state? '. Zinc is an essential ion for many metallo-enzymes being required for 
catalytic activity, as well as having a structural role in certain protein?. Although 
replaceable by other metal ions, the zinc-enzyme complex is usually the most 
efficient. The importance of zinc ion in catalysis by O-lactamase 11 has long been 
recognised4o, and, in addition to its catalytic role, its structural role has also been 
reported 
60 
.4 
The zinc ion in mono-nuclear metallo-enzymes is most often coordinated to three 
amino acid residues and a water molecule'. A I-Es residue is the most frequent 
ligand, although Glu, Asp, or Cys residues are also found coordinated to zinc. 
Good models, such as zinc complexes of macrocyclic polyamines, are available to 
probe the role of the zinc ion in metallo-enzymes96,97. Studies of these models 
suggest that the major role of the zinc ion is to act as a Lewis acid, which is also 
reflected by the effect of the zinc-complex on the pl-C. value of the water ligand. 
It is known that the pK. of the zinc-bound water is detennined by the electronic 
properties of the metal complex as a whole and by the electrostatic contributions 
from nearby residues98,99,10'. From studies on mutated binding sites in CA II 
(carbonic anhydrase II found in the red blood cells) the three histidine residues 
were found to be responsible for the electrostatic stabilization of the zinc- 
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hydroxide and the negatively charged transition state. These results highlight the 
importance of these neutrally charged ligands in. maintaining the low zinc-water 
pK. "'. The principal role proposed for the zinc complex of the carbonic anhydrase 
metallo-enzyme is the electrostatic stabilisation of the negatively charged transition 
state, which is a dominant factor for catalysis. The zinc complex is also responsible 
for the lowering of the pYC. of its bound water, thereby supplying a nucleophilic 
hydroxide ion for catalysis at neutral pH 102 . 
It is proposed that the zinc ion in metallo-enzymes is involved in coordinating the 
nucleophilic water molecule at the'active site, correctly positioning it for attack at 
the carbonyl function of the substrate and increasing its nucleophilicity by lowering 
its pK. 
63 , 77M 
. Reciprocally the low pK. of the zinc bound water in metallo-enzyme 
is a good indication of the Lewis acidity of the zinc ior?, 103 . The substrate could 
bind directly to the metal ion, which would polarize the substrate without 
displacing the metal bound water resulting in a pentacoordinate intermediate'. 
Model studies of zinc complexes? ""' have shown that most zinc-bound hydroxide 
species have an efficient nucleophilicity independent of the coordination number of 
the zinc and of the nature of the other ligands. However, although a decrease in the 
pK. of the zinc-bound water makes zinc-bound hydroxide available at lower pH it 
also reduces its nucleophilicity compared with the hydroxide anion. By definition, a 
lower pY., acid produces a weaker conjugate base and, usually, a weaker 
nucleophile. Hydroxide-ion bound to zinc is not a powerful nucleophile. 
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Similar to carbonic anhydrase, the zinc ion in P-lactamase II is coordinated to three 
histidine residues and a water molecule. The role of zinc in P-lactamase II is 
thought to involve the suPply of a hydroxide ion for nucleophilic attack on the 
carbonyl of the P-lactam ring, and the subsequent stabilisation of the tetrahedral 
intermediate (TI) formed (Scheme 1-1). 
6H 
k, ' k2 
k., 
H' . 10 
/I... %. 
Scheme 1-1 ' 
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1.8 Zinc-metallo-protease inhibition 
1.8.1 Metallo-protease inhibitors , 
The prototypic carboxypeptidase A has been extensively used as a model for the 
105 
study of metallo-enzyme inhibition . 
Compounds such as phosphonates have been reported to be effective inhibitors of 
CPA106,107 
. with the CBz-Phe-Vaf-(O)-Phe-enzyme complex displaying one of the 
strongest interactions with a Ki of II fM. This appears to be one of the lowest 
values ever measured for a Ki. These phosphonates are thought to act as transition 
state analogues of the general base mechanism of catalysis of CPA. 
Other compounds such'as 2-benzyl-3,4-epoxybutanoic acid"s arg-. known to 
inactivate the enzyme by reaction of Glu270 with the epoxide, forming a covalent 
adduct. The importance of the stereochemistry of this compound in the inhibition 
mechanism of this enzyme (and particularly for the development of effective 
inhibitors) has been highlighted". 
Thiols have been reported to be good inhibitors of zinc metallo-proteases: Dithiols 
such as dithiotriatol inhibit efficiently the VanX enzyme which is a metallo D, D- 
dipeptidase responsible for the resistance of the bacterium Enterococcusfaecium 
to vancomycin'09. Furthermore, carboxypeptidase A is competitively inactivated by 
compounds such as (S)-2-mircapto-2-benzylpropanOic acid"O 
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Captopril is one of the first orally effective hypotensive agents and is specially 
designed to inhibit the angiotensin converting enzyme (ACE), a zinc 
metalloprotease involved in the production of angiotensin 11, a vasoconstricting 
agent"'. This thiol compound is active site directed, zinc coordinating and with a 
subnanomolar Ki value. Many other inhibitors have been synthesised on the basis of 
12,113 the captopril structure and its interaction with the zinc active site of ACE' 
CH3 1 11 
HS"', N 
0 coi, 
Captopril 
The design of compounds which have a thiol (mercaptan) moiety as a zinc-binding 
ligand has proved to be an effective way to synthesise potent inhibitors of metallo- 
enzymes. 
1.8.2 Zinc-p-lactamase inhibitors 
One approach to the problem of resistant bacterial strains has been the 
development of P-lactamase* inhibitors. No clinically useful inhibitors of these 
enzymes have been found yet, although they can be inhibited by metal chelating 
agents such as EDTA, and also by some mercurial compounds3'. 0 
When the work reported in this thesis was started there were very few known 
inhibitors but over the past few years, the synthesis of several potential zinc-D- 
lactamase inhibitors have been reported : 
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Van Hove el al. 114 report the synthesis of compounds A and B (Figure 1.13) which 
displayed weak inhibitory action of metallo-P-lactamases. 
H%C"O"ý 
0 
Q091 
H02C"ýýN"'-ýý 
s 
I YL, ý< 
10 (B) 
Figure 1.13 
These compounds lead to a small inactivation of the P-lactamase II, which could be 
immediately restored upon addition of zinc sulfate to the system inhibited by (A). 
Trifluoromethyl alcohols and ketones 
- 
(Figure, J. 14) were reported tol,, have an 
inhibitory action on several metallo- P-lactamases with Ki varying from 3 00 to 1000 
VM for (C) and from 30 to 1000 pM for (D) depending on the side chain R and the 
stereochemistry"', "'. Earlier studies on trifluoromethyl ketones' 17 described their 
interaction with carboxypeptidase A, where the compounds bind to the enzyme as 
a gem-diol, with one of the hydroxyl groups being coordinated to the zinc ion. 
i 
Figure 1.14 
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Payne craL 11' report the progressive and irreversible inhibition - of metallo-0- 
lactamase from several bacterial strains by some mercaptoacetic acid thiol ester 
derivatives. The mechanism of inhibition is thought to be due to the hydrolysis by 
the enzyme of the inhibitor, subsequently releasing the mercaptoacetic acid 
component, which then forms a disulfide bound with Cys168 of the second zinc 
active site under the conditions of the assay. The study of the different range of 
potencies of these compounds against 'diffeient metallo-o-lactamases indicates 
some differences between their active sites. 
Later, Goto el al. "9 confirmed the effectiveness of low molecular weight thiols 
such as mercaptoethanol, mercaptoacetic acid and ethylmercaptoacetate as 
reversible inhibitors of the binuclear zinc-p-lactamase from Serrafia marcescens. 
Recently, biphenyl tetrazoles (BPTs) were found to be, potent non-peptide 
inhibitors of B. firagilis metallo-o-lactamases 120 , where the tetrazole group of the 
compound is thought to interact directly with one of the two zinc ions of the 
enzyme. The inhibitory action is increased by using appropriate substituents on the 
molecule. 
1.9 Research aims 
As previously reported, the metallo-P-lactamases show little or no susceptibility to 
traditional P-lactamase inhibitors such as clavulanic acid and sulbactam. At present, 
no clinically useful inhibitor is known. None of the compounds described above act 
as inhibitors of all known metallo-P-lactamases. The specific inhibition observed 
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for enzymes from different strains highlights the structural heterogeneity of these 
enzymes. 
Although great advances have been made in the understanding of metallo-enzyme 
catalysis, some areas remain unclear. 
It is therefore important to characterise the mechanism of action of these enzymes. 
The aim of this work is to contribute to a more detailed knowledge of the kinetics 
and mechanism of catalysis of metallo-p-lactamase in general through the study of 
the kinetic parameters and inhibition of the Bacillus cereus P-lactamase II. This 
thesis discusses the pH dependence and kinetic solvent-isotope effects, as well as 
the effect of the zinc concentration on the enzyme catalysis. 
AL, seen previously, thiols tend to be good inhibitors of metallo-enzymes through 'L. 1 
coordination of the sulfur to the zinc ion. Herein is reported the synthesis of thiols 
as potential inhibitors, acting as analogues of the tetrahedral intermediate formed 
during the hydrolysis of the substrate, and the study of the kinetics and mechanisms 
of inhibition. These compounds are related to the primary penicillin type structure 
with suitable modifications to make them bind strongly to the zinc active site. 
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2. 'Experimental 
2.1 Synthesis 
All solvents and reagents were used as obtained from commercial sources unless 
otherwise stated. 
'H and 13 C NTýR were recorded at 270 MHz on a Bruker AC-270 spectrometer. 
The chernical shifts (SH) are quoted in p. p. m. and referenced to TMS. The 
abbreviation used are s: singlet, d: doublet, t: triplet, dd : doublet of doublet, dt : 
doublet of triplet, m: multiplet. The coupling constants are given in Hertz. 
Infiared spectra were obtained on a Perkin Elmer 1600 Series FTK as nujol mulls 
or chloroform solutions. The absorptions are given in wavenumbers (cm7 1). 
The melting points are not corrected and were recorded on a Gallenkamp melting 
point apparatus. 
The mass spectra were recorded on a VG (Fisons Instruments) Quattro, (II) SQ 
mass spectrometer. Only the mass to charge ratio of the molecular ion is reported. 
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2 LI Synthesis ofN(2-mercaptoethyl)phenylacetamide (1) 
PhCH2CONH 
(1) 
HS) 
Phenylacetyl chlori I de (5.5 mmoles) was added dropwise to a solution of cystarnine 
(2.5 mmoles) in water (40 ml) containing sodium hydroxide (11.25 mmoles) and 
was cooled to 0 *C. The mixture was vigorously stirred. At the end of the reaction, 
the white precipitate formed was filtered and washed with water. The solid was 
recrystallised from hot methanol. The reaction was followed by TLC in 
chloroform/methanot/ammonia system (10: 12: 1, by vol). The disulfide thus 
obtained was reduced by adding sodium borohydride (88 mmoles) to a solution of 
the disulfide (4.4 mmoles) in ethanol/water (5: 3, v/v). The mixture was heated to 
90 T and stirred for I hour. The reaction was stopped by cooling the mixture 
which was then acidified to pH 2 with dilute hydrochloric acid. After evaporation 
of the ithanol, the product was separated by filtration, the filtrate was extracted 
with chloroform to obtain the remaining thiol. The combined extract were washed 
with water and dried over anhydrous sodium sulfate. The solvent was removed by 
rotary evaporation to give a white product. The total yield was 87 The reaction 
was followed by TLC in chloroform/methanol system (99: 1, v/v). After exposure 
of the TLC plates to iodine vapour, the thiol appeared as a white spot on a tanned 
background. 
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'H-NMR 81, (CDC13) 7.30 (5 H, m, Ar-H), 5.75 (1 H, m, NH), 3.55 (2 H, s, 
CH2- 
Ar), 3.35 (2 H, CHA 2.52 (2 H, dt, J 6.6 and 8.5, CH2-S)3.1.18 (I H, t, J 8.5, 
SH). 
IR (Nujol) v.. 3253 (amide NH), - 2544 
(SH), 1637 cm7' (amide CO) 
mp 40-44 *C: literature value 50-52 *C 
A pY.. "of 9.5 0.10 of the thiol wasýdete'muned frorn'the' dependence of the 
absorbance of an aqueous 2.52 x 10-4 M solution at 238 nm as a function of pl-L as 
shown below. 
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Z 1.2 Syn th esis of N-ph enylacetylglycin e (2) 
PhCH2CONH 
(2) 
010H 
Phenylacetyl chloride (10.8 mmoles) was added dropwise to a solution of glycine 
(8.9 mmoles) in water (40 n-J) containing sodium hydroxide (45 mmoles) and was 
cooled to 0 'C. The mixture was vigorously shaken. The solution was subsequently 
acidified with, dilute hydrochloric acid (acid to congo red) and the product 
separated as white crystals which were filtered, washed with water, and dried 
under vacuum. The total yield was 67 %. 
'H-NMR 8H (DMSO) 8.39 (1 H, t, J 5.8, NH ), 7.26 (5 H, m, Ar-H), 3.77 (2 H, d, 
aCH2 Gly, J 5.8), 3.48 (2 H, s, CH2-Ar). 
13 C-NMR Sc (DMSO) 168.8 (COOH), 168.1 (CONH), 133.62 126.67 125.7v 123.9 
(C6H5), 39.5 (CH2-Ar),, 38.3 (ccCH2GIy). 
LR (nujol) v. 3373 (amide NH), 1727 (COOH), 1609 wý1 (amide CO), 
mp 120-122 T 
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Z1.3 Synthesis ofN-phenylacetyl-L-cysteine(3) 
PhCH2CONH-' C02H 
(3) 
HS 
Phenylacetyl chloride (13 mmoles) was added dropwise to a solution of cystine 
(5.9 mmoles) in water (60 H) containing sodium hydroxide (30 mmoles) and was 
cooled to- 0 T. The mixture was vigoroýisly stirred. After the end of the reaction, 
the solution was acidified with dilute hydrochloric acid (acid to congo red) and the 
disulfide product separated as a white precipitate which was filtered and then dried. 
Yield 80 
'H-NMR Sli (DMSO) 8.54 (1 H, d, J 7.9, NH (cys)2), 7.26 (5 H, M, Ar-H), 4.50 
(I I-L rn, aCH (cys)2). 3.50 (2 I-L s, CHrAr), 3.16 and 2.95 (2 I-L m, PCH2 (CYS)2 J 
4.6, J 9.5, J 13.6). 
13 C-N? dR Sc (DMSO) 171.87 (COOH), 170.25 (CONH), 136.0,129.0,128.1s 
126.3 (C(, H5), 51.3 (aCH (cys)2), 41.9 (CH2-Ar), 40.3 (OCH2 (CYS)2)- 
IR (Nujol) v. 3319 (amide NH), 1720 (COOH), 1660 enf 1 (anüde CO) 
ES MS [M-11]': m/z 475 
The disulfide was then reduced by adding sodium borohydride (100 mmoles) to a 
solution of the disulficle (5 mmoles) in ethanol/water (5: 3, v/v). The mixture was 
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heated to 90 T, and stirred for I hour. The reaction was stopped by cooling the 
mixture which was then acidified to pH 2 with dilute hydrochloric acid. After 
evaporation of the ethanol, the aqueous solution was extracted with ethyl acetate 
(3 x 30 n-d). The combined extracts were washed with water and dried over 
anhydrous sodium sulfate. The solvent was removed on a rotary evaporator to give 
an oil which solidified. Yield 90 
I 
'H-NMR 511 (DMSO) 8.47 (1 H, d, J 7.8, NH cys), 7.25 (5 H, m, Ar-H), -4.40 
(I H, m, aCH cys), 3.53 (2 11, s, CH2-Ar), 2.82 (2 I-L rn, OCH2 cys), 2.45 (1 I-L 
SH). 
13 C-NMR 8c (DMSO) 171.6 (COOH), 170.4 (CONH), 13 6.39129.1 v 128.21,126.4 
(C6Hs), 54.5 (ctCH cys),, 41.9 (CHrAr), 25.7 (OCH2cys). 
IR (nujol) v. 3342 (amide NH), 2550 (SH), 1731 (COOH), 1623 ctif' (amide 
CO) 
ES MS [M-H]': m/z 238 
II. 
mp 85-88 T, 
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21.4 Synthesis ofN-phenylacetyl-DL-penicillamine (4) 
PhCH2CONH C02H 
(4) 
HS) 
CH3 
CH3 
Phenylacetyl chloride (0.98 mmoles) was added dropwise to a solution of 
penicillarnine (6.7 mmoles) in water (50 n-d) containing sodium hydroxide 
(33 mmoles) and was cooled to 0 T. The n-dxture was vigorously stirred. The 
solution was subsequently acidified with dilute hydrochloric acid (acid to congo 
red) and the product separated as a white precipitate, which was filtered, washed 
with water and dried under vacuum. Yield 42 %. 
'H-NMR ýH (DMSOj 8.34 (1 H, d, 'NH, J 9.2), 7.3'2'(5 H, m, Ar-H), 4.44 (1 H 
aCH), 3.58 (2 IL dd, CH2-Ar, JAB 13.8), 2.86 (1 H, s, SH) an'd 1.38 and 1.36 
(6 I-L 2 s, yCH3),, 
SSS 
13 C-NMR 8c (DMSO) 171.2 (COOH), 170.3 (CONH), 136.3,129. OP 128.1,126.3 
(C6H5), 61.3 (aCH), 45.5 (PC), 41.8 (CH2-Ar), and 29.7,29.6 (yCH3) - 
IR (nujol) v. 3365 (amide NH), 2571 (SH), 1728 (COOH), '1635 cfffl (amide 
CO) 
ES MS [M-H]'n-dz 266 
mp 118-120 T 
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ZI. 5 Synthesis ofN-carbobenzoxy-L-and-D-cysteine (5) 
PhCH20CONH C02H 
HS 
N, N'-Dicarbobenzoxy-cystine (Z-cystine) was synthesised according to the method 
121 
of Du Vigneaud et Nüller . 
Cystine (0.0125 moles) was dissolved in a solution of sodium hydroxide (25 ml, 
I M) and stirred at 0 T. Carbobenzoxychloride (0.0375 moles) along with sodium 
hydroxide (50 ml, 2 M) were add6d in' 10 'portions' 6ring the course of 
30 minutes. Stirring was continued for I hour after the addition of all the reactants. 
The mixture was allowed to warm to room temperature, washed twice with ether 
(30 a), and then was immediately, acidified with 6M hydrochloric acid. The 
insoluble precipitate was 
-filtered 
and the filtrate then extracted four times with 
ethyl acetate (30 H). The precipitate was dissolved ip ethyl acetate with the help of 
heat and combined with the ethyl acetate extracts. The solution was then, washed 
twice with 5% hydrochloric acid (50 n-fl) and twice withwater (50 n-d). It was then 
dried with anhydrous sodium sulfate and conceptrated, under reduced pressure. The 
oily residue was crystallised in chloroformto give a white compound. Yield 50 %. 
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Z-Cystine 
'H-NMR 5,1 (DMSO) 7.77 (1 H, d, NH, 8.4), 7.3 5 (5 H, m, Ar-H), 5.07 (2 H, 
CH2-0), 4.36 (I H, m, aCH), 3.20 and 2.97 (2H, m, PCH2J4.1, JIO. I, J13.7) 
13 C-NMR Sc (DMSO) 172.3 (COOH), 156.2 (OCONH), 136.9,128.4p 128.1.11, 
127.9 (CýHs), 65.7 (CH2-0),. 53.1 (aCH), 39.6 (DCH2), ý 
IR (nujol) v. , 3329 (anÜde NH), 1730 
(COOH), 1655 cnfl (amide CO) 
ES MS [M-Ifl'rn/z 509 
The disulfide is reduced using sodium borohydride according to the method of 
D'An&o'22. 
Z-cystine (2.18 mmoles) was dissolved in 20 ml of ethanol. To this solution at 67- 
70 T was added dropwise a solution containing 4 equivalents of sodium 
borohydride (8.74 mmoles) in 10 ml of ethanol. The stirred reaction mixture was 
heated at 75 - 80 T for one hour. After cooling to 25 OC, the solution was added 
to 50 nil of iced water. To this stirred solution, 6M hydrochloric acid was added 
dropwise at 0- 10 T until pH 3 was obtained. After evaporating under reduced 
pressure to remove the ethanol, the solution was extracted three times into ethyl 
acetate (20 ml), washed three times with distilled water and dried over anhydrous 
sodium sulfate. After removing the solvent under reduced pressure, 1 .0g of 
colourless oil was obtained. Yield 90 %. 
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Z-Cysteine 
'H-NMR 8H (DMSO) 7.64 (1 H, d, NH, J 7.9), 7.36 (5 H, m, Ar-H),, 5.08 (2 H, 
CH2-0), 4.14 (1 H, m, aCH), 2.91 and 2.75 (2 H, m, PCHA and 2.51 (1 H, m, 
SH) 
13 C-NMR Sc ZDMSO) 172.3 (COOH), 156.2 (OCONH), 136.9,128.5,127.9.1, 
127.8 (C6H5), 65.7 (CH2-0), 56.6 (ccCH), 25.6 (OCH2) 
IR (nujol) v. 3327 (amide NH), 2571 (SH), 1719 (COOH), 1640 cin7l (amide 
CO) 
ES MS [Nl-H]'m/z 254, 
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ZI. 6 Synthesis ofN-carbobenzoxy-L-cysteinyt-glycine (6) 
Synthesis of N-carbobenzoxy-DL-cysteinyl-glycine 
0 
PhCH20CONH 
(6) HN-\ IH 
HS C02H 
All N-carbobenzoxy-cysteinyl-anfino acids were synthesised using the saine 
procedure, which is based on the method of Vanderhaeghe and Adriaens23. Details 
are given below, but subsequently only the analytical data are reported. 
The compounds'. names are abbreviated according to the following model: 
(Z-Cys-GlyOMe)2for NN'-dicarbobenzoxy-cystinyl-glycine methyl ester 
(Z-Cys-GlyOH)2 for NN'-dicarbobenzoxy-cystinyl-glycine 
Z-Cys-GlyOH for N-carbobenzoxy-cysteinyl- ycine 
A solution of NN'-dicarbobenzoxycystine (6 mmoles) in dichloromethane (50 ml), 
cooled to 0 T, was treated with dicyclohexylcarbodiiinide (12 mmoles), a solution 
of triethylamine (12 mmoles) aild glycine methylester hydrochloride (12.6 mmoles) 
in dichloromethane (50 ml). The mixture was stirred at 0T for I hour and then for 
24 hours at room temperature. The precipitated dicyclohexylurea was filtered, the 
filtrate washed twice with IM sulfuric acid (30 H) and twice with 5% sodium 
bicarbonate (30 n-J). The organic layer was dried over anhydrous sodium sulfate 
and evaporated, to dryness in vacuo. The residue was dissolved in acetone, the 
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insoluble part was removed by filtration and the solvent evaporated to give a white 
product. Yield 90 
(Z-Cys-GlyOMe)., 
'H-NMR 811 (DMSO) 8.50 (1 H, t, I NH Gly, J 5-6), 7.66 (1 H, d, NH(CYS)2s, J 
8.5), 7.36 (5 I-L m, Ar-H), 5.05 (2 FL, s, CH2-0),, 4.36 (1 I-L m, aCH(Cys)2), 3.85 
(2 I-L d, ctCH2GIY), 3.58 (3 H, s, OCHA3.14 and 2.85 (2 li, m, OCH2(CYS)2J4.0, 
J 10.1, J 13.3) 1 
13 C-NMR Sc (DMSO) 170.8, (CO-NHGly),, 170.1 (COOCH3), 156.1 (OCO- 
NH(CYS)2), 136.9,128.4,127.8,127.7 (C6Hs), 65.6 (CH2-0), 53.6 (OCH3), 51.7 
(aCH(Cys)2), 40.8 (OCH2(Cys)2), 38.6 (aCH2GIy) 
IR (nujol) v. 3303 (amide NH), 1740 (COOMe), 1687 and 1659 cnf 1 (C=O). 
ES MS [M+Cl]"m/z 685 
(Z-Cys-GlYOMe)2 (5 mmoles) was dissolved in 50 ml of methanol. The mixture 
was cooled to 0- 10 *Q and a solution of lithium hydroxide(I 0.2 mmoles) in water 
(17 ml) was added dropwise to the stiffed solution. After 18 hours,, 50 ml of water 
were added and the methanol was subsequently removed by evaporation. The 
solution was then washed twice with diethyl ether (25 ml) to remove any starting 
material. The aqueous phase was acidified to pH 2 with dilute hydrochloric acid 
and the product separated as a yellow precipitate which was filtered, washed with 
water, and dried in vacuo. Yield 70 
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(Z-Cys-GlyOH)2 
'H-NMR 8H (DMSO) 8.31 (1 H, t, NH - Gly, J 5.9), 7.63 (1 H, d, NH(CYS)2:, 
J 8.5), 7.3 6 (5 H, 'M, Ar-H), 5.05 (2 H, s, CH2-0), 4.3 6 (1 H, m, aCH(Cys)2), 3.76 
(2 H, d, aCH2GIY), 3.16 and 2.85 (2 I-L m, OCH2(CYS)2) 
13 C-NMR Sc (DMSO) 170.8 (CO-NHGly), 170.6 (COOH), 156.1 (OCO- 
NH(CYS)2):, 136.9,128.4,127.7j, 127.2 (C6H5), 65.6 (CH2-0), 53.6 (aCH(Cys)2), 
40.9 (OCH2(CYS)2), 40.0 (ccCH2GIY) 
ER (nujol) v. 3309 (amide NH), 1729 (COOH), 1689 (amide CO), 1653 cm" 
(OCONH) 
ES MS [M-H]"m/z 62 1, [M-312]* m/z 3 10 
(Z-Cys-GlyOH)2 (2 mmoles) was dissolved in 20 ml of ethanol. To this solution at 
67-70 T was added dropwise a solution containing 4 equivalents of sodium 
borohydride (8.74 mmoles) in 10 nil of ethanol. The stiffed reaction mixture was 
heated at 75 - 80 T for one hour. After cooling to 25 T, the solution was added 
to 50 n-d of iced water. To this stirred solution, 6M hydrochloric acid was added 
dropwise at 0- 10 T until pH 3 was obtained. After evaporating under reduced 
pressure to remove the ethanol, the solution was extracted three times into ethyl 
acetate, washed three times with distilled water and dried over anhydrous sodium 
sulphate. Removal of the solvent gave an oil (Yield 97 %). The reaction was 
followed by TLC in ethanoVchloroform/acetic acid system (9: 2: 0.5, v/v/v). 
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Z-Cys-GlyOH 
'H-NMR 811 (DMSO) 12.63 (1 H, s, COOH), 8.34 (1 H, t, NH Gly), 7.51 (1 H, dl, 
NHCys), 7.36 (5 H, m, Ar-H), 5.05 (2 H, s, CH2-0), 4.18 (1 H, m, aCHCys), 3.77 
(2 H, m, aCH2GIy), 2.83 and 2.67 (2 H, m, PCH2CYS), 2.3 7 (1 H, t, SH J 8.5) 
13 C-NMR Sc (DMSO) 171.3 (CO-NHGly), 170.7 (COOH), 156.2 (OCO-NHCys),, 
137.1,128.5,127.9, '127.2 (CýH5), 65.8 (CHrO), 57.4 (ccCHCys), 41.0 
(aCH2GIy), 26.6 (OCH2CYS) 
IIR (nujol) v. 3285,3215 (amides NH), 2500 (SH))ý 1728 (COOH), 1686,1635 
erd' (amides CO) 
ES MS [M-H]- m/z 311 
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ZI. 7 Synthesis of N-carbobenzoxy-L-cysteinyl-DL-alanine (7) 
0 
PhCH20CONH 
CH3 
(7) HN 
HS 
IH --< 
C02H 
(7rleCys-DI. rAlaOMe)2 
'H-NMR 5H (DMSO) 8.49 (1 H, m, NHAla), 7.60 (1 H, m, NH(Cys)2), 7.3 6 (5 H, 
ni, Ar-H), 5.05 (2 IL s, CH2-0), 4.29 (2 IL rn, aCHAla and ctCH(Cys)2), 3.62 (3 
I-L s, OCH3), 3.11 and 2.88 (2 I-L m, OCH2(CYS)2),, 1.27 (3 H, d, DCH3AIa J 7.3) 
13C-NMR 5c (DMSO) 172.7 (COOCH3), 170.2 (CO-NHAla), 156.1 (OCO- 
NH(Cys)2), 136.9,128.5,128.4,128.1 (C6H5), 65.9 (CH2-0), 53.6 (aCH(Cys)2). 
5 1.9 (OCHA 47.8 (ccCHAla), 40.1 (OCH2(CYS)2),, 17.0 and 16.8 (RCH3AIa) 
ER (nujol) v. 3420 and 3333 (amides NH), 1743 (CO0Me), 1690 (amide CO), 
1651 cnfl (OCONH) 
ES MS [M-H]'m/z 677 
(7, -L-Cys-Dlj-AlaOH)2 
'H-NMR 5H (DMSO) 8.32 (1 H, m, NHAla), 7.59 (1 H, m, NH(CYS)2), 7.3 5 (5 H, 
rn, Ar-H), 5.05 (2 I-L s, CH2-0), 4.3 8 (1 H, m, aCH(CYS)2,, ), 4.23 (1 H, m, 
aCHAla), 3.15 and 2.87 (2 H, m, OCH2(CYS)2), 1.29 (3 K m, PCH3AJa) 
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13 C-NMR 8c (DMSO) 174.1 (COOH), 170.2 (CO-NHAla), 156.2 (OCO- 
Nli(CYS)2), 137.0,128.5,128.0,128.8 (C6H5), 65.8 (CH2-0); 53.8 (ccCH(CYS)2), 
47.9 (otCHMa), 40.7 (OCH2(CYS)2)j. 17.5 (RCH3AIa) 
IR (nujol) v.. 3326 (amides NH), 1718 (COOH), 1669 (amide CO), 1659 crdl 
(OCONH) 
ES MS [Nl-H]'m/z 649 
Z-L-Cys-Dl, -AlaOH 
'H-NMR SH (DMSO) 8.33, (l 11, m, NHAla), 7.44 (1 H, tn, NHCys), 7.34 (5 11, 
m, Ar-H), 5.06 (2 H, s, CH2-0), 4.26 (2 H, m, aCHCys and aCHAla), 2.73 (2 H, 
m, PCH2Cys), 2.25 (1 IL m, SH), 1.29 (3 IL m, PCH3AIa) 
13 C-NMR 5c (DMSO) 174.4 (COOH), 170.3 (CO-NHAla), 156.2 (OCO-NHCys),, 
137.22 128.70 128.43,128.0 (C6Hs), 66.0 (CH270), 57.3 (aCHCys), 4.8.1 (aCHAla), 
27.0 (OCH2CYS),, 17.7 (OCH3AIa) 
IR (nujol) v. 3413 and 3322 (arnides NH), 2571 (SH), 1,719. (COOH), 1671 
(arnide CO), 1659 cnf 1 (OCONH) 
ES MS [M-H]« m/z 325 
mp 40-44 T 
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ZI. 8 Synthesis ofN-carbobenzaty-L-cysteinyl-DL-ialine (8) 
0 CH3 
PhCH20CONH 
-CH3 
NH- 
(8) HS C02H 
(Z-I, -Cys-DL-ValOMe)2 
'H-NMR 81, (DMSO) 8.3 0 (1 H, m, NHVal), 7.60 (1 H, m, NH(CYS)2), 7.3 5 (5 H, 
m, Ar-H), 5.05 (2 IL s, CHrO), 4.40 (1 IL m, aCH(Cys)2), 4.21 (1 H, 
aCHVal), 3.64 (3 H, s, OCHA 3.09 and 2.90 (2 IL rn, OCH2(CYS)2), 2.05 (1 H, 
PCHVal), 0.86 and 0.85 (6 FL d, yCH3Val J 4.6) 
13 C-NMR 8c (DMSO) 171.8 (COOCHA 170.5 (CO-NHVal)' 155.9 (OCO- 
NH(Cys)2), 136.9,128.4,127.8,127.6 (C6H5), 65.6 (CH2-0), 57.5 (aCHVal), 
53.7 (aCH(Cys)2), 51.8 (OCH3), 40.5 (PCH2(Cys)2), 30.1 and 29.9 (DCHVal),, 
19.0 and 18.1 (yCH3Val) 
ER (nujol) v.. 3303 (NH), 1739 (CO0Me), 1693 (amide CO), 1656 cnf 1 
(OCONH) 
ES MS [M-H]'m/z 733 
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(Z-1, Cys-Dl, -ValOH)2 
'H-NMR 81, (DMSO) 8.17 (1 H, m, NHVal), 7.65 (1 H, m, NH(CYS)2), 7.35 (5 H, 
m, Ar-H), 5.05 (2 H, s, CH2-0), 4.43 (1 H, m, aCH(CYS)2), 4.17 (1 H, m, 
aCHVal), 3.13 and 2.90 (2 H, m, OCH2(CYS)2), 2.06 (I H, m, PCHVal), 0.86 (6 H, 
3, yCH3Val) 
13 C-NMR 8c (DMSO) 172.7 (COOH), 170.3 (CO-NHVal), 155.9 (OCO- 
NH(Cys)2), 136.9,128.4,127.7,127.1 (C6H5), 65.6 (CH2-0)3.57.2 (aCHVal), 
53.9 (aCH(Cys)2), 40.6 (OCH2(Cys)2), 30.1 (OCHVal), 19.2 and 17.9 (YCH3val) 
IR (nujol) v,. 3309 (NH), 1715 (COOH), 1661 cnf 1 (C=O) 
Z-I, -Cys-DI. -ValOH 
'H-NMR 8H (DMSO) 8.15 (1 H, in, NHVal), 7.60 (1 IL m, NHCys), 7.35 (5 H, 
m, Ar-H), 5.05 (2 IL s, CH2-0), 4.19 (2 IL m, aCHCys and (xCHVal), 2.80 (2 H, 
m, PCH2CYS), 2.05 (1 I-L rn, PCHVal), 0.86 (6 IL 3, yCH3Val) 
13 C-NMR 5c (DMSO) 172.9 (COOH), 170.5 (CO-NHVal), 156.1 (OCO-NHCys),, 
137.12 128.5,128.23.127.9 (C6H5),, 65.7 (CH2-0),, 57.2 (aCHVal and aCHCys), 
30.2 (OCHVal), 26.9 (OCH2Cys), 19.2 and 18.0 (yCH3Val) 
IR (nujol) v. 3317 (NH), 2625 (SH), 1718 (COOH)$ 1668 cm7l (C=O) 
ES MS [M-H]'ni/z 353 
mp 37-40 T 
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ZI. 9 Synthesis ofN-carbobenzaAU7-L-cysteinyl-L-leucine (9) 
CH3 
CH3 
0 
PhCH20CONH 
NH 
(9) 
HS COOH 
(Z-1, Cys-I. -LeuOMe)2 
'H-NMR SH (DMSO) 8.39 (1 H, rn, NHLeu), 7.62 (1 K m, NH(Cys)2), 7.35 (5 
H, m, Ar-H), 5.05 (2 I-L s, CHrO), 4.33 (2 H, m, aCH(CYS)2 and aCHLeu), 3.61 
(3 I-L s, OCH3), 3.13 and 2.89 (2 H, m, OCH2(CYS)2), 1.5 5 (3 H, m, PCH2Leu and 
yCHLeu), 0.85 (6 K rn, 8CH3Leu) 
13 C-NMR 8c (DMSO) 172.7 (COOCH3)3.170.4 (CO-NHLeu), 156.0 (OCO- 
NH(CYS)2)2 136.9,128.3,127.7,127.2 (C6H5), 65.6 (CH2'0), 53.7 (aCH(Cys)2), 
51.9 (OCHA 50.4 (aCBLeu), 40.4 (OCH2(CYS)2), 39.5 (OCH2Leu), 24.2 
(yCHLeu), 22.8 and 21.3 (8CH3Leu) 
IR (nujol) v. 3266 (anüdes NH), 1746 (CO0Me), 1703 (amide CO), 1655 cnfl 
(OCONH) 
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(Z-I, -Cys-I., -LeuOll)2 
'H-NMR 811 (DMSO) 8.20 (1 H, d, NHLeu J 7.9), 7.60 (1 H, d, NH(CYS)2 J 8.1), 
7.35 (5 H, m, Ar-H), 5.05 (2 H, s, CH2-0), 4.34 (1 I-L m, aCH(CYS)2), 4.23 (1 I-L 
m, aCBLeu), 3.13 and 2.87 (2 H, m, OCH2(CYS)2),, 1.59 (3 H, m, PCH2Leu and 
yCHLeu), 0.86 (6 IL rn, SCH3Leu) 
13 C-NMR 8c (DMSO) 173.7 (COOH), 170.2 (CO-NHLeu), 156.0 (OCO- 
NH(Cys)2), 136.9,128.4,128.0,127.8 (CýH5), 65.6 (CH2-0), 53.8 (ccCH(Cys)2),, 
50.5 (aCHLeu), 40.1 (OCH2(CYS)2), 39.8 (OCH2Leu), 24.3 (yCHLeu), 22.9 and 
21.4 (BCH3Leu) 
IR (nujol) v. 3312 (NH), 1693 (COOH), 1655 cnf 1 (C=O) 
Z-I. -Cys-l. rLeuOH 
'H-NMR 5H (DMSO) 8.22 (1 H, m, MHLeu), 7.53 (1 I-L m, NHCys), 7.35 (5 H, 
ni, Ar-H), 5.05 (2 H, s, CH2-0), 4.25 (2 I-L m, aCHCys and aCHLeu), 2.85 (2 H, 
ffý PCH2CYS), 1.58 (3 11, ni, PCH2Leu and yCHLeu), 0.88 (6 I-L ni, 8CH3Leu) 
13 C-NMR 8c (DMSO) 174.9 (COOH), 170.2 (CO-NHLeu), 156.0 (OCO- 
NHCys), 13 6.9,128.4,127.8,127.7 (C6H5), 65.6 (CHrO), 57.18 (ccCHCys), 50.5 
(aCBLeu), 40.1 (OCH2Leu), 26.45 (OCH2Cys), 24.5 (yC]HLeu), 22.9 and 21.4 
(8CH3Leu) 
IR (nujol) v. 3308 (NH), 2503 (SH), 1714 (COOH), 1661 crrfl (C=O) 
ES MS [M-H]"m/z 361 
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ZLIO Synthesis of N-carbobenzoxy-L-cysteinyl-DL-serine and N- 
carbobenzoxy-DL-cysteinyl-L-scrine(IO) 
0, 
OH 
PhCH20CONH 
NH 
(10) HS OOH 
(Z-I, -Cys-Dl, -SerOMe)2t (Z-Dl, -Cys-I. -SerOMe)2 
'H-NMR 8H (DMSO) 8.30 (1 H, m, NHSer), 7.65 (1 H, m, NH(Cys)2), 7-36 (5 H, 
m, Ar-H), 5.06 (2 IL s, CH2-0), 4.42 (2 IL m, ccCH(CYS)2 and aCHSer), 3.72 (2 
I-L m, PCH2Ser), 3.63 (3 H, s, OCH3), 3.15 and 2.88 (2 H, m, 
OCH2(CYS)2) 
13 C-NMR 8c (DMSO) 170.8 (COOCH3)3,170.5 (CO-NHSer), 156.1 (OCO- 
NH(Cys)2), 136.9,128.4,128.1,127.8 (C6Hs), 65.6 (CH2-0), 61.2 (OCH2Ser), 
54.9 (aCHSer), 53.7 (aCH(CYS)2), 52.0 (OCH3), 40.5 (OCH2(CYS)2) 
ER (nujol) v. 3505 (NH), 1738 (CO0Me), 1700 (amide CO), 1651 cnf 1 (C=0) 
ES MS [M-H]'m/z 709 
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(Z-I, -Cys-DI. -SerOH)2, (Z-DI. -Cys-I. -SerOH)2 
'H-NMR811 (DMSO) 8.10 (1 H, m, NHSer), 7.65 (1 H, m, NH(Cys)2), 7.35 (5 H, 
m, Ar-H), 5.05 (2 H, s, CH2-0), 4.42 (1 H, m, aCH(CYS)2), 4.28 (1 H, m, 
aCHSer), 3.67 (2 H, m, PCH2Ser), 3.16 and 2.86 (2 H, m, 
OCH2(CYS)2) 
13C-NMR Bc (DMSO) 171.8 (COOH), 170.3 (CO-NHSer), 156.2 (OCO- 
NH(Cys)2), 136.9,128.5,127.9,127.8 (C6H5), 65.7 (CH2-0), 61.4 (RCH2Ser), 
54.9 (aCHSer), 53.8 (aCH(Cys)2), 40.5 (OCH2(CYS)2) 
IR (nujol) v. 3298 (NH), 1718 (COOH), 1703 and 1650 cnf 1 (C---O) 
ES MS [M-H]"m/z 681 
Z-L-Cys-DI. rSerOH, Z-DI, -Cys-I. -SerOH 
'H-NMR 811 (DMSO) 8.10 (1 H, m, TýHSer), 7.53 (1 H, m, NHCys), 7.37 (5 Hs 
m, Ar-H), 5.06 (2 IL s, CHrO), 4.30 (2 I-L m, aCHCys and (xCHSer), 3.68 (2 I-L 
m, PCH2Ser), 3.15 and 2.87 (2 K m, OCH2Cys), 2.29 (IH, m, SH) 
13 C-NMR 8c (DMSO) 171.8,171.7 (COOH), 170.2,170.1 (CO-NHSer), 156.0 
(OCO-NHCys), 136.9,128.4,127.8,127.7 (C6H5), 65.6 (CH2-0), 61.4,61.2 
(OCH2Ser), 57.5 (ccCHCys), 55.2,55.1 (aCHSer), 26.6 (OCH2Cys) 
IR (nujol) v,,. 3301 (OIL NH), 2609'(SH), 171,8 (COOH), 166-3(C=O) 
ES MS [M-HI'm/z 341 
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Z1.11 Synthesis ofN-carbobenza)y-D-cysteinyl-D-penicillamine (11) 
0 
HS CH3 
PhCH20CONH 
NH- CH3 
(11) HS 
COOH 
(7eD-Cys-D-PenicillamineOMe)2 
'H-NMR SH (DMSO) 8.25 (1 IL m, NHPen), 7.60 (1 H, m, NH(CYS)2), 7.3 5 (5 H, 
m, Ar-H), 5.04 (2 I-L s, CHrO), 4.50 (21L m, aCH(CYS)2 and (xCBPen), 3.63 (3 
H. s, OCH3), 3.04 and 2.73 (2 H, m, OCH2(CYS)2). 1.33 (6 I-L m, yCH3Pen) 
13 C-NMR Sc (DMSO) 170.5 (COOCH3), 169.9 (CO-NHPen), 156.0 (OCO- 
NH(CYS)2)j. 136.9,128.4,127.9,127.7 (C6H5), 65.6 (CH2-0), 61.5 (aCHPen), 
54.9 (ccCH(Cys)2), 51.9 (OCHA 45.21 (OCPen), 40.4 (OCH2(CYS)2), 29.5 and 
24.19 (ICH3Pen) 
IR (ntýol) v.,,., 3324 (NH), 1734 (COOMe), 1675 cnf 1 (C--O) 
ES MS [M+Cl]'nVz 835 
1 
(7, -D-Cys-D-PenicillamineOH)2 
'H-NMR 8H (DMSO) 8.20 (1 H, m, NBPen), 7.57 (1 H, m, NH(Cys)2), 7.3 5 (5 H, 
m, Ar-H), 5.04 (2 I-L s, CH2-0), 4.67 (1 K m, aCHPen), 4.34(l H, rn, 
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ctCH(CYS)2), 3.63 (3 H, s, OCHA 2.89 (2 H, m, OCH2(CYS)2)3,1.35 (6 H, m, 
yCH3Pen) 
13 C-NMR 8c (DMSO) 171.4 (COOH), 170.2 (CO-NHPen), 155.1 (OCO- 
I 
NH(CYS)2)3,136.9,128.4,, 128.1,127.9, (C6H5), 65.6 (CH2-0), 59.4 (aCHPen), 
53.0 ((xCH(Cys)2), 45.21 (PCPen), 40.2 (OCH2(Cys)2), 26.8 and 19.7 (yCH3Pen) 
IR (nujol) v.,.., 3416 (NH), 2500 (SH), 1719 (COOH), 1671 cnfl (CO) 
Z-D-Cys-D-PenicillamineOH 
'H-NMR SH (CDC13) 8.31 (1 H, d, NBPen), 7.35 (6 H, m, NHCys and Ar-H), 
5.11 (2 11, s, CHrO), 4.82 (1 IL m, aCHPen), 4.68(l H, m, aCHCys), 2.96 (2 H, 
ni, OCH2CYS),, 1.41 (6 IL m, yCH3Pen) 
13 C-NMR 8c (CDC13) 173.1 (COOH), 171.8 (CO-NBPen), 155.2 (OCO- 
NH(CYS)2)7 135.9,128.5,128.3,128.1 (C6H5), 67.2 (CH2-0), 59.5 (aCBPen),, 
53.6 ((xCHCys), 57.0 (DCPen), 41.6 (OCH2CYS), 26.7 and 19.8 (yCH3Pen) 
IR (nujol) v. 3303 (NH), 2570 (SH), 1719 (COOH), 1669 enf 1 (CO) 
ES MS [M-3H]" m/z 383 (probably disulfide bond between cysteine and 
penicillamine) 
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21.12 Synthesis ofN-carbobenzoxy-cysteinyl-phenylaianine(12) 
Ph 
PhCH20CONH 
NH- 
(12) HS COOH 
(&I, -Cys-Dl, -PheOMe)2 
'H-NMR 8H (DMSO) 8.50 (1 I-L m, NBPhe), 7.60 (1 H, m, NH(Cys)2), 7.3 5 (5 I-L 
rn, ZAr-H), 7.24 (5 IL rn, PheAr-H), - 5.05 (2 H, s, CH2-0), 4.52 (1 IL m, 
aCBPhe), 4.34 (1 I-L m, aCH(CYS)2), 3.61- (3 IL m, OCH3), 2.87. (4 IL m, 
OCH2(CYS)2 and PCH2Phe) 
13 C-NMR 8c (DMSO) 171.6 (COOCH3), 170.2 (CO-NBPhe), 155.9 (OCO- 
NH(Cys)2), 137.0,136.9,129.22,129.1,127.8,127.0,126.6, (ZC6H5 and 
PheC6Hs), 65.6 (CHrO), 53.7 and 53.5 (aCH(CYS)2 and aCBPhe), 52.0 and 51.9 
(OCH3), 40.4 and 40.0 (OCH2(Cys)2), 36.8 and 36.5 (OCH2Phe) 
IR (nujol) v.. 3321 (NH), 1743 (CO0Me), 1717 and 1669 enf 1 (CO) 
(Z-I, -Cys-I. -PheOMe)2, (Z-D-Cys-D-PheOMe)2 
'H-NMR 811 (DMSO) 8.45 (1 I-L d, NBPhe, J 7.9), 7.62 (1 d, M(CYS)23, 
J 8.5 ), 7.34 (5 H, m, ZAr-H) , 
7.21 (5 I-L m, PheAr-H), 5.06 (2 H, s, CHrO),, 4.53 
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(I H, m, aCHPhe), 4.39(l H, m, aCH(Cys)2), 3.59 (3 H, s, OCHA 3.05 and 2.85 
(4 H, m, OCH2(CYS)2 and PCH2Phe) 
13 C-NMR Sc (DMSO) 171.7 (COOCH3)j. 170.4 (CO-NB? he), 156.0 (OCO- 
NH(Cys)2), 137.0,136.9,129.2,128.4,128.3,127.9,127.8,127.7 (ZCýH5 and 
PheCA), 65.8 (CH2-0), 53.8 (aCH(CYS)2), 52.0 ((xCBPhe and OCH3), 40.4 
(PCH2(CYS)2), 39.5 (PCH2Phe) 
(Z-IeCys-D-PheOMe)2v (Z-D-Cys-l, -PheOMe)2 
'H-NMR 51, (DMSO) 8.51 (1 11, d, NBPhe, J 7.9), 7.56 (1 K d, NH(CYS)23, 
J 8.5 ), 7.34 (5 I-L rn, ZAr-H), 7.21 (5 K m, PheAr-H), 5.04 (2 H, s, CH2-0), 4.52 
(I IL m, aCBPhe), 4.3 3 (1 IL m, aCH(Cys)2), 3.62 (3 I-L s, OCHA 3.00 and 2.75 
(4 IL m, OCH2(CYS)2 and PCH2Phe) 
13 C-NMR Sc (DMSO) 171.7 (COOCH3), 170.3 (CO-NHPhe), 156.0 (OCO- 
NH(CYS)2)s 137.0,136.9,129.3,128.4,128.3,127.9,127.8,127.7 (ZC6Hs and 
PheCýH5), 65.7 (CHrO), 53.6 (ccCH(Cys)2), 52.0 (aCHPhe and OCH3), 39.9 
(OCH2(CYS)2), 36.8 (OCH2Phe) 
(Z-IeCys-DI. rPheOH)2 
'H-NMR 81, (DMSO) 8.28 (1 IL m, NI]Phe), 7.53 (1 H, m, NH(CYS)2), 7.35 (5 H, 
m, ZAr-H), 7.21 (5 I-L m, PheAr-H), 5.03 (2 I-L s, CH2-0), 4.50 (1 M, 
(xCBPhe), 4.32 (1 I-L m, aCH(Cys)2), 2.90 (4 H, m, OCH2(CYS)2 and PCH2Phe) 
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13 C-NMR Sc (DMSO) 172.6 (COOH), 170.1 and 170.0 (CO-NBPhe), 156.0 
(OCO-NH(CYS)2)), 137.3,136.9,129.3,129.2,128.4,128.2,127.9,127.73,127.1s 
126.5 (ZC6H3 and PheC6Hs), 65.7 (CH2-0)1,53.8,53.6 and 53.4 (aCH(CYS)2 and 
aC]HPhe), 40.0 (OCH2(Cys)2), 36.9 and 36.6 (OCH2Phe) 
IR (nujol) v. 3308 (NH), 1712 (COOH), 1651 cnil (CO) 
ES MS [M-H]'rWz 801 
(7. rleCys-l, -PheOH)2, (7eD-Cys-D-PheOH)2 
'H-NMR 5H (DMSO) 8.13 (1 H, d, NHPhe, J 7.8), 7.54 (1 I-L d, NH(Cys)2,. 
J 8.7 ), 7.3 2 (5 IL ný ZAr-H), 7.22 (5 IL m, PheAr-H), 5.04 (2 H, s, CH2-0), 4.44 
(I IL m, aCBPhe), 4.31 (1 I-L m, aCH(Cys)2), 3.06 and 2.88 (4 K m, OCH2(CYS)2 
and PCH2Phe) 
13 C-NMR 8c (DMSO) 172.4 (COOH), 169.9 (CO-NHPhe), 155.9 (OCO- 
NH(CYS)2)), 137.2,136.8,129.1,128.3,128.1,127.7,127.6,126.4 (ZC6H5 and 
PheC6H5), 65.6 (CH2-0)3.53.8 (ccCH(Cys)2), 5'3.4 (ccCBPhe), 40.4 (OCH2(CYS)2), 
36.5 (OCH2Phe) 
(Z-I, -Cys-D-PheOH)29 (Z-D-Cys-l, -PheOH)2 
'H. NMR 81, (DMSO) 8.2 1, (1, H, -d, - NHPhe, J 8.2), 7.48 (1 K d, NH(CYS)2, 
J 8.7 ), 7.32 (5 I-L rn, ZAr-H), 7.20 (5 FL m, PheAr-H), 5.04 (2 IL s, CH2-0), 4.48 
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(I H, m, aCHPhe), 4.32 (1 H, m, aCH(Cys)2), 3.00 and 2.74 (4 H, m, OCH2(CYS)2 
and PCH2Phe) 
13 C-NMR 8c (DMSO) 172.5 (COOH), 169.9 (CO-NEPhe), 155.9 (OCO- 
NH(Cys)2), 137.2,136.8,129.2,128.3,128.1,127.8,127.6,126.4 (ZCýHs and 
PheC6Hs), 65.6 (CH2-0), 53.7 (aCH(CyS)2)2 53.3 (ccCBPhe), 39.9 (OCH2(CYS)2)3. 
36.8 (OCH2Phe) 
Z-I. rCys-DI. -PheOH 
'H-NMR 8H (DMSO) 8.28 (1 K m, NHPhe), 7.53 (1 H, m, NHCys), 7.35 (5 IL 
m, ZAr-H), 7.21 (5 H, rn, PheAr-H), 5.04 (2 H, s, CH2-0), 4.50'(1 H, 
aCBPhe), 4.19 (1 I-L m, aCHCys), 2.90 (4 I-L m, PCH2Cys and PCH2Phe) 
13 C-NMR Bc (DMSO) 173.0 (COOM, '170.4'and- 170.1 (CO-NHPhe), 156.3 
(OCO-NHCys), 137.7,137.3,129.6,128.7,128.2,128.0,126.8 126.5 (ZC6H5 and 
PheCýHs), 66.0 (CHrO), 57.5 and 57.4 (aCHCys), 53.9 and 53.0(aCBPhe), 37.3 
and 37.0 (OCH2Phe), 26.8 and 26.7 (OCH2CYS) 
IR (nujol) v. 3314 (NH), 2570 (SH), 1719 (COOH), 1669 cnf ' (CO) 
ES MS [M-H]'m/z 401 
Z-I. rCys-I. -PheOH, Z-D-Cys-D-PheOH 
'H-NMR 8H (DMSO) 8.21, (l H, d, -, NHPhe, 'j 7. '7-)',, -7.36 (6 H, m, NHCys and 
ZAr-H), 7.23 (5 H, m, PheAr-H), 5.04'ý2'H, s, '-*CH2'0j, 4.44 (I'H, "m, aCHPhe), 
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4.14 (1 H, m, aCHCys), 3.00 and 2.68 (4 H, m, PCH2Cys and PCH2Phe), 2.25 
(IH, m, SHCys) 
13 C-NMR 8c (DMSO) 172.6 (COOH), 170.0 (CO-NBPhe), 155.9 (OCO- 
NH(Cys)2), 137.3,136.9,129.1,128.3,128.1,127.8,127.7,126.4 (ZC6H5 and 
PheC6li5), 65.5 (CH2-0), 57.1 (ccCHCys), 53.5 (ccCl-IPhe), 36.5 (OCH2Phe), 26.3 
(OCH2CYS) 
IR Z-IrCys-l, -Phe-OH (nujol) v. 3312 (NH), 2569 (SH), 1717 (COOH), 1692 
and 1658 enýl (CO) 
IR Z-D-Cys-D-Phe-OH (nujol) v. 3314 (NH), 2567 (SH), 1715 (COOH), 1693 
and 1658 crifl (CO) 
ES MS Z-L-Cys-l, -Phe-OH and Z-D-Cys-D-Phe-OH [M-H]"m/z 401 
mp 140-146 * 
Z-I. -Cys-D-PheOH, Z-D-Cys-I. -PheOH 
'H-NMR 81, (DMSO) 8.28 (1 H, d, NBPhe, J 8.2), 7.34 (6 I-L m, NHCys and 
ZAr-H), 7.23 (5 I-L m, PheAr-H), 5.04 (2 H, s, CH2-0), 4.49 (1 fL m, aCBPhe), 
4.15 (1 I-L m, aCHCys), 2.99 and 2.52 (4 I-L m, PCH2Cys and PCH2Phe), 2.03 
(I I-L m, SHCys) 
13 C-NMR 5c (DMSO) 172.3 (COOH), 169.7 (CO-NBPhe), 155.9 (OCO-NHCys), 
137.310 136.93,129.2,128.4,128.2,127.9,127.8,127.7 (ZC61is and PheC6Hs), 
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65.76 (CH2-0)$ 57.0 ((xCHCys), 53.3 (aCBPhe), 36.9 (OCH2Phe), 26.5 
(OCH2CYS) 
IR Z-I, -Cys-D-Phe-OH (nujol), v.. 3308 (NH), -. 2568 (SH), 1718 (COOH), 
1669 cnil (CO) i 
ES MS Z-I-. -Cys-D-Phe-OH and Z-D-Cys-l, -Phe-OH [M-H]'m/z 401 
mp 118-122T 
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Synthesis of N-carbobenzoxy-L-cysteinyl-DL-proline(13) 
PhCH20C( 
(13) 
(Z-I. rCys-Dl, -ProOMe)2 
13 C-NMR Bc (DMSO) 172.6 (COOCHA 168.6 (CO-NBPro), 156.1 (OCO- 
NH(Cys)2), 136.9,128.4,128.1,127.9 (ZC6H5), 65.7 (CH2-0), 58.8 (aCHPro), 
51.8 (aCH(Cys)2), 52.0 (OCH3), 46.6, (SCH2Pro), 39.8 (OCH2(CYS)2), 28.6 
(OCH2Pro), 24.5 (yCH2Pro) 
(Z-I, -Cys-DI. -ProOH)2 
13 C-NMR 8c (DMSO) 173.1 (COOH), 168.5 (CO-NUPro), 156.0 (OCO- 
NH(CYS)2)3,136.9,128.4,127.8,127.7 (ZC6H5), 65.7 (CH2-0)2 58.8 (aCHPro), 
51.7 (aCH(Cys)2), 46.5 (8CH2Pro), 39.8 (RCH2(Cys)2), 28.7 (OCH2Pro), 24.5 
(yCH2PrO) 
ER (nujol) v. 3296 (NH), 1716 (COOH), 1630 erd' (CO) 
ES MS [M-H]« rüh 702 
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Z-I, -Cys-DI. rProOll 
'H-NMR 5il (DMSO) 7.64 (1 H, m, NHPro), 7.34 (5 H, m, ZAr-H), 7.21 (5 H, m, 
PheAr-H), 5.05 (2 H, m, CH2-0), 4.22 and 3.66 (2 H, m, ccCBPro and (xCHCys), 
2.88,2.70v 2.12 and 1.88 (8 H, m, PCH2Cys and CH2PrO) 
13 C-NMR 8c (DMSO) 173.5,173.4 (COOH), 169.1 (CO-N'BPro), 156.2 (OCO- 
NHCys), 137.3,127.7,128.4,128.1,127.9 (ZC6H5), 65.9 (CH2-0), 60.7 
(aCHCys), 57.2,56.9 (aCBPro), 46.9 (8CH2Pro), 29.1 (OCH2Pro), 25.7 
(OCH2CYS), 24.4,24.7 (yCH2Pro) 
IR (nujol) v. 3295 M, 2606 (SH), 1716_(COOH), 1630 cnil (CO) 
ES MS [M-H]« m/z 351 
mp 60 - 65 T 
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ZI. 14 Synthesis ofN-mercaptoethyl-4-L-thiazolidinecarboxylic acid (14) 
s 
HS 
C0 OH 
(14) 
The preparation of 4-L-thiazolidinecarboxylic acid methyl ester was undertaken 
according to the method of Ratner and Clarke 
124 
. 
A solution of 4-L-thiazolidinecarboxylic acid (0.093 moles) in 100 ml of methanol 
which had been saturated with dry hydrogen chloride, was refluxed for one hour. 
The solution was then evaporated -under reduced pressure to obtain the 
hydrochloride of the methyl ester as a white solid, yield 94 %. To a suspension of 
I 
the ester hydrochloride (0.087 moles) in 5H of water, covered with about 30 ml 
of ether, anhydrous potassium carbonate was added slowly in excess (1.2 mole- 
equivalent). The ether layer was separated and extraction of the aqueous layer with 
ether was repeated twice. The combined organic layers were dried over anhydrous 
sodium sulfate and the ether was evaporated under reduced pressure to obtain a 
colorless oil which was purified further by distillation under reduced pressure. 
Yield 70 %. 
'H-NMR 8H (DMSO) 4.13 and 4.04 (2 H, dd, yCH23, JAB 9.0), 4.02 (1 H, m, 
aCH), 3.64 (3 I-L s, OCH3),, 31 3.33 (1 H, M NM, -3.04 and 2. '84 (2 H, two q, DCH2, 
JAB 10.3JAx 6.7JBx 6.0), 
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13 C-NMR 5c (DMSO) 171.7 (COOCH3), 64.8 (aCH), 52.2 (OCH2), 52.0 (OCH3), 
36.0 (yCH2) 
IR (nujol) v.,,,, 3311 (NH) and 1740 cfff 1 (COOMe) 
A mixture of equimolar amount of 4-L-thiazolidinecarboxylic acid methyl ester 
(0.061 moles) and ethylenesulfide (0.061 moles) in a glass lined bomb was heated 
for eighteen hours at 85 T. The unreacted ethylene sulfide was then evaporated 
under reduced pressure to give a colorless oil, -with a ratio of 3 to I of 
product/starting material. Overall yield 80 %. Attempts to separate the product 
from the starting material were not successful at this stage and further reactions 
were followed without further purification. 
'H-NMR Sti (DMSO) 4.30 (1 H, m, aCH), 4.01 (2 IL m, yCH2), 3.63 (3 H, 
OCH3), 3.08 and 2.80 (2 H, m, PCHA 2.60 (4 H, m, 2 CH2), 2.36 (1 H, t, SH, J 
7.3) 
13 C-NMR Sc (DMSO) 173.1 (COOCH3), 69.5 (aCH), 58.8 (yCH2), 56.9 (CHA 
52.1 (OCH3), 31.9 (OCH2), 23.2 (CH2SH) 
IR (nujol) v. 2552 (SH), 1736 cm7l (COOMe) 
ES MS [M+H]'m/z 208 
The product was dissolved in 50 ml of methanol. The mixture was cooled to 
0- 10 T, (10.2 mmoles) of lithium hydroxide in water (17 n-A) was added 
dropwise to the stirred solution. After 18 hours reaction 50 n-A of water were 
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added, and the methanol was subsequently removed by evaporation. The aqueous 
Q solution was then extracted with ethyl acetate. The aqueous layer was 'then 
acidified to pH I with dilute hydrochloric acid and extracted twice with ethyl 
acetate. The pH of the aqueous solution was then adjusted to pH 7 and the water 
was removed by Iyophilisation. The product was then dissolved in methanol. The 
insoluble fraction was filtered and acetone was added to the methanol. A yellow 
product precipitated upon addition of the acetone- and was filtered. NMR of the 
precipitate reyealed the presence of compound (14) as well as others such as the 4- 
L-thiazolidinecarboxylic acid. 
Attempt to separate the mixture by column chromatography was not successful as 
the compounds decomposed. The mixture was solubilised in ethanol and addition 
of chlorofonn induced the fonnation of a yellow precipitate. NMR of the 
precipitate showed that the main compound was the disulfide of compound (14). 
However ESMS of the product showed the presence of other compounds (results 
not shown). 
'H-NMR SH (D20) 4.76 and 4.3 3 (2 H, two d, CH2, JAn 10.4), 4.59 (1 H, m, CH), 
3.80,3.69,, 3.58,, 3.40 and 3.11(6 H, m, CH2) 
13 C-NMR Sc (D20) 170.3 (COOH), 70.3 (CH), 58.1 (CH2), 54.4 (CH2), 33.0 
(CH2), 32.4 (CH2) 
ES MS [2M+H]+ m/z 385 
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The product was reduced using sodium borohydride. The yellow precipitate was 
dissolved in 20 ml of ethanol. To this solution at 67 - 70 T was added dropwise to 
a solution containing 4 equivalents of sodium borohydride in 10 H of ethanol. The 
stirred reaction mixture was heated at 75 - 80 T for one hour. After cooling to 
25 'C, the solution was added to 50 ml of iced water. To this stirred solution, 6M 
hydrochloric acid was added dropwise at 0- 10 T until pH 3 was obtained. The 
acidic solution was then evaporated under reduced pressure. The mixture proved 
to be very difficult to separate and pure (14) was not obtained. No further studies 
on the compound were carried out. 
75 
Experimental 
21.15 Synthesis of 3-oxoperhydroll. 3]thiazolo[4.3-blil. 3]thiazole-7a- 
carboxylic acid (15) 
OOH 
(15) 7 
A solution of dithiodiglycolic acid (6 mmoles) in dichloromethane (50 n-d), cooled 
to 0 T, was treated with dicyclohexylcarbodiinýde (12 mmoles) and with a 
solution of 4-L-thiazolidinecarboxylic acid methyl. ester (12.6 mmoles) in 
dichloromethane (50 ml). The mixture was stirred at 0T for I hour and then for 
24 hours at room temperature. The precipitated dicyclohexylurea was filtered, the 
filtrate was washed twice with IM sulfuric acid (30 ml) and twice with 5% 
sodium bicarbonate (30 ml). The organic layer was dried over anhydrous sodium 
sulfate and evaporated to dryness in vacuo. The residue was dissolved in acetone, 
the insoluble part was removed by filtration and the solvent evaporated to give a 
white product. The product of the reaction (5 mmoles) was dissolved in 50 H of 
methanol. The mixture was cooled to 0- 10 T, a solution of lithium hydroxide 
(10.2 mmoles) in water (17 n-d) was added dropwise to the stiffed solution. After 
18 hours, 50 ml of water were added, and the methanol was subsequently removed 
by evaporation. The solution was then washed twice with diethyl ether 
(20 H) to remove any starting material. The aqueous phase was acidified to pH 2 
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with dilute hydrochloric acid and the product separated as a yellow precipitate 
which was filtered, washed with water, and dried in vacuo. Yield 60 %. 
'H-NMR 811 (DMSO) 4.66 and 4.06 (2 H, two d, yCH2,, JAB8.7), 4.05 and 3.88 (2 
H, two d, OCH2, > JAB 15.5 ), 3.5 5 and 3.12 (2 H, two d, aCH2 JAB 10.7) 
13 C-NMR Sc (DMSO) 170.4 (COOH), 169.4 (CO-NH), 73.8 (Cq), 43.6 (yCH2), 
3 8.7 (ccCH2), 3 6.3 (p CH2) 
IR (nujol) v. 1734 (COOH 1646 cnf 1 (CONH) 
ES MS [M-H]'m/z 204, [2M-H]'mlz 409 
mp 206-208 T 
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ZI-16 Synthesis ofN-mercaptoacetyl-4-thiazolidinecarboxylic acid (16) 
0 
/-S 
HS (16) 
02H 
The procedure was based on the method of Oya et al. 125 . 
Benzoylation of thioglycolic acid 
To 50 ml of IM sodium hydroxide and 20 H of ether, thioglycolic acid 
(33 mmoles) and benzoyl chloride (39 mmoles) were added. While the temperature 
was kept between 0 and 5 T, 5.4 g of potassium bicarbonate was added in 4 
portions over a period of 10 n-dnutes with vigorous stirring. The reaction was left 
stirring for a further 20 minutes at room temperature. The ether layer was removed 
and the solution extracted again with ether (2 x 20 ml). The solution was then 
acidified with 6M hydrochloric acid and the white precipitate filtered off and 
washed with water to remove all unreacted thioglycolic acid. Yield 80 %. The 
product was used without further purification. 
'H-NMRSH(DMSO) 7.75 (5 H, rn, C6H5), 3.91 (2 H, s, CH2) 
13 C-NMR 8c (DMSO) 190.2 (CO-S), 1'69.6 (COOH), 134.0,129.2,129.1,127.1, 
126. (C6H5), 31.53 (CH2) 
mp 88 - 90 T 
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S-benzoylmercaptoacetic acid (27 mmoles) was dissolved in 20 n-d of 
dichloromethane, cooled to 0T and was treated with dicyclohexylcarbodiimide 
(27 mmoles). After 10 minutes 4-L-thiazolidinecarboxylic acid (I equivalent) was 
added to the solution. The mixture was stirred at room temperature for 2 hours. 
The precipitated dicyclohexylurea was filtered off and the filtrate washed twice 
with sodium bicarbonate (30 ml). The aqueous solution was acidified with 6M 
hydrochloric acid. The separated oil was extracted into ethyl acetate. The extracts 
were washed with water (3 x 10 ml), dried over anhydrous sodium sulfate and 
concentrated under reduced pressure to give a yellow oil. Yield 20 %. The product 
was used without further purification. 
ES MS [M-H]"ni/z 3 10 
S-benzoylmercaptoacetyl4-thiazolidine carboxylic acid (3 mmoles) was treated 
With 28 % aqueous ammonia (30 ml) and the mixture was stirred for I hour at 
room temperature. The excess ammonia was removed in vacuo and the by- 
product, benzamide was extracted into ethyl acetate (3 x 10 ml). The aqueous layer 
was acidified with dilute hydrochloric acid and extracted with ethyl acetate (3 x 20 
nýfl). The extracts were washed with water until neutral pH, dried over anhydrous 
sodium sulfate and concentrated in vacuo to give a colorless oil. Yield 50 %. The 
product was purified by 'preparative TLC (ethyl acetate/chlorofor'm, 2: 1). The 
NMR of the isolated fraction showed that the sample was very impure. ' 
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2.2 Kinetic Studies 
2.2.1 Material 
Deionised water was used for preparation of buffers and other aqueous solutions. 
D20, NaOD, DO were obtained from Goss Scientific Ltd. Cephaloridine was 
supplied by Glaxochern Research group. Most buffers, benzylpenicillin, and 
cefuroxime were purchased from Sigma. 
The buffers used were acetate (pK. 4.75), MIES (pK. 6.15), MOPS (pl-C, 7.20), 
TAPS (pK. 8.40), CAPSO (pK. 9.60), hexafluoroisopropanol (pY-, 9.30) and 
CAPS (pY.. 10.4). The ionic strength was maintained at a constant level with 
sodium chloride or potassium chloride (AnalaR grade). 
Kinetic studies were carried out using the class B P-lactamase enzyme from 
Bacillus cereus 569/H which was kindly supplied by Professor Jean-Marie Fr6re, 
University of Li6ge, Belgium. The enzyme was isolated using the following 
procedure: 
The strain used was BL21/pET-BcIl, the part I of the gene coding for the mature 
protein was cloned after the T7 promoter. The vector used was pET9a. The gene 
was introduced between the Ndel and Bamffl sites. The size of the plasmid is equal 
to 5.2 kbases. 
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Production of the enzyme 
The bacteria was grown on a liquid LB media (Lennox L Broth Base) containing 
50 gg/ml Kanamycin. An overnight preculture of BL21/pET-BcIl at 37 T under 
orbital agitation was prepared. The culture (30 n-d) was inoculated in fresh media 
(1 1) containing the selection agent (kanamycin 50 gg H"). The culture was 
incubated at 37 T under orbital, agitation. When the culture reached an optical 
density of 0.6 at a wavelength of 600 nrn, isopropyl-o-D-thiogalactopyranoside 
(EPTG) was added (I mM final concentration), which induced the production of 
BcII. The culture was then incubated for a further three hours at 37 T. 
Purification 
The culture was centrifuged at 5000 rpm for 15 minutes. The supernatant was 
discarded and the pellet resuspended in Hepes buffer (50-100 H, 10 mM, pH 7.5, 
50 gM ZnC12,, 1/20 to 1/10 of the culture volume). The cells were disrupted by 
French press, sonication or cell disrupter. The cell debris were removed and the 
solution was centrifuged for 30 minutes at 20000 g. The supernatant was dialyzed 
overnight against 100 volume of Hepes buffer (same composition). After dialysis, 
the solution was loaded on a S-Sepharose fastflow column (Pharmacia, LKB 
Biotechnology) previously equilibrated with the Hepes buffer. After an extensive 
washing of the column with the buffer, the elution was carried out with a linear 
gradient of NaCl in the same buffer. The salt concentration at the end of the 
gradient was 0.6 M at which the enzyme was eluted. The fractions containing the 
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cnz)7ne were pooled and concentrated by ultrafiltration (An&on). The purity of 
the sample was evaluated by SDS-PAGE and specific activity. The yield of this 
step was around 95 % and the purity -A-as about 90 %. Where a more 
homogeneous solution was required the sample was dialyzed overnight against the 
Ilepes buffer in order to eliminate the salt. The dialysed sample was then applied 
on a Mono S-Sepharose FIRMS column (Pharmacia, LKB Biotechnology) 
previously equihbrated with the Hepes buffer. After washing, elution of the enzyme 
was performed using a linear salt gradient, with the same solution used for the first 
purification step. Tle active fractions were pooled and concentrated. The second 
purification step gave a pure and homogenous enzyme solution. 
2-Z2 Equipment 
UV-Vis wavelength scans were performed using a Cary 1/3 (Varian) 
spectrophotometer. The temperature was kept constant at 30 *C with a water 
circulator and a peltier systerm 
The pHs of solutions were measured using either a JENIVAY 3020 or a Beckman 
440 p1l meter fitted %ith A&IASCI, or Hg/Hg2C12 Russel Semi-micro electrode, 
which were calibrated prior to use. 
2.23 Kinetic assays 
Generally, 25 pi of a stock solution of substrate was injected into 2.5 ml of buffer 
solution (0.05NI ,I-I NI, 30 *C, unless otherwise stated) and stiffed. 25 W of a 
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stock solution of enzyme was then added to the system. In general, the substrate 
and enzyme concentrations in the cell were 0.12 to 1.1 mM and 0.04-2.0 VM 
respectively. The experiment was repeated by adding more substrate at the end of 
the reaction. 
Hydrolysis of the substrate was followed by measuring the decrease in absorbance, 
at 260 mn for cephaloridine and cefuroxime, and at 230 mn for benzylpenicillin, as 
a function of time. Unless otherwise stated, for stability reasons, zinc sulfate was 
added to the stock solution of enzyme, at a concentration which was 10 fold 
greater than the enzyme concentration. 
Assuming that enzyme catalysis follows standard Michaelis-Menten kinetics, the 
kinetic constants were generally measured'by following the entire course of the 
reaction. Below saturation, [S]<<K., the curves were fitted to a simple first order 
rate law to obtain the pseudo-first-order rate constants k,, b, which were shown to 
be first order in enzyme concentration and independent of substrate concentration. 
The second-order rate constant k,.. /K. was obtained by dividing kt, by the 
concentration of enzyme used. Complete time curves were studied because of 
increased accuracy and there was no evidence of either product inhibition or 
enzyme denaturation. Repeat kinetics runs by injecting more substrate into the cell 
after the first reaction was complete gave identical pseudo-first-order rate 
constants. Furthermore, rate constants obiainýd frofii initial rate studies also gave 
identical rate constants. Above saturation, 'when the subsirate'concentration was 
too high for complete UV assays, the initial rates were determined with low 
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substrate concentrations and analysed according to the Hanes equation below. 
Hanes plot was preferred over other treatments plots such as Lineweaver-Burk 
126 because it does not give such misleading values of experimental errors . 
[S] 
+ 
K. 
V. V. 
Unless otherwise indicated, the reported rate constants are within 5% of the stated 
value. 
Curve fittings were achieved using ENZFITTER (Elsevier Biosoft, Cambridge, 
UK) or SCEENTIST (MicroMath Scientific Software, Utah, USA) software. 
2.2.3.1 Effects of buffer concentration andionic strength on fl-laclamase II 
activity 
The effect of the buffer concentration [over the range 0.010 - 0.200 M] on the 
D-lactamase 11 catalysed hydrolysis of cephaloridin'e, was measured with MOPS 
and phosphate buffers at 30 *C and pH 7.0. The enzyme concentration used was 
0.1 W and substrate cephaloridine 0.14 mM. The ionic strength of the buffer was 
maintained at 1.0 M by var ying the concentration of sodium chloride. 
The effect of the ionic strength [over the range, 0.17 - 1.50 M] on the P-lactamase 
11 catalysed hydrolysis of cephaloridine, was measured at 30 T and pH 7.0 with 
MOPS and phosphate buffer (0.01M). The enzyme concentration used was 0.1 JIM 
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and substrate cephaloridine 0.13 mM. The ionic strength of the buffer was kept 
constant by adjusting with the calculated amount of sodium chloride. 
2. Z3.2 pHlpD dependence of ewyme activity 
The pH dependence of the rate of the P-lactamase II catalysed hydrolysis of 
cephaloridine, benzy1penicillin and cefuroxime was studied. The buffers used were 
acetate (pH 4.0-5.3), MES (pH 5.6-6.5), MOPS (pH 7.0-8.0), TAPS (pH 8.0-9.4), 
CAPSO (pH 9.1-10.0), hexafluoroisopropanol (pH 9.0-10.5) and CAPS (pH 10.1- 
11) at 30'C, 0.05 M and I=1.0 M (NaCI). The concentration of enzyme used was 
0.04-2.0 pM and the concentration of zinc was 0.4840 gM. The substrate 
concentration was 0.12 mM for cephaloridine,, 1.10 mM for benzy1penicillin and 
0.28 mM for cefuroxime. The zinc concentration used was 0.840 pM. 
For solvent kinetic isotope effect experiments, the buffers were prepared in D20, 
and adjusted with NaODor DCL'The pD was measured using the following 
equation: pD = pH meter reading + 0.40 127 
Z2.3.3 Effect of zinc concentration oýi the fl-laclamase II activity 
The effect of zinc concentration's "on the rate (k,. /K. ) of the 0-lactamase II 
catalysed. hydrolysis of benzylpenicilfin was studied over a range of pH [4 - 7]. The 
enzyme activity was determined by monitoring the D-lactamase Il catalysed 
hydrolysis of benzy1penicillin (0.9 mm) at 30 T, in buffer solution (0.05 M, 
I=I M) containing various concentrations of zinc sulfate. The stability of the 
85 
ExperiMental 
substrate was tested, prior to the assay, in the presence of the metal ion 
concentration used for the enzymatic assays. 
The zinc ion content of the P-lactamase II stock solution was determined by atomic 
absorption spectrometry on a Perkin Elmer AAnalyst 100 Atomic Absorption 
Spectrometer. The hollow cathode lamp wavelength was set at 213.9 nm, with a 
current of 7 mA, and a slit width of 0.7 mn. Zinc nitrate solutions of different 
concentrations were used as standards. 
2. Z3.4 Methanolysis Studies 
The effect of the methanol concentration on the first order rate constant km for the 
P-lactamase III catalyses hydrolysis of cefuroxime was studied at pH 7.0 (MOPS 
buffer 0.05M, ionic strength IM (KCI), 30 "C). The cefuroxime, concentration used 
was 0.29 mK the enzyme concentration was 0.05 gM and the methanol 
concentration varied from 0-1 M. The experiment was repeated at pH 7.0 (MOPS 
buffer 0.05K ionic strength IM (KCI), 30 "C), methanol concentration IK with 
8.1 mM cefuroxime and 2 tiM enzyme. The hydrolysis product was analysed with 
mass spectrometry. The mixture was extracted twice with ethyl acetate after 
adjusting the pH to 2.5 with 0.1 M hydrochloric acid. Ethyl acetate was evaporated 
and the product analysed by ESMS. No methyl ester of the substrate was detected. 
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2.2.3.5 Inhibition Studies 
The compounds synthesised for this work and described in the first part of the 
experimental section were tested as inhibitors of P-lactamase II. Due to solubility 
problems in aqueous solution, the stock solutions of the compounds were prepared 
in ethanol. 
Unless otherwise stated, 25 pl. of solution of inhibitor at a given concentration, 
were added to 2.5 H of buffer containing 25 pl of a given concentration of 
substrate. The stability of the substrate in the presence of inhibitor was checked 
prior to the injection of the enzyme to the system. The time dependence of the 
inhibition was studied either by incubating the enzyme with inhibitor for different 
times before adding the substrate or by adding more substrate at the end of the 
reaction. Zinc sulfate was also added to the mixture in order to investigate metal 
chelating reactions, and restoration of the enzyme activity. The reproducibility was 
checked by repeating the assay with different concentrations of inhibitor. 
The Idnetic parameters were determined from the second-order rate constant 
k. t/K. - Inhibition constants Ki were calculated using the equations for competitive 
inhibition: 
Rate = 
kcst, [E]. [S] 
[S]+K 
. 
(Ki +[I] 
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(k 
_(k (_K1 LKm)i Km)oL[I1+Ki 
Equation 2.1 
where second-order rate constant with inhibitor 
and second-order rate constant without inhibitor 
if a= 
(kcA) 
then aK 
1 
Km 
01+ 
and Ki a- XIII 
_ a) 
Km 
= 
Km 
+ 
Km (kcat), (icat) 
0 
(kct)o(ý' 
Equation 2.2 
Values of Ki were. also obtained directly from the transformation of Equation 
2.1 to Equation 2.2 and by plotting 
K. ) 
against [1] to give an intercept on 
(!: 
ý 
I 
the inhibitior concentration axis of - Ki. 
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Results and Discussion 
3. Results and discussion 
3.1 Dependence of enzyme activity on buffer concentration and ionic 
strength. 
The effect of buffer species on enzyme kinetics has been previously reported'2' and 
can lead to inactivation or activation of the enzyme due to the reaction of the 
buffer with the substrate or the enzyme. Some proteins denature in pure water and 
require a moderate ionic strength for the stability of its active conformation 
129,130 
and so, the effect of salt concentration is also important 131 
A careful evaluation of these parameters on the enzyme catalysis is therefore 
necessary. The effect of buffer concentration and ionic strength on the second- 
order rate constant k, ,,, 
/K. for the P-lactamase II catalysed hydrolysis of 
cephaloridine was studied with both MOPS and phosphate buffers, whilst keeping 
all other variables constant. 
3.1.1 Effect of buffer concentration on fi-lactamase H activity 
The effect of buffer concentration on the second-order rate constant, kt/K., for 
the P-lactamase II catalysed hydrolysis of c'ephaloridine was studied 'with MOPS 
and phosphate buffers, pH 7.0,30 OC, 'at a constant ionic strength of 1.0 M 
(maintained with NaCl). The values of k. I JY, are listed in Table 3-1. ' 
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Table 3-1 Effect of buffer concentration on (kc. JK. ) for the P-lactamase 11 
catalysed hydrolysis of cephaloridine, pH 7.0,30 T, enzyme 0.1 gM 
Buffer 
0- Concentration (AV 
MOPS 
k,. IK., 
Phosphate 
k,,,. IK., (At' Xl) 
0.010 8.02 x 104 7.77 x 
104 
0.025 8.56 x 104 6.81 x 
104 
0.050 7.92 x 104 6.66 x 104 
0.075 7.37 x 104 6.08 x 104 
0.100 6.47 x 104 4.21 X 104 
0.150 6.22 x 104 4.61 X 
104 
0.200 6.05 x 104 
Figure 3.1 shows graphically the influence of the buffer concentration on kt/Y., 
for P-lactamase II catalysed hydrolysis of cephaloridine. The activity of the enzyme 
is influenced by the buffer concentration at fixed pH. An increase in the 
concentration of both MOPS (o) and phosphate (+) buffers induces a decrease in 
the rate of hydrolysis: a 50 % decrease in activity is observed when using 0.15 M 
phosphate buffer, compared with that at zero buffer concentration. The effect of 
the buffer concentration on the rate of hydrolysis is more pronounced with 
phosphate than with MOPS buffer, which may be due to a smaU inhibitory action 
of this buffer on the enzyme activity. Such effects have already been observed for 
carboxypeptidase which is similarly inhibited by phosphate ions 128 . It 
is difficult to 
propose a definitive physical explanation for this decrease in activity, but it does 
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demonstrate the importance of controlling buffer concentration when making 
comparisons in activity under different sets of conditions. 
9.00- 
0 
00 
7.00- + 
5.00- 
3.00 - 
1.00- 
0.00 0.05 0.10 0.15 0.20 0.25 
Buffer (M) 
Figure 3.1 Dependence on buffer concentration for the rate constant (ktAK, ) 
of the P-lactamase 11 catalysed hydrolysis of cephaloridine (o MOPS, + 
phosphate), pH 7.0130 T, enzyme 0.1 pM 
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3.1.2 Effect of ionic strength on fl-lactamase H activity 
The ionic strength dependence of the P-lactamase 11 activity with cephaloridine as 
the substrate has been studied using MOPS and phosphate buffers (0.01 M), at pH 
7.0 and at 30 *C, over the range 0.15-1.50 M ionic strength, varied with NaCl. The 
results are shown in Table 3-2. 
Table 3-2 Effect of ionic strength on the rate constant (k, JK, ) for 
P-lactamase H catalysed hydrolysis of cephaloridine, pH 7.0,30 T, enzyme 
0.1 tim 
Ic 
Strength (7W 
Buffer MOPS 
k,. IK. 
Buffer Ph osph ate 
0.17 4.73 x 104 3.81 X 104 
0.50 5.48 x 104 4.63 x 104 
1.00 7.01 X 104 6.51 X 104 
1.50 7.43 x 104 8.11 X 104 
The effect of varying the ionic strength with NaCl on the second-order rate 
constant (k,. t/K. ) of P-lactamase 11 catalysed hydrolysis of cephaloridine is shown 
graphically in Figure 3.2. The activity of the enzyme increases with increasing ionic 
strength. A two fold increase in the value of the second-order rate constant 
is observed when increasing the ionic strength form 0.01 to 1.0 M. Many enzymes 
have been found to be influenced by the ionic strength, which can affect their 
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stability and solubility as well as their catalytic activity 
130,132,133 
. The 
influence of 
ionic strength is complex and it is not very clear exactly how the reaction rate is 
affected, because several factors may be involved: 
Non specific salt effects as counterions - the addition of salts reduces the 
interaction between charged specieS134, the presence of counterions around charged 
groups weakens these interactions and may, for example, change the binding 
interactions between the enzyme and substrate or even increase the availability of 
the enzyme by decreasing binding of the enzyme to the charged glass cell 135 . 
Specific salt effects on protein folding: increases in ionic strength usually alter 
primarily electrostatic interactions in enzyme such as salt bridges or functionally 
linked ion binding136 .A higif ionic' strength may stabilise the enzyme through 
changes in the charge distribution involved in maintaining the active conformation 
of the protein 
137'138'139. SaItS May also affect the solubility of the enzyme (salting 
140,141 in/salting out effect on enzyme) 
Ionic strength may also favour substrate-enzyme interaction by decreasing the 
solubility of the substrate in the salted buffer. ,- 
The effect observed 6re is probably a generalized salt effect rather than a specific 
ion binding since it is rI elativ I ely small. The effect , of , the NaCI concentration on the 
activity of A. hydrophilia metallo-p-lactamase seems different from that observed 
here for B. cereus P-lactamase 11. For the former enzyme, a decrease in k,. IY., 
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values was observed when increasing NaCI concentrationS76 , but this effect was not 
explained. 
Based on the results of these studies, most subsequent experiments were 
undertaken using MOPS buffer at 0.05 M concentration and at constant ionic 
strength of I M. 
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Figure 3.2 Dependence on ionic strength for the rate constant (k,. t/K. ) of the 
P-lactamase H catalysed hydrolysis of cephaloridine (o MOPS, + phosphate), 
pH 7.0,30 *C, enzyme 0.1 tLM 
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3.2 pH dependence of the rate of hydrolysis 
In order to help determine the catalytic mechanism of P-lactamase 11, the pH 
dependence of kinetic parameters was measured over the pH range of 4-11. The 
pH dependencies of kt/K. for the P-lactamase II catalysed hydrolysis of 
cephaloridine and benzy1penicillin are shown in Figure 3.3 and Figure 3.4, 
respectively. The pH dependence of k,. t for the P-lactamase II catalysed hydrolysis 
of cefuroxime is shown in Figure 3.5. To ensure enzymic activity at extreme pH 
values, the enzyme concentrations used were high at these pH values and 
subsequently the zinc concentration was also higher and the concentration varied 
along the pH rate profile. The interpretation of the pH rate profile was made 
difficult at this stage as the effect of the zinc concentration on the pH rate profile 
(see chapter 3.4, page 13 1) was not taken into account at the time of these studies. 
3. ZI pH dependence of the second-order rate constant (k,., Wj of hydrolysis of 
cephaloyidine catalysed by fl-ladamase H 
The values of lcý. X. for the P-lactamase III catalysed hydrolysis of cephaloridine 
were deterrnined by observing the first-order disappearance of the substrate at 
cifferent pHs (Table 3-3). 
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Table 3-3 pH dependence of k,., K,, for the P-lactamase 11 catalysed 
hydrolysis of cephaloridine at 30 T and ionic strength 1.0 M (NaCl). Enzyme 
concentration 0.1-2 pM, zinc concentration 240 pM 
PH k,., IK. *. ffý sý4) PH k,. 1K. (M ýs 
4.23 1.33 x 102 5.25 3.77 x 104 
4.23 1.82 xW 5.25 3.77 x 104 
4.47 1.24 x 103 5,60 4.88 x 104 
4.55 1.15 x 103 6.00 5.47 x 104 
4.67 1.52 x 103 6.50 5.99 x 104 
4.75 6.55 x 103 7.00 5.60 x 104 
4.78 1.44 x 103 7.50 5.73 x 104 
4.78 1.84 x 103 8.00 5.83 x 104 
4.78 2.15 x 103 8.50 6.31 X 104 
5.04 2.45 x 103 9.23 6.37 x 104 
5.05 8.36 x 103 9. ý2 4.59 x 104 
5.06 4.94 x 103 9.75 2.61 X 104 
5.06 4.25 x 103 10.00 104 1.92 x 
5.06 7.14 x 103 10.24 1.34 x 104 
5.24 1.29 x 104 10.50 8.31 X 103 
The values of log k,. t/K. are plotted as a function of the pH in Figure 3.3. The pH 
dependence of log k,. t/Y.. for the P-lactamase II catalysed hydrolysis of 
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cephaloridine is bell-shaped, with a slope of 2 below pH 5.5 and a slope of -1 
above pH 9.5. These results indicate that there are at least three catalytically 
essential ionisations of the free enzyme, two acidic groups with very similar pK. 
values on the acidic pH limb and one base on the basic pH limb. 
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Figure 3.3 Dependence on pH for the second-order rate constant (log k., /K. ) 
of the P-lactamase H catalysed hydrolysis of cephaloridine, 30 *C, ionic 
strength 1.0 M (NaCI) 
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The calculated kinetic parameters and the apparent ionisation constants are shown 
in Table 34. It was not possible to distinguish between pK., and pK. 2, the two 
ionisation constants corresponding to the acid limb of the pH-rate profile, from the 
experimental data. 
Table 34 Kinetic parameters of the pH dependence of the P-lactamase H 
catalysed hydrolysis of cephaloridine, at 30 T and ionic strength 1.0 M 
(NaCI) 
Substrate k,. IK. (Mls-1) pK. I=pK. 2 pK..; 
Cephaloridine 6.76 (± 0.4) x 104 5.64 (±0.05) 9.64 (±O. I) 
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3. Z2 pH dependence of the second-order rate constant of hydrolysis of 
benqlpenicillin catalysed by Alactamase II 
The pH dependency of k,. /K. for the P-lactamase II catalysed hydrolysis of 
benzy1penicillin was studied over the pH range 4.2-10.5 (Table 3-5). 
Table 3-5 pH dependence of k. tAK. for the P-lactamase H catalysed 
hydrolysis of benzy1penicillin at 30 T and ionic strength 1.0 M (NaCl). 
Enzyme concentration 0.1-2 ILM, zinc concentration 240 pM 
PH k,. o(K. (MIX1) PH k,. IK. (Af 
4.25 2.59 x 1()2 8.00 3.67 x 105 
4.50 9.74 x l& 8.50 2.96 x 103 
5.00 3.20 x 103 9.00 2.60 x 103 
5.25 3.40 x 104 9.23 2.64 x 105 
5.25 1.94 x 104 9.40 1.61 x 105 
5.60 1.22 x 105 9.51 1.60 x 105 
5.65 1.17 x 103 9.52 1.88 x io, 
5.79 1.35 x 105 9.75 1.16 x 105 
6.00 3.88 x 105 9.85 9.67 x 104 
6.00 1.29 x 105 10.00 8.40 x 104 
6.50 3.62 x 105 10.07 4.72 x 104 
7.00 3.24x 105 10.24 4.42 x 104 
7.50 4.0 x 105 
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The plot of log kt/K. against pH for the D-lactamase II catalysed hydrolysis of 
benzy1penicillin as the substrate (Figure 3.4) is also a bell-shaped curve with again 
a slope of 2 below pH 6 and a slope of -1 above pH 9. The pK. values measured 
pK., = pK. 2 = 5.83 ± 0.05 and pY%. 3 = 9.30 ± 0.1 (Table 3-6) were very sinfflar to 
those obtained for the P-lactamase II catalysed hydrolysis of cephaloridine. The 
similar observations for two different substrates indicate that an intrinsic property 
of the enzyme is being reflected. The kinetic parameter k,. t/K. changes with the 
ionisation states of the free enzyme. In order to make comparisons with the 
ionisation dependency of the enzyme-substrate complex, a substrate was chosen 
which easily saturates the enzyme making it easy to measure the value of k,. t. 
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Figure 3.4 Dependence on pH for the rate constant (log k,. t/K. ) of the 
lactamase H catalysed hydrolysis of benzylpenicillin, 30 T, ionic strength 1.0 
M (NaCl) 
Table 3-6 Kinetic parame I ters of the pH dependence of the P-lactamase H 
catalysed hydrolysis of benzylpenicillin, at 30 T and ionic strength 1.0 M 
(NaCl) 
Substrate k,. IK. (AV fl) -pK. I=pK. 2- pK. 3 
Benzylpenicillin , 4.27, (± 0.6) x 105 5.83 (± 0.05) 9.30 (± 0-1) 
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3-Z3 pH dependence of the first-order rate constant (k,. j of hydrolysis of 
cefuraxime catalysed by P-lactamase H 
The pH dependence of k,. for the P-lactamase II catalysed hydrolysis of 
cefuroxime was investigated (Table 3-7). As the K. value for the P-lactamase II 
catalysed hydrolysis of cefuroxime was quite small (45 ±5 1IM34) , km values were 
easily determined from initial rate measurements under saturation conditions. 
Table 3-7 pH dependence of k,. t for the P-lactamase H catalysed hydrolysis of 
cefuroxime at 30 T and ionic strength 1.0 M (NaCI). Enzyme concentration 
0.1-2 pM, zinc concentration 240 pM 
PH kw ft4) PH kw ft") 
4.29 0.03 5.95 17.48 
4.52 0.12 6.05 39.66 
4.75 0.33 6.14 23.82 
5.04 2.76 6.25 25.42 
5.28 5.78 6.50 42.44 
5.51 7.89 7.01 33.04 
5.77 14.02 7.49 26.58 
5.77 10.89 8.00 44.30 
5.77 13.15 8.48 45.70 
5.84 33.30 9.02 39.90 
5.84 28.50 9.50 35.28 
5.84 24.60 10.00 '21.80 
5.95 16.90 10.50 6.92 
5.95 18.80 
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Figure 3.5 shows the plot of log kt against pH from the data in Table 3-7. A bell- 
shaped curve was obtained with again a slope of 2 at low pH and a slope of -1 at 
high pH. The pH dependence of k,,. t reflects the ionisation of the enzyme-substrate 
complex which appears, from these results, to be governed by the same ionisations, 
as those in the free enzyme. 
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Figure 3.5 Dependence on pH for the rate (log kc. t) of the P-lactamase H 
catalysed hydrolysis of Cefuroxime, 30 C, ionkstreýgth 1.0 M (NaCQ 
The calculated Idnetic parameters and corresponding ionisation constants are 
shown Table 3-8. 
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Table 3-8 Kinetic parameters of the pH dependence of the P-lactamase H 
catalysed hydrolysis of cefuroxime, at 30 T and ionic strength 1.0 M (NaCl) 
Substrate kcat (sý') PKal7TKa2 pK. 3 
Cefuroxime 35 (± 5) 5.73 (± 0.05) 
I- 
9.87 (± 0.1) 
3. Z4 Discussion 
The pH dependency of k,,., reflects the ionisation of the enzyme-substrate complex, 
but more precisely those of the amino acids residues of the enzyme involved in the 
rate-detennining step in the overall reaction 
142 
. whereas the pH dependence of 
k,,, /K. reflects the reactions of uncomplexed substrate or enzyme. 
The pH dependence of log k,.. t/K. for the hydrolysis of cephaloridine and 
benzy1penicillin are shown Figure 3.3 (page 98) and Figure 3.4 (page 102). The pH 
dependence of log k,. t for the hydrolysis of cefuroxime is shown in Figure 3.5 
(page 104). They all display a chara cteristic bell-shaped curves. Both kt and 
kw/K. are pH independent between pH 6 and 9. The logarithmic plots decrease 
with a slope of -1.0 at higher pH values but, suprisingly, with a slope of 2.0 at 
lower pH values. However, slopes of 2 for pH-rate profiles have been observed for 
other enzymes at low pH 143 
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The fact that similar behaviour is seen for three different substrates and for both 
k,. t/K. and kt shows that this is an intrinsic property of the enzyme and not the 
substrate. 
These results indicate the presence of at least three ionisable groups essential for 
enzyme activity, two acidic groups on the low pH side with very similar pK. values 
indiscernible from 5.6 ± 0.2, and one on the high pH side vvith a pK. of 9.5 ± 0.2. 
The observed pK. values must necessarily be the intrinsic pK. values of groups on 
the enzyme, since the same pK. values are obtained from the pH-rate profile of the 
hydrolysis of different substrates. Furthermore, identical pK. values were measured 
from the pH dependence of Ki for the thiol (1) (chapter 3.6.2.1), which further 
corroborates these findings. 
To ensure that. the rate constant measured was not compromised by loss of activity 
at low pHs (due to enzyme degradation or denaturation), the stability of the 
enzyme was determined at these pHs. The enzyme loses no more than 10 % of the 
original activity when repeated hydrolysis reaction are performed, by adding more 
substrate after completion of the first hydrolysis. Furthermore, the enzyme was left 
at pH 4.0 for the corresponding time to that required for complete hydrolysis of the 
substrate, and its activity was, then checked by'changing the pH to 7.0. The rate 
constants measured for hydrolysis were identical to those obtained under normal 
conditions at pH 7.0. Circular dichioism spectra were recorded with the 
lactamase Il at pH, 4.5 14 -4, which, showed, no change indicative of apparent 
denaturation of the enzyme at this pH. 
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The scheme for the ionisation of the free enzyme which is consistent with the pH 
rate profiles is shown in Scheme 3-1, where the active form of the enzyme is EH. 
py, al pKa2 
- 
pKa3 
Elb --ýr- EH2 -- EH - . or- E 
lemx 
Product 
Scheme 3-1 
Below saturation the observed pseudo first order rate constant, k,,,, varies with pH 
according to Equation 3.1, which generates a bell-shaped pH-rate dependency. At 
high pl-L K., and K. 2 are much greater than (11) and k, ýb. is given by 
k'"1(l+K. 31(W)). The inflection at high pH thus coffesponds to Ko. At low pH, 
two inflections should theoretically be seen and at pHs below pY-. j the rate 
constant would show and inverse second order dependence on (W) concentration. 
A logarithrnic plot of ko. against pH would thus show a slope of 2 at low pH. 
However, if pK., and pV, 2 are close then it is difficult to experimentally distinguish 
between them. 
kabs 
=-+ (H+)2 
km&x 
(H') / K&2 / K&, K&2 +I+ K&3 / (H+) 
Equation 3.1 
To illustrate the difficulty in distinguishing two close pY... values, theoretical curves 
were calculated using Equation 3.1, with different ApKs and plotted in Figure 3.6, 
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Figure 3.7 and Figure 3.8. It is clear from these plots that even when the two low 
pK. values are separated by two pK. units it is not easy to evaluate the two values 
accurately. 
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Figure 3.6 Theoretical curves generated from Scheme 3-1 and Equation 3-1. 
Parameters used: pK., = 4, pK. 2 = 6, pK. 3 = 9.1, log k" = 2.0 
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Figure 3.7 Theoretical curves generated from Scheme 3-1 and Equation 3-1. 
Parameters used: pK., = 4, pKa2 5, pK. 3 9.1, log k"" = 2.0 
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Figure 3.8 Theoretical curves generated from Scheme 3-1 and Equation 3-1. 
Parameters used : pK., = 4.5, pK. 2 = 5, pK. 3 = 9.1, log k" = 2.0 
The above plots demonstrate that if an enzyme has two catalytically important acid 
residues, the pY.. values are not easily distinguished unless separated by at least 
two pH units. 
In the case of the O-Jactamase H the activity of the enzyme is linked to the 
ionisation of two acidic groups both with pY... values indistinguishable from 5.6 and 
of one basic group with a pK. of 9.5. The assignment of these pK. values to 
specific active site residues is still arnatter of debate and is discussed below. 
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Earlier studies on pH dependence of the reaction of synthetic substrates with 
carboxypeptidase A, showed ionisation of two groups in the free enzyme, one with 
a pK. of 6.4 which was attributed to a Glu, and the other one with a pK, value of 
9.4 which was assigned to zinc-bound water79,80. However, mechanistic 
investigations led to different assigmnents for these inflections, with the low pY,,. 
value being assigned to the zinc bound water'45,146,147,90 and the high pK. value to 
49,149 
the Tyr 248 phenol group or to the His 196 residue' 
The pK. of hydrated zinc is about 9.615', however, it is known that coordination of 
a water molecule to a metal centre in enzymes significantly lowers its pY,., with 
reported values as low as 5-615 1,15ZI53 , this 
is mainly due to the environment of the 
zinc ion in the enzyme and to the Lewis acid properties of the metal. 
Carbonic anhydrase is a mono zinc metallo-enzyme which catalyses the reversible 
hydrationOf C02to HC03 The zinc ion is coordinated by three histidine residues 
153,154,155,156 
and a water molecule which has a pl-C, of about 6 
The pY.. of the zinc-bound water in the binuclear zinc metallo-p-lactamase from B. 
ftagilis is reported to be 6.2 for the free enzyme". However upon binding to the 
substrate, this pY%.. value is thought to be reduced to 4.2, mainly because of a more 
favourable deprotonation of the zinc-bound water to generate a negative charge 
which is better stabilised by the positive charge of the two zinc ions6'. 
By analogy with the other metallo-enzymes, we propose that one of the acid 
groups responsible for the low pY, value (5.6) observed for the pH dependence of 
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P-lactamase 11 catalysed hydrolysis of D-lactarns reflects ionization of the zinc- 
bound water. This proposal is substantiated by the pH dependency of the inhibition 
of P-lactamase 11 by thiol (1) reported later in chapter 3.6.2.1. The other low pK, 
value may reflect the ionisation of an essential arnino acid residue. 
Aspartate 90 is a highly conserved amino-acid in metallo P-lactamase sequences", 
which is located in the active site at 2.6 A from the zinc-bound water of the P- 
lactamase 1158. It has been suggested that it has a catalytic role as a general base'. 
It is therefore likely that the second pK. value of 5.6 reflects the ionisation of this 
amino acid residue. 
The identity of the acidic group with the high pK. value of 9.5 on the enzyme has 
not been established. 
The mechanistic deductions made from these pH-rate profiles are discussed later, 
as are alternative interpretations. 
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3.3 Kinetic solvent isotope effects 
Kinetic solvent isotope effects were determined for the second-order rate constant 
(k. t/K. ) of the P-lactamase 11 catalysed hydrolysis of various P-lactams. The pD- 
rate profile for cephaloridine and benzy1penicillin are shown in Figure 3.9 and 
Figure 3.10 respectively. 
3.3.1 pD dependence of the second-order rate constant (kwWj of hydrolysis of 
cephaloridine catalysed by fl-laciamase H 
Values of k,. /K. for the P-lactamase 11 catalysed hydrolysis of cephaloridine were 
determined at different pD values (Table 3-9). The plot of log k,. /K. is shown in 
Figure 3.9. The curve is bell-shaped and, sinfilar to the pH dependence of lcw/K., 
there is a second-order dependence of the rate constant on the (D") concentration 
at low pD. The kinetic parameters obtained and ionisation constants are shown in 
Table 3 -10. 
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Table 3-9 pl) dependence of k,. t/K. for the P-lactamase 11 catalysed 
hydrolysis of cephaloridine at 30 *C and ionic strength 1.0 M (NaCl). Enzyme 
concentration 0.1-2 AM, zinc concentration 2-40 AM 
pD II kcatlKm (M pD kcatWm (AI4 sý4) 
4.77 4.47 x 102 8.01 7.26 x 104 
5.04 2.67 x 103 8.21 8.03 x 104 
5.25 1.47 x 104 8.47 7.29 x 104 
5.56 1.78 x 104 8.58 8.01 X 104 
5.68 3.27 x 104 8.99 8.27 x 104 
5.98 5.50 x 104 9.48 4.37 x 104 
6.47 8.51 X 104, 10.05 3.25 x 104 
6.96 7.29 x 104 10.60 1.85 x 104 
7.47 7.33 X 104 11.03 8.76 x 103 
7.47 7.73 x 104 
1 
11.52 1 4.41 X 103 
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Figure 3.9 Dependence on pD for the second-order rate constant (log k,, AK, ) 
of the P-lactamase 11 catalysed hydrolysis of cephaloridine, 30 OC, ionic 
strength 1.0 M (NaCI) 
Table 3-10 Kinetic parameters of the pD, dependence of the P-lactamase H 
catalysed hydrolysis of cephaloridine, at'30 *C and ionic strength 1.0 M 
(NaCQ 
Substrate k, ýýW. (Ml s4) pK. I=pK. 2 pK. 3 
cephaloridine 7.94 0.05) x1 04 5.70 (±0.05), , 
10.14 0-1) 
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3.3.2 pD dependence of the second-order rate constant (k,,. IK. ) of hydrolysis of 
benzylpenicillin catalysed by fl-lactamase H 
The pD dependence of k., /K. for the P-lactamase II catalysed hydrolysis of 
benzylpenicillin was also investigated (Table 3-11). The results are presented in 
Figure 3.10 as a plot of log kt/K. against pD. The curve is bell-shaped and the pD 
dependency is sin-filar to that observed for cephaloridine, there is a slope of 2 at 
low pD indicating the second-order dependence on hydronium ion concentration of 
the rate at low pD and a slope of -1 at high pD. The results are shown in Table 3- 
12. 
Table 3-11 pl) dependence of k. JK. for the P-lactamase H catalysed 
hydrolysis of benzy1penicillin at 30 *C and ionic strength 1.0 M (NaCI) 
Enzyme concentration 0.1-2 ILM, zinc concentration 240 pM 
pD 
1 
kcatIKm ffi14 äý1) ýpD kcatIKm (Arl ýe"') 
4.77 7.21 x 102 8.47 2.40 x 105 
5.04 2.43 x 103 8.47 2.35 x 105 
5.04 2.61 x 103 8.99 2.49 x 105 
5.25 1.30 x 104 8.99' 2.59'x 10' 
5.56 -7.01 X 
104 ý -, - ý 9.48 , 2.44 x 105 ' 
5.98 
t 
1.14 x 105 9.48 3.05 x 105 
6.47 1.47 x 105 10.05 1.. 23 x 103 
6.96, 1.8 1x lo, 10.05 05 1.61 x1 
7.47 1.66? c 105 10.60 1()4 5.86 x 
7.47 1.76 x 103 
' 
11.03 104 2.43 x 
8.01 95 1.65 x. l 11.52. 4.13 X 103 
8.01 1.53 x 10' 
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Figure 3.10 Dependence on pD for the rate constant (log kcaJKm) of the 
P-lactamase H catalysed hydrolysis of benzylpenicillin, 30 T, ionic strength 
1.0 M (NaCQ 
Table 3-12 Kinetic parameters of the pD dependence of the P-lactamase H 
catalysed hydrolysis of benzylpenicillin, at 30 T and ionic strength 1.0 M 
(NaCl) 
Substrate (Ae sý') 'pK. I=pK. 2 pK. 3 
Benzylpenicillin 2.34 5) 105 5.91 0.05) 10.04 (± 0.1) 
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3.3.3 Determination of the kinetic parametersfor the fl-lactamase H catalysed 
hydrolysis of fl-lactams in H20andD20 
3.3.3.1 Cephaloridine 
The kinetics parameters K. and k,. for the P-lactamase II catalysed hydrolysis of 
cephaloridine were detem-dned in H20 and D20from linear plots of substrate 
concentration versus substrate / initial rate (Hanes plot), and analysed according to 
the Hanes equation below: 
[S] 
+ 
K. 
V.. V. 
U 
A[A]IAt values were measured at different substrate concentrations, and dividing 
A[A]/At by Ae gave the initial rates. The results are listed in Table 3-13 for H20 
and Table 3-14 for D20. At concentrations of cephaloridine, above Ix 10'3 M some 
product inhibition was observed. A decrease in the rate of hydrolysis was observed 
when repeated hydrolyses were performed. Therefore the cephaloridine 
concentrations used for the kinetic parameters determination were kept below 10-3 
M. 
The results were plotted and are shown in Figure 3.11 for H20 and Figure 3.12 for 
D20- Using the Hanes plot- and fitting the results to'a linear regression gave the 
slope equal to IN. and the intercept equal to K. /V. The kinetic parameters are 
listed in Table 3-15 (page 122). 
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Table 3-13 Initial rates measured for the P-lactamase 11 catalysed hydrolysis 
of cephaloridine in H20 at 30 T, pH 7.0, ionic strength 1.0 M (NaCI), enzyme 
concentration 0.1 pM, zinc concentration 2 pM 
Ae(M'cm-') Cephalotidine(Ap initial rate (M, ý") substratelinitial rate (s) 
AE26o= 9444 ± 1.00 x 10-1 5.725 x 10'8 1.747-x _102 
645 
Ae26o= 9444 ± 2.00 x 10'5 1.338 x 10,7 1.495 xW 
645 
AP-260=9444 ± 2.88 x 10'5 1.956 x 10.7 1.472 x 102 
645 
Ac26o= 9444 ± 4.80 x 10-5 2.722 x 10-7 1.763 X 102 
645 
A&260-'ý 9444 ± 7.68 x 10-5 4.707 x 10-7 1.632 x 102 
645 
AF-260=9444 ± 1.00 X 10-4 7.069 x 10-7 1.415 xW 
645 
A6260=9444 ± 2.00 x 104 1.256 x 10-6 1.592 x 102 
645 
AF-260=9444 ± 2.88 x 10-4 1.440 x 10'6 2.000 x 102 
645 
AS280=4141 ± 4.80 x 10-4 2.625 x 10"6 1.829 x 102 
306 
AP-280==4141 ± 7.68 x 10'4 2.852 x 10"6 2.693 xW 
306 
AF-290=1990 ± 1.00 x 10-1 3.880 x 10'6 2.577 x 102 
40 1 1 
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Figure 3.11 Hanes plot for the P-lactamase II catalysed hydrolysis of 
cephaloridine in H20, pH 7.0,30 *C, ionic streng. th 1.0 M (NaCI) 
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Table 3-14 Initial rates measured for the P-lactamase 11 catalysed hydrolysis 
of cephaloridine in D20 at 30 *C, pD 7.0, ionic strength 1.0 M (NaCI), 
Enzyme concentration 0.1 pM, zinc concentration 2 pM 
, de(Aflcm-1) Cephaloridine(30 initialrate(Ms) substratezinitiatrate(s) 
jär-26o=8057 1. o0 x io-, 7.587 x 10-" 1.318 x 
102 
300 
As26o=8057 ± 2.88 x 10»3 2.184 x 10,7 1.319 x 102 
300 
jär-26ü--8057 ± 4.80 x 10»5 3.399 x 
10"7 1.412 x 102 
300 
AF, 26o=8057 ± 7.68 x 10'5 5.120 X lo"7 1.501 x 102 
300 
, är. z6o=8057 ± 1 OOE x 
10-4 7.232 x 1T7 1.383 x 102 
300 
AF-2604057 ± 2.00 x 10-4 1.437 x 10-6 1.392 x 102 
300 
As28o= 4284 2.88 x IW4 1.720 x 10"6 1.674 x 102 
140 
iäC28o= 4284 4.80 x 10-4 2.400 x 10«6 2.000 x 102 
140 
jäF-29oý 1708 7.68 x 
10'4 3.049 x 10-6 2.519 x 102 
34 
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Figure 3.12 Hanes plot for the P-lactamase H catalysed hydrolysis of 
cephaloridine in D20, pD 7.0,30 *C, ionic strength 1.0 M (NaCI) 
Table 3-15 Kinetic parameters for the P-lactamase H catalysed hydrolysis of 
cephaloridine in H20 and D20 at 30 *C, pH/pD 7.0. 
Solvent ]IT'"Pes) K. 11ý. (Ms) k,. (f) K. (M 
H20 115514 152 86.6 1.3 x 10'3 
D20 
_-'154836, 
127 64.6 0.82 x 10'3 
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3.3-3.2 Bemylpenicillin 
The kinetic parameters for the P-lactamase 11 catalysed hydrolysis of 
benzy1penicillin were also determined in H20 and D20 from linear plots of 
substrate concentration versus substraterinitial rate (Figure 3.13 for H20 and 
Figure 3.14 for D20) and analysed according to the Hanes equation. The results 
are listed in Table 3-18 (126). 
Table 3-16 Initial rates measured for the P-lactamase H catalysed hydrolysis 
of benzy1penicillin in H20 at 30 *C, pH 7.0, ionic strength 1.0 M (NaCl), 
Enzyme concentration 0.1 pM, zinc concentration 2 pM 
, dg(Mlcm-1) Ben; pipenicillin(" initialrate(Mýil) Substratelinitial 
rate (s) 
, 
äc230= 967 ± 50 5.20 x 10-4 7.44 x 10-6 69.89 
, 
äc23o= 967 ± 50 6.94 x 10«'4 9.87 x 10«'6 70.33 
, 
äc23o= 967 ± 50 8.67 x 10-4 , 1.21 x 1T5 71.83 
, 
är. 
230= 967 ± 50 . ()0 X 
10,3 1.05 x -io-, 95.24 
, 
äc23o= 967 ± 50 1.04 x 10-' 1.34 x 1T5 77.69 
A£233--ý 954 ± 45 1. OS X 10-3 1.22 x 10'5 88.82 
AF, 237= 642 ± 22 1.45 x 
10-3 1.48 x 10-3 98.31 
AF, 233--2»954 ± 45 1.62 x 10-3 1.39 x 10-5 116.97 
Ar. 233ý= 954 ± 45 2.18 x 10-3 
' 
1.46 x IO's 148.77 
är, 237= 642 ± 22 2.60 x 10'3 2.47 x 10'5 105.26 
AF-248=172 ± 10 3.63 x 10'3 2.12 x 10 170.99 
A8248= 172 ± 10 4.00 x 10«3 2.88 x 10»5 139.08 
AS248= 172 ± 10 4.35 x 10-3 2.58 x IO's 168.80 
AF-248= 172 ± 10 6.40 x 10-3 2.53 x 10'5 252.76 
AF-248ý 172 ± 10 6.00 X 10-3 2.70 x 10'5 222.30 
dAF-248=172 ± 10 9. o() x 1()-3 2.77 x 10-3 325.03 
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Figure 3.13 Hanes plot for the P-lactamase H catalysed hydrolysis of 
benzy1penicillin in H20, pH 7o6,30 "C, ionic strength 1.0 M (NaCI) 
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A similar experiment was repeated in D20 
Table 3-17 Initial rates measured for the P-lactamase 11 catalysed hydrolysis 
of bcnzylpenicillin in D20at 30 *C, pD 7.0, ionic strength 1.0 M (NaCI) 
Enzyme concentration 0.1 pM, zinc concentration 2 pM 
, de(M'cm-') Ben2y1penicillin(m initial rate (Msý") Substratelinitial 
rate (s) 
Ac230= 1022 ± 24 5.20 x 10-4 7.16 x 10'6 72.66 
Ac23o= 1022 ± 24 6.94 x 10 -4 9.67 x 10'6 71.74 
Ac23o= 1022 ± 24 &67 x 10"4 1.09 x 10" 79.69 
Ae23o= 1022 ± 24 1.04 x 10-3 1.19 x 10-1 87.77 
A&237= 642 ± 22 - 1.00 x 101 , 9.75 x 10'6 102.56 
Ae237= 642 ± 22 2.00x 10 1.27 x 10's 157.48 
AF-248= 182 ±9 41 . 00 x'10" 1.72 x 
10-5 232.29 
AF-248= 182 ±9 
I-- 
T 
6.40 x 10-3 1.98 x 10-' 323.07 
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Figure 3.14 Hanes plot,. Ifor, 
the P-lactamase H catalysed hydrolysis of 
benzy1penicillin in D20, pD 7.0,30 *C, ionic strength 1.0 M (NaCI) 
Table 3-18 Kinetic parameters for the P-lactamase H catalysed hydrolysis or 
benzylpenicitlin in H20 and D20 at 30 *C, pH/pD 7.0 
Solvent 11V. (31"s) K. IV.. (Ms) k. (ký1) K. (AV 
H20 2.913 x 104 54.36 343 1.87 x 10'3 
D20 4.385 x 104 50.34 228 1.15 X 10-3 
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3.3.3.3 Cefuroxime 
As K. for the P-lactamase 11 catalysed hydrolysis of cefuroxime is low, 45 ±5 
gM", is was easy to work at substrate concentrations as high as 6 times K. for k,. t 
determination. The initial rates were measured at pH and pl) 7.0 and k,. t was 
determined by dividing the initial rates by the enzyme concentration. Values of k,. / 
K. were determined by following the entire course of the hydrolysis of 23.9 pM of 
cefuroxime at X= 260 run at pH and pD 7.0. A good pseudo-first order rate 
constant kb. was measured which, when divided by the enzyme concentration, gave 
k,,,,, / 
Table 3-19 k,. t and kc. t/K. 'for the P-lactamase II catalysed hydrolysis of 
cefuroxime in H20 and D20 at pH /pD 7.0,30 *C, ionic strength 1.0 M (KCI) 
Solvent ký «, ) ký,. ý. (Af' ý"') 
pH 7.0 35 ±5 7.74 ±1x 105 
pD 7.0 22 ±3 6.31 ± 0.7 x 105 
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3.3.4 Discussion of the kinetic solvent isotope effects 
To determine the kinetic solvent isotope effects on the P-lactamase II kinetic 
parameters and ionisation constants, " the pH dependencies of kt/K. were 
detennined in D20for the P-lactamase II catalysed hydrolysis of cephaloridine and 
benzy1penicillin (Figure 3.9 and Figure 3.10 respectively, pages 115 and 117). 
Solvent kinetic isotope effects on k,. t, were also determined by measuring the initial 
rate of the P-lactamase R catalysed hydrolysis of cephaloridine, benzylpenicillin and 
cefuroxime in D20, the data were analysed using Hanes plots (Figure 3.11, Figure 
3.12, Figure 3.13 and Figure 3.14, page 120,122,124 and 126). The kinetic 
parameters and ionisation constants in H20 and D20 and the solvent isotope effects 
are summarized in Table 3-20. 
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Table 3-20 Kinetic parameters for the P-lactamase 11 catalysed hydrolysis of 
fl-lactams 
Benzylpenicillin Cephaloridine Cefuraxime 
pK., = PK. 2(H20) 5.83 ± 0.05 5.46 ± 0.05 5.73 0.1 
pK., = pK. 2 (D20) 5.91 ± 0.05 5.70 ± 0.05 
ApK'. "O/D, 10 +0.08 +0.24 
pK, 3 (H20) 9.30± 0.1 9.64 d: 0.1 9.87 ± 0.1 
pK. 3 
(D20) 10.04 ± 0.1 10.14 ± 0.1 - 
ApK H20/D20 a3 +0,74 +0.50 
(kcat/Km) H20 M-1 S-1 4.27 (± 0.6) x 105 6.58 (: t 0.4) x 104 7.74 (± 1) x 10' 
(k. t/K. )%OAVSýl 2-34(±0.5)xW 7.87 (± 0.05) x 
104 
6.31 (± 0.7) x 105 
(ka&t/K. ) 1120 
(k 
cat 
/K 
. 
)D2O 
1.82 0.85 1.23 
k 
H20 
S-1 
cat 
336 ± 10 87± 5 35 ±5 
k 
D20 
S-1 cat 
232 ± 10 65 ±5 22 ±3 
V20 /k D20 
cat cat 
1.4 1.3 1.6 
Changing the solvent from H20 to D20 alters the pY... of acidic groups - generally 
the pY,,. in D20is about 0.3 to '0.4 higher than in H20 
127 
. There is also the 
possibility of a primary kinetic isotope effect if a bond to hydrogen is broken in the 
rate-limiting step. Interpreting observed kinetic solvent isotope effects on the rate 
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of enzyme catalysed reactions usually assumes that all ionisable protons of the 
enzyme are rapidly exchanged in D20. 
The pD dependence of the rate constants (both k,. dK. and k,. t) of the P-lactarnase 
11 catalysed hydrolysis of P-lactams, pD below 5, shows an inverse second order 
dependence on deuterium-ion concentration. The slope of log k,. /K. against pD 
being 2.0. As with the studies in H20, - 
it was not possible to separatq the two low 
pK. values. The similar behaviour of the enzyme in H20 and D20 again indicates 
that the observations reflect an intrinsic property of the enzyme. The increase in 
pK, 3 of about 0.6 ± 0.2 in D20 is in the range expected for a weak acid. It was 
hoped that the change in solvent to D20 may have a differential effect on pK., and 
pKa and thus make it easier to identify the'individual pKs. Unfortunately, this was 
not the case and it is not clear whether the apparent change in pKj and pY,. 2is real 
or simply an experimental consequence of their close values. 
A relatively small kinetic solvent isotope effect was observed on k,. t/K. and kt. 
(kc&t/Km) H, 0 
(km /K. ) 
DZO was 1.82 for the hydrolysis of benzylpenicillin, 0.85 for 
cephaloridine and 1.23 for cefuroxime and k 
H20 k D20 was 1.4 for cat cat 
benzylpenicillin, 1.5 for cephaloridine and 1.6 for cefuroxime. 
The mechanistic significance of these solvent kinetic isotope effects is discussed in 
chapter 3.7. 
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3.4 Zinc dependence of P-lactamase 11 activity 
3.4.1 Determination of the zinc concentration of the &Iactamase H stock 
solution. 
The zinc content of the stock solution to the P-lactamase II was measured by atomic 
absorption. It was found that the molar ratio of zinc to enzyme in the stock solution 
was two to one. Thus an experiment conducted with 1.0 x 10-8 M enzyme and no 
added zinc ion actually contained 2.0 x 1071 M Zn (II). 
Because the rates were so slow at low pH and to ensure that the enzyme catalysed 
reaction was being observed, higher concentrations of P-lactamase II were used. 
Subsequently, the lowest zinc concentration attained was restricted by the enzyme 
concentration used. 
3.4.2 Zinc dependence of the P-lactamase H activity atpH ZO 
The dependence of the second-order rate constant (k,, A/K. ) for the P-lactamase II 
catalysed hydrolysis of cephaloridine on the zinc ion concentration was exarnined at 
pH 7.0,30 T and at constant ionic strength of IM (NaCl), the results are 
II 
summarized in Table 3-21. It is important to note that the zinc concentrations used 
in this study are not found in physiological conditions. 
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Increasing the zinc ion concentration from 10-7 M to 10-3 M does not strongly affect 
the rate (kw/K. ) of the catalysed hydrolysis of cephaloridine at pH 7.0 as only a 30 
% increase is observed in the rate for a 10 4 fold change in metal-ion concentration. 
Table 3-21 Effect of zinc concentration on the rate constant (k., /K. ) of the 
P-lactamase H catalysed hydrolysis of cephaloridine (0.15 mM) at pH 7.0, 
30 *C, ionic strength 1.0 M (NaCI), enzyme concentration 0.1 pM 
Zinc concentration (7W 
II kwW. (M ý') 
2.0 xI o-7 7.54 x 104 
3.0 x 10-7 7.96 x 104 
1.2 x 10"6 7.39 x 104 
1.0 x 10-1 8.42 x 104 
1.0 x 10 9.19 X 104 
1.0 x 10 10.28 x 104 
Many zinc proteases are inhibited by excess zinc, such as thermolysin, ACE, 
carboxypeptidase A7'. However, B. cereus P-lactamase II is reported to be fully 
active with one zinc ion, and the binding of a second zinc ion of lower affinity 
slightly increases its activity 76 
In order to determine the importance of zinc concentration on P-lactamase Il 
activity, the zinc content of the enzyme stock solution was measured. The zinc 
content of the enzyme stock solution was found to be two moles of zinc for one 
mole of enzyme and it could therefore be argued that the results listed in Table 3- 
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21 are not valid as two zinc are already present with the enzyme. However, it was 
reported in early studieS43'44 that the P-lactamase 11 binds two zinc, one zinc being 
tightly bound with a dissociation constant of I pM and the second loosely bound 
with a dissociation constant of 24 mM. Because of the low affinity of the second 
zinc for the enzyme, it can be assumed that only one zinc is bound to the enzyme in 
the stock solution at neutral pl-L therefore validating the results of the studies of 
the effect of the zinc concentration on the enzyme activity. 
3.4.3 Effect of the zinc concentration of the fl-lactamase H activity at lowpH 
N 
The pH dependence of the rate constant (kt/K. ) for the P-lactamase II catalysed 
hydrolysis of benzylpenicilfin was studied at different zinc concentrations (Table 3- 
22) at low pH. To ensure that the effect of zinc concentration observed on the 
enzyme catalysed reaction was not due to any background reaction, the experiment 
was performed for a fixed zinc concentration and pH with two different enzyme 
concentrations. Identical results wer6 obtained showing that the effect on the 
enzyme catalysed reaction was independent of the enzyme concentration. 
Figure 3.15 shows the effect of zinc ion concentration on P-lactamase II activity at 
different pH values, whilst Figure 3.16 shows the pH-dependence of P-lactamase II 
activity in the presence of different zipc concentrations at'low pH. 
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Table 3-22 k,., /K. of P-lactamase 11 catalysed hydrolysis of benzy1penicillin at 
different zinc ion concentrations over p1l range 4-6 at 30 *C, ionic strength 
1.0 M (NaCQ. Enzyme concentration 0.1-6 pM 
Zincconcentration(30 1.0x10jm 1. OX10-3M 1. OXIO-4M 
PH kelK. (Aflsl) kwK. (Ws) 
5.98 5.13 x 103 4.71 x 105 5.15 x 10' 
5.44 4.81 x 105 4.20 x 105 4.36 x 105 
5.49 4.76 x 105 4.27 x 105 4.56 x 105 
5.05 3.70 x 105 4.09 x 105 3.26 x 105 
4.51 3.01 x 103 , 1.34 x 105 ý 
1.01 X 104 
1 
4.25 
1 
1.01 x io, 
-- 
2.31 x 103 1.25 x 103 
4.03 2.86xIi 
t 
2.90x--IÖ-'- 3.30 x 102 
Zin c con cen tration (AO i. oxio-Sm 1. OXIO-6M 
Pii k, lK. kwX. (Hl sý4) 
5.98 4.33 x 105 3.85 x 10' 
5.71 3.216 x 105 
5.53 1.625 x 105 
5.49 3.24 x 105 
5.44 2.98 x 105 
5.27 2.76 x 103 
5.21 1.420 x 1()4 
5.05 8.87 x 104 2.51 x 103 
4.51 7.54 x 102 
4.25 2.02 x 102 
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The effect of zinc ion concentration on the second-order rate constant k,, t/Km was 
studied over the pH range 4-6 and was found to be pH dependent (Figure 3.15) 
The enzyme activity greatly decreased below pH 5.5 when lowering the zinc 
concentration and increased upon the addition of zinc. No observable activity was 
seen at pH 4.0 with zinc concentrations lower than I Cr4K but increasing the zinc 
concentration restored the enzyme activity. The effect of zinc concentration on the 
enzyme activity, however, decreased as the pH increased such that enzyme activity 
becomes independent of the zinc concentration above pH 6. 
The plot of the rate constant (log k.. t/K. ) of the P-lactamase II catalysed hydrolysis 
of benzy1penicillin against the logarithm of zinc concentration (Figure 3.15) shows 
a first order dependence on the zinc concentration, as the slopes at the different 
pHs are unity. 
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Figure 3.15 Plot of log zinc concentration against the rate constant (log 
kcaA(, ) of the P-lactamase H catalysed hydrolysis, of benzy1penicillin over the, 
pH range 4-6 
The results in Table 3-22 were also plotted as the logarithm of k., /K. against pH 
(over the pH range 4- 6) for different zinc concentrations (Figure 3.16). This plot 
shows that the enzyme activity is retained at low pH when increasing the zinc 
concentration as the enzyme is still active at pH 4.0 when using zinc concentrations 
above I O"4M. The pH-rate profile observed decrease with a slope of 3 at low pH 
I 
values. The other notable feature of Figure 3.16 is that the apparent pY, shifts from 
about 6 at low zinc ion concentration to about 4.5 with 0.01 M metal-ion. 
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Figure 3.16 pH-log k., /K. profile for the P-lactamase H catalysed hydrolysis 
of benzy1penicillin at different zinc concentrations 
It can be seen from the plot above that the enzyme activity at low pH for the 
different zinc concentrations is third order in hydronium ion concentration. This 
result suggest that in addition to the ionisation of the two acidic groups previously 
reported in the pH-rate profile discussion, we could also be observing the effect of 
competition between the hydronium, ion and the tightly bound zinc for the enzyme 
metal binding ligands, therefore loosing the zinc upon decreasing pH. 
Another possible explanation for this effect could be the binding of a second zinc 
ion at low pH upon increase of the zinc concentration. The binding of the second 
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zinc could have a structural or a catalytic role. Analogy with other binuclear 
lactamases may suggest a fairly direct interaction between the two metal ions. 
OH2 
Enz-Zn---OH2 Enz-Zn--, OH2 ------ Zn 
I N.., 
AsP90CO2H 
AsP90CO2H 
Inactive Inactive 
OH2 
Enz-Zn---OH Enz-Zn---OH------2ý 
lSP9OCO2H '\ 
AspgOC02H 
Inactive Inactive 
. 
0112 
Enz-Zn---OH2 ...... ; Zý 
`\ 
"I ", 
AsP90CO2' 
OH2 
Inactive 
Enz-Zn---OH Enz-Zn---OH ----- ; Zn 
AsP90CO2' 
AsP90CO2 
Active 
Active 
OH 
Enz-Zn---OH ----- ; zn 
As'P90CO2- 
Inactive 
Scheme 3-2 
Scheme 3-2 shows the possible ionisations involved when the enzyme binds one or 
two zinc ions. 
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When the enzyme is mononuclear, enzyme activity is observed when the two 
important groups zinc-bound water and Asp90 are in their deprotonated forms. 
The apparent pK. values of these two group have been previously determined 
during the pH-rate profile studies and were found to be indiscernible from 5.6. 
Therefore below pH 5.6, protonation of these groups generates an inactive 
enzyme. 
When the enzyme binds two zinc ions, it is again inactive when the two 
catalytically important groups, zinc-bound water and Asp90 are in their protonated 
forms. The second metal ion binds weakly as its coordination is modulated by the 
active site and Kd for the second zinc was found to be 24 nIW3,44. Increasing zinc 
concentrations drives the equilibrium toward the binuclear enzyme. The binding of 
the second zinc lowers the apparent pK. value of the catalytically important groups 
and so generates active enzyme at lower pH than in the mononuclear case. 
Assuming that three ionisations, of the enzyme shown in Scheme 3-3, pYI, pK. 2 
and pK. 3, are indiscernible from each other, then curve fitting of the pH-rate profile 
was achieved using Equation 3.2 and are plotted in Figure 3.16. This allows us to 
calculate the apparent pK, on the acidic limb for the pH-rate constant (log lcu/K, ) 
profiles of the P-lactamase H catalysed hydrolysis of benzylpeniciflin at different 
zinc concentrations. 
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py,. l pK. 2 PKC EI14 - Ell., im- EH2 -- EH 
pKa4 
- 
Product 
E 
Scheme 3-3 
kow =+ (H+)3 (2 x (li") / Ka2) / K, 3K., K, 2+1+K. 4 
/ (H+) 
Equation 3.2 
The results are summarized in Table 3-23 and show that the apparent acidic pY-.. 
value of the enzyme is significantly affected by the zinc concentration decreasing 
from 5.91 at low zinc concentration to 4.47 for 10' M zinc. 
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Table 3-23 
Zincconcentration(31) CalcalatedapparentpK. ialues 
1.0 x 10-1 4.47 ± 0.1 
1. o x 10-3 4.76 ± 0.1 
1.0 x 0-, 5.12 d: 0.1 
1.0 x lo-, 5.46: * 0.1 
1.0 X 10-6 5.91 ± 0.2 
The same effect of the zinc concentration on the enzyme activity at low pH has 
been previously reported with carboxypeptidase, A157 and also with matrilysin"', a 
matrix metallo-proteinase whose pH rate-dependence at low pH is measured with 
excess zinc chloride to ensure maximal activity. In these cases, the metal ion pH 
dependence is thought to be due to a'loss of the catalytically important zinc ion 
57 
upon lowefing of the pHl 
VaHadares et al. 76 report the inactivation of A. hydophila metallo-O-lactamase 
upon addition of a second zinc to the normally monozinc enzyme. A pure 
noncompetitive inhibition is observed with a Ki of 46 gM. This phenomenon is 
reversible upon dialysis of ihe enzyme against a zinc free buffer. This enzyme 
requires only one zinc for full catalytic activity. They also reported that the metal- 
ion dependency of the activity was strongly pH dependent. 
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Carboxypeptidase A is also similarly inhibited by an excess of zinc in the pH range 
7-9159, such inhibition is thought to be due to the binding of a second zinc ion to 
the enzyme active site. 
The influence of the zinc concentration on enzyme activity is very different for the 
B. fragilis metaHo-o-lactamase for which the binding of both zinc ions is required 
for full catalytic activityý". However, for some B. ftagilis strains, the inhibition of 
the metallo-p-lactamase activity occurs as the concentration of zinc sulfate was 
increased beyond the concentration which allowed maximum activity"'. The 
binding of a second zinc has been reported not to be essential by Carfi el aL73 for 
most class B P-lactamases and it was therefore suggested that the tightly bound 
zinc2 in B. ftagilis metallo-p-lactamases was the result of an evolutionary 
phenomenon73 
From our study of the effect of excess zinc on the P-lactamase II activity, the 
second zinc ion was found not to be impoitant for catalysis at physiological pH. 
However its binding at low pH restores the enzyme activity. 
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3.5 Alethanolysis 
Site directed mutagenesis studies on P-lactamase 11 have found Aspartate 90 to be 
kinetically importantss. A possible mechanism for P-lactamase 11 catalysis is that the 
hydrolysis of the P-lactam proceeds through nucleophilic attack of the aspartate. 
group forming an anhydride intermediate (Scheme 34). 
0 
0 N Asp90 A 90 PO 
N---Zýý-- 0 ++ nH 0% ----Zn---- 0 
H 
NEs, 
ý 110nb Asp90 p- 
zn 
. ad 
00%. \ 
0 
Jilo 
ý-O-C 
NH,.. 
Asp90 
+ 
----Zn----O-H 
Scheme 34 Nucleophilic catalysis by Asp 90 
Methanol is a better nucleophile than water toward manysubstrates and could react 
with the anhydride intermediate, forming the, methyl ester in preference to the 
hydrolysis product. 
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The effect of methanol concentration on the rate constant, k,. t, of the B-lactamase 
11 catalysed hydrolysis of cefuroxime was investigated at pH 7.0. Cefuroxime was 
used as a substrate because of its small K. ValUe34 (45 ±5 pM) when compared 
with benzylpenicillin and cephaloridine, and k,. t was easily measured under 
saturation conditions. The results are presented in Table 3-24. 
Table 3-24 Effect of methanol concentration on the rate constant (k,. t) of the 
P-lactamase H catalysed hydrolysis of cefuroxime at pH 7.0,30 T and ionic 
strength 1.0 M (NaCI). Enzyme concentration 0.02 pM, zinc concentration 
0.4 pM 
Methanol concentration k,. ft') 
0.00 29.0 
0.50 29.1 
0.75 28.3 
1.00 28.9 
If the catalytic mechanism involves the' formation of an enzyme-anhydride 
intermediate [EA] the overall process can be represented as in Scheme 3-5 and k,. t 
would be given by Equation 3.3. In the presence of methanol, both hydrolysis and 
methanolysis could occur competitively as a function of methanol concentration. If 
k2>>k3+k4(MeOH) the rate of anhydride fonnation is faster than its breakdown and 
k, w would be given by k3+ k4(MeOH), the rate of degradation of the anhydride. In 
this case km would increase with the methanol concentration as the intermediate 
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accumulates. If k3+ k4(MeOH) >>k2, then ", would reflect the rate of formation of 
the anhydride intermediate and therefore would be unaffected by the methanol 
concentration. 
ki k2 k3 
- ES IL E+S --W- [EA] E+P 
k-i 
k4MeOH 
methyl ester +E 
Scheme 3-5 
k 
k2 k3k4 (Meoll) 
k2+ k3 +k4(MeOH) 
Equation 3.3 
Table 3-24 summarizes the results of this experiment. No effect due to the 
methanol concentration was observed and there was no detectable enzyme 
catalysed fonnation of a methyl ester. This is indicative, but not proof, that the 
anhydride mechanism does not occur. 
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3.6 Inhibition studies 
3.6.1 Synthesis 
As previously reported, an efficient strategy to prepare metalloenzyme inhibitors 
was to design compounds with a thiol group, which would be a better chelating 
agent to the active site than the substrate. 
Here, we report the main synthetic scheme followed for the preparation of the 
compounds tested as inhibitors during this work. 
N(2-mercaptoethyl)phenylacetamide (1) was prepared according to Scheme 3-6. 
PhCH2C0C1 
H2N - -->- hCH2CONH 
Cystamine NaOH OOC 
p 
NaBH4 
EtoH/H2() 
lf A 
2 PhCH2CONW--^ý 
H 
Scheme 3-6 Synthesis of N(2-mercaptoethyl)phenylacetamide (1) 
Cystamine was reacted with phenylacetyl chloride under Schotten-Baumann 
conditions. The final product (1) was obtained by reduction of the disulfide to the 
thiol with sodium borohydride. 
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The synthesis of this compound has been previously reported in a patent 
concerning the preparation of N-protected 2-aminoethanethioIS161 . The synthesis 
proceeds via the silyl protected sulfur intermediate of the 2-aminoethanethiol 
(Scheme 3-7). 
H2N 
ClSi(CH3)3 
H2N ,,., 
ý-Si(CHA 
Do 
CH3CN OOC 
((CH3)2CH)2NCH2CH3 CH3CN OOC 
((CH3)2CH)2NCH2CH3 
PhCH2COCI 
PhCH2CONH HCI PhCH2CONJI ., 
ý-Si(CHA 
Scheme 3-7 Synthesis of N(2-mercaptoethyl)phenylacetamide (1) 
2-Aminoethanethiol was reacted with trimethylchlorosilane in the presence of base, 
the product fonned was then acylated with phenylacetyl chloride. The thiol was 
subsequently deprotected by hydrolysing the silyl intennediate with dilute aqueous 
acid (yield 95 %). 
N-Phenylacetylglycine (2) was"synthesised by reacting glycine wIth phenylacetyl 
chloride under Schotten-Baumann conditions (Scheme 3-8). The reaction was 
straightforward and a good yipld was obtained. 
PhCH2COCI 
H2N,,,. CO2H 
NaOH, OoC 
ow PhCH2CONH,,,, 
-, 
CO2H 
(2) 
Scheme 3-8 Synthesis of N-phenylacetylglycine (2) 
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N-Phenylacetyl-cysteine (3) was synthesised according to the route shown in 
Scheme 3-9. Reaction of cystine with phenylacetyl chloride produced NN'- 
phenylacetylcystine which was subsequently reduced to the corresponding thiol (3) 
with sodium borohydride. The reduction of the disulfide to the thiol was confirmed 
by 13 C-NNIR analysis, as a change in the chemical shift for the PCH2 was observed 
going from 40 ppm for the disulfide to 2§ ppm for the thiol (this was the case for 
all the thiols synthesised during this work). 
H2N C0211 PhCH2COCI PhCH2CONH 
C02H 
NaOH, Ooc 
-S -S 22 
Cystine NaBH4 
EtOll/ H20 
PhCH2CONH C02H 
2x 
(3) HS 
Scheme 3-9 Synthesis of N-phenylacetyl-cysteine (3) 
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N-Phenylacetyl-penicillamine (4) was obtained by reacting penicillatnine with 
phenylacetyl chloride under Schotten-Baumann conditions (Scheme 3-10). There 
was no need to protect the thiol group during the reaction because of the steric 
hindrance around it. 
112N C02H 
WS 
HSX., 
CH3 
CH3 
PhCH2COCI 
10- 
NaOll, OOC 
PhCH2CONH C02H 
(4) CH3 
HS CH3 
Penicillamine 
Scheme 3-10 Synthesis of N-phenylacetyl-penicillamine (4) 
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Because of the difficulties encountered when attempting to prepare N- 
phenylacetylcysteinyl dipeptides, peptides with N-carbobenzoxy side chains were 
used for the following syntheses. N-Carbobenzoxy-cysteine (5) was prepared by 
reacting cystine with carbobenzoxy chloride and subsequently reducing the 
disulfide to the thiol using sodium borohydride (Scheme 3-11). 
H2N C02H 
PhCH20COC' 
PhCH20CONH C02H 
NaOH, OOC 
-S 
2 -S 
Cystine NaBH4 
EtOll/ H20 
lr, A 
PhCH20CONH C02H 
2x 
. (5) HS 
Scheme 3-11 Synthesilý of N-carbobenzoxy-cysteine (5) 
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Scheme 3-12 shows the protocol used for the preparation of the N-carbobenzoxy- 
cysteinyl-amino acids: N-carbobenzoxy-cysteinyl-glycine (6), carbobenzoxy- 
cysteinyl-alanine (7), N-carbobenzoxy-cysteinyl-valine (8), N-carbobenzoxy- 
cysteinyl-leucine (9), N-carbobenzoxy-cysteinyl-serine (10), N-carbobenzoxy- 
cysteinyl-penicillamine (11), N-carbobenzoxy-cysteinyl-phenylalýne (12) and N- 
carbobenzoxy-cysteinyl-proline, (13) shown in Figure 3.17. 
0 
PhCH20CONH 
N-\ 
-HS C02H 
(6) 
0 CH3 
PhCH2OCONH 
NH 
CH3 
HS 0), 2H 
0 OH 
PhCH20CONH 
NH 
HS COÖH 
(10) 
0 
-PhCH20CONH 
CH3 
HS C02H 
(7) 
CH3 
CH3 
0 
PhCH20CONH 
NH 
HS COOH 
(9) 
0 
HS ' CH3 
PhCH20CONH 
NH- CH3 
HS 
COOH 
(11) 
Ph 0 
PhCH20CONI PhCH20CONH 
NH 
HS COOH Hs 
(12).: 
(13) 
Figure 3.17 
151 
Results and Discussion 
The dipeptides were prepared by coupling NN"-dicarbobenzoxy-cystine with a 
5 
series of amino acid methyl esters in the presence of dicyclohexylcarbodiiniide. The 
methyl esters were subsequently deprotected by hydrolysis with lithium hydroxide. 
In the next step, the reduction of the disulfide with sodium borohydride led to the 
corresponding thiols. 
PhCH20CONH C02H CIT3ý + ýH-C%Me PhCH20CONH 0 
R- '' R 
DC, C, NEt3, DCM 
-S 2 
C02Me 
UOH 
MeOH/H20 
5-10 OC 
PhCH20CONH 0 
R 
HS" C02Me 
PhCH20CONH 0 
NaBH4 R 
EtO]HU700C 
-S)- MH 
C02H 
2 
R-H, CH3, CH(CH3)2, CH2CH(CH3)2, CH20H, CH2Ph 
DCUI 
Scheme 3-12 Synthesis of N-carbobenzoxy-cysteinyl-amino acids 
Good results were obtained during the coupling reaction between NN'- 
dicarbobenzoxy-cystine and*the ainino acids methyl esters (Yield 80 - 95 %). 
The hydrolysis step with lithium hydroxide led to 50 - 80 % yield for most of the 
dipeptide hydrolyses except for (Z-Cys-PheOH)2 for which very low yields were 
obtained (< 20 %). This was mainly due to the poor solubility of (Z-Cys-PheOMe)2 
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in methanol. Attempts to improve the yield were made using different solvents 
during the hydrolysis procedure without significant success. 
Reduction of the disulfide dipeptides to the corresponding thiols gave good yields 
(> 95 %). N-carbobenzoxy-cysteinyl-penicilla'nu*ne (11) was obtained as the 
reduced compound and immediately tested as an inhibitor. However, oxidation 
occurred over a month as shown by NMR analysis and ESMS also showed that a 
disulfide bond was formed. The 13 C NMR showed no change in the chemical shift 
of CHrSH on the cysteinyl side chain but the PC carbon of penicillamine side chain 
changed from 45 pprn to 57 ppm and so it was concluded that an intramolecular 
disulfide bond between the cysteine thiol and the peniCillarnine thiol was probably 
formed. 
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N-mercaptoethyl-4-L-thiazolidinecarboxylic acid (14) was synthesised via the route 
shown in Scheme 3-13.4-thiazolidinecarboxylic acid was protected as the methyl 
ester in the first step, then thioethylation of the methyl4-L-thiazolidinecarboxylate 
arnine with ethylene sulfide gave the N-mercaptoethyl-4-L-thiazolidinecarboxylic 
acid methyl ester. At this stage a mixture of product/starting material was obtained 
(3: 1). The methyl ester was subsequently'hydrolysed using lithium hydroxide. 
Several attempts to separate the product (14) from the 4-thiazolidinecarboxylic 
acid were made, such as liquid chromatography, to purify the product. 
Unfortunately, the compounds decomposed on the column. The product was 
finally isolated as a yellow precipitate. The' 13 C NMR showed that the majority of 
the compound was the disulfide of (14) but ESMS revealed the presence of other 
compounds. The disulfide was reduced using sodium borohydride but no further 
studies were made on the compound. 
HN 
C02H 
HCI 
Do 
MeOW reflux 
(s 
HN 
C02Me 
'ý7 8o oc s 
H 
I 
UOH 
of N- 
C02H EtOEU H20 
HS 
/--ý C02Me 
Scheme 3-13 Synthesis or N-mercaptoethyl4-thiazolidinecarboxylic acid (14) 
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3-Oxoperhydro[I. 3]thiazolo[4.3-b][1.3]thiazole-7a-carboxylic acid (15) was 
obtained when attempting to prepare N-mercaptoacetyl4-thiazolidinecarboxylic 
acid (16) following the route shown in Scheme 3-14. Dithioglycolic acid was 
coupled with 4-thiazolidinecarboxylic acid methyl ester in the presence of 
dicyclohexylcarbodiirnide. The product of the reaction was then hydrolysed with 
lithium hydroxide and the main pýroduct isolated was 3- 
oxoperhydro[I. 3]thiazolo[4.3-b][1.3]thiazole-7a-carboxylic acid (15). 
H02C HN DCC 
C02Me DCM 
0 oc 
C02Me 
UOH 
MeOH/H20 
0-10 OC 
N- C02H 
0-: 
)ý 
Scheme 3-14 Synthesis of 3-oxoperhydro[l. 3]thiazolo[4.3-bI [1.3]thiazole-7a- 
- carboxylic acid (15) 
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The compound (15) is thought to be produced according to the mechanism 
outlined in Scheme 3-15. The product of the coupling reaction undergoes 
cyclisation when treated with lithium hydroxide. The cyclisation reaction may 
occur faster than the hydrolysis of the methyl ester. 
. OH 
1 
)2Me 
N-) C02H 
0. 
ý 
-I 
Scheme 3-15 
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After failing to prepare N-mercaptoacetyl4-thiazolidinecarboxylic acid (16) 
(Scheme 3-14) a different route was followed (Scheme 3-16). Mercaptoacetic acid 
was first S-benzoylated with benzoyl chloride under Schotten-Baumann conditions. 
The protected carboxylic was then coupled with 4-thiazolidinecarboxylic acid. The 
thiol was deprotected. with NH401-L and attempts were made to purify the product 
by preparative TLC. The purification was not successful, as revealed by the NMR 
of the product isolated. 
HS,,,. C02H PhCOCI PhCOS.,,,. CO2H 
10 
NaOH 
0-5 OC 
<s 
HN 
DCC 
C02H 
DCM 
0 /-S 0 /-S 
NH40H 
HS (16) C02H , PhCOS, C02H 
Scheme 3-16 Synthesis of N-mercaptoacetyl4-thiazolidinecarboxylic acid (16) 
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3.6.2 Inhibition studies with N(2-mercaptoethyl)phenylacetamide (1) 
PhCH2CONH 
HS-) 
It is known that compounds like captopril interact with the zinc ion in the active 
site of the metallo-enzyme ACE 162. Its design was based-on a substrate related 
structure with the introduction of a thiol group to induce coordination to the zinc 
ion of the enzyme 163 Thiol compounds have been found to be good inhibitors of 
metallo-enzymeslog"64and, by analogy, potential inhibitors of P-lactamase II have 
been synthesised and tested against P-lactamase II during this work. They are all 
related to the primary structure of the substrate benzylpenicillin and most of them 
contain a thiol group which is a potential ligand for the metal ion. 
The effect of varying the concentration of N(2-mercaptoethyl)-phenylacetanýde (1) 
on the rate (k,. /K. ) of the P-lactamase II catalysed hydrolysis of cephaloridine was 
studied and the results are shown in Table 3-25. 
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Table 3-25 Effect of thiol (1) on the rate (kc. JK. ) of the P-lactamase 11 
catalysed hydrolysis of cephaloridine at pH 7.0,30 T and ionic strength 1.0 
At (NaCl). Enzyme concentration 0.1 pM, zinc concentration 2 pM 
77tiol (1) k,. X,. (Ml ýfl 
0.00 x 10 6.68 x 104 
1.00 X 10-4 3.25 x 104 
2.00 x 10-4 2.23 x 104 
3.00 x 10'4 1.74 x 104 
4.00 x 10 L44 x 104 
5.00 x 10-4 1.15 x 104 
-4 6.00 x 10 1.01 Xý 104 
The results were plotted as k,. /K. against inhibitor concentrations (Figure 3.18) 
and assuming competitive inhibition, the curve was fitted to the Michaelis-Menten 
equation for competitive inhibition with S<<K. Equation 3.4. 
WK 
Il+ Ki 
Equation 3.4 
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7.00- 
6.00 
5.00 
W 
4.00- 
3.00 - 
x 
2.00- 
1.00- 
0.00 
0.00 1.00 2.00 3.00 4.00 5.00 6.00 
104 X [Inlfibitor (1)] (M) 
Figure 3.18 Effect of the N(2-merca' toethyl)-* henylacetamide (1) pp 
concentration on km/K. for the P-lactamase H catalysed hydrolysis of 
cephaloridine. (The squares are exPerimental values'and the solid line is calculated 
from the Equation 3.4). 
When the results were plotted as "t against inhibitor, concentrations (Figure 
3.19), a linear relationship was obtained. This linear relationship ýetween the two 
variables can be described by the Equation 3.5 which is indicative of competitive or 
mixed infdbition. 
m=( 
Km) 
kca +11ii 
Equation 3.5 
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: --L-00- 
0.75 - 
0.50 
0.25- 
y- 1389,. 6x + 0.1595 
aeo i 
-0.0002 -0.0001 0.0001 0.0002,9.000 0.0004 -0.0005 0.0006 
Inhibitor (1) (M) 
Figure 3.19 Plot of -, the , N(2-mercaptoethyl)-phenylacetamide (1) 
concentration against K. /kc., for the P-lactamase H catalysed hydrolysis of 
cephaloridine 
The plot of " versus the inhibitor concentration is a straight line, from which 
Ki was extrapolated as the intercept on the x axis (-Ki). 
From this study the N(2-mercaptoethyl)phenylacetanide (1) was found to behave 
as a competitive inhibitor of the P-lactamaie II'with a Ki 100.0 pK as the results 
obtained agreed with that obtained from Equation 3.4 for competitive inhibition, 
although a repeat of this experiment at different substrate concentrations would be 
ideal to verify this. 
This inhibitor was chosen for more detailed mechanistic studies. --- 
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3.62.1 pH dependence ofpKifor the P-laciamase II catalysed hydrolysis of 
P-laciams inhibited by N(2-mercaptoethyl)phetiylacelamide (1) 
The inhibitory action of N(2-mercaptoethyl)phenylacetamide (1) on the 0- 
lactamase II catalysed hydrolysis of P-lactams was studied as a function of pH. The 
inhibitor concentration used was 2x 10-4 M. The substrate concentration being 
below K., the second-order rate constant k,. t/K. was measured with and without 
inhibitor at different pH values. The Ki values were deduced from the Mchaelis- 
Menten equation for competitive inhibition (Equation 3.4). The results are given in 
Table 3-26 as pKi (-IogKi) against pH for the studies of the hydrolysis of 
cephaloridine. 
Table 3-26 The pH dependence of the inhibition dissociation constant (pK) of 
N(2-mercaptoethyl)phenylacetamide (1) for the P-lactamase H catalysed 
hydrolysis of cephaloridine at 30 *C and ionic strength 1.0 M (NaCQ. Enzyme 
concentration 0.1-2 IM, zinc concentration 240 IM 
pH pKi (AV pH pKi VW 
4.47 3.10 7.00 4.08 
4.73 3.42 7.50 4.13 
4.78 3.67 8.00 4.19 
5.04 3.80 8.50 4.17 
5.06 3.65 9.51 4.12 
5.25 4.11 9.75 3.95 
5.60 4.03 10.00 3.80 
6.00 4.07 10.24 3.64 
r7ý0 4.09 10.50 3.54 
162 
Results and Discussion 
The results were plotted as the pKi versus pH, and are shown in Figure 3.20. 
4.50 
4.00 
3.50 
3.00 
2.50 
74 
89 10 
pH 
Figure 3.20 pH dependence of the inhibition constants (pKj) of N(2- 
mercaptoethyl)phenylacetamide (1) for the P-lactamase H catalysed 
hydrolysis of cephaloridine 
As shown on the above plot the curve is bell-shaped with slopes of 1,0 and -1, 
indicating that the binding of the inhibitor to the enzyme is tightest between pH 6 
and 9 and also pH independent. The affinity of the inhibitor for the enzyme falls off 
on the extremes of the profile as Y, increases (pK- decrease) at high and low pHs. 
ALassurning that ionisation processes occur at the inflection points, the expression of 
Ki as a function of pH can be given by Equation 3.6. 
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Ki 
iapp I+ (H+)/K., + K&2/(H+) 
Equation 3.6 
From a best fit calculation (solid line on the graph) using the equation above, 
approximate pKs were determined (Table 3-27) 
Table 3-27 
Substrate pK. i PKm2 Ki (IM 
Cephaloridine 5.32 9.93 67.4 
In order to demonstrate that the Ki values obtained were independent of the nature 
of the substrate used to monitor enzyme activity, the pH dependence of pKi for the 
inhibition of P-lactamase II by thiol (1) was also studied with benzy1penicillin as a 
substrate. Second-order rate constants were measured with and without inhibitor at 
different pH and the results are listed in Table 3-28 as pKi at various pH values. 
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Table 3-28 The pil dependence or the inhibition dissociation constant (pKj) of 
N(2-mercaptoethyl)phenylacetamide (1) for the P-lactamase H catalYsed 
hydrolysis of benzylpenicillin at 30 T and ionic strength 1.0 M (NaCI). 
Enzyme concentration 0.1-2 gl%l, zinc concentration 240 pM 
PH pKi (Al) PH pKi (7W 
5.25 3.64 9.00 4.11 
5.60 3.97 9.23 4.24 
5.65 3.55 9.40 4.06 
5.79 3.76 9.51 4.05 
6.00 4.43 9.52 4.17 
6.00 3.64 9.75 4.01 
6.50 4.38 9.85 4.04 
7.00 4.35 10.00 3.91 
7.50 4.43 10.07 3.86 
8.00 4.41 10.24 3.68 
8.50 4.37 10.50 3.69 
The results were plotted in Figure 3.21 which gave a bell-shaped curve and similar 
to the pKi -pH profile observed for cephaloridine, slopes of 1,0, -1 were seen for 
this substrate also. 
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pH 
Figure 3.21 pH dependence of the inhibition constants (pKj) of N(2- 
mercaptoethyl)phenylacetamide (1) for the' P-lactamase H catalysed 
hydrolysis of benzy1penicillin 
Fitting the curve to the theoretical 'Equation 3.6, the kinetic parameters were 
determined from the inflection points and are shown in Table 3-29.: 
Table 3-29 
Substrate pKj pK. 2 Ki (p" 
Benzylpenicilfin 6.103 9.75,,, 
. 
44.4 
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3.6. Z2 Discussion 
Inhibition constants represent pure equilibrium binding of a compound to the 
enzyme, the Kj-pH profiles inflections should therefore reflect intrinsic pK. 
142 
values . By contrast, pK'. values obtained from kinetic studies may be the result of 
kinetic ambiguities such as changes in rate limiting step. It is therefore of interest to 
compare enzyme ionisation constants obtained by the two methods. The inhibition 
constants should of course, be independent of the substrate used to monitor 
enzyme activity. This was confirmed by using both benzy1penicillin and 
cephaloridine as the substrate for P-lactamase II activity. I 
Inhibition constants Ki were measured as a function of pH for the inhibition of the 
P-lactamase Il activity by N(2-mercaptoethyl)phenylacetarrýde (1). The pH- 
dependence of pIC, for the P-lactamase H catalysed hydrolysis of both cephaloridine 
and benzylpenicillin (Figure 3.20 and Figure 3.2 1), have a characteristic bell-shaped 
curve with a slope of I at lower pH values and a slope of -1 at higher pH values. It 
shows that the binding is maximal and pH independent between the two inflection 
points, with diminished enzyme affinity, at the pH extremes. -ý 
It is interesting to note that the acid limb of the pKj-p'H profile shows a definite 
slope of I in contrast to the value of 2.0 exhibited in the rate-pH profiles. This 
clearly indicates that the slope of 2.0 observed in the kinetic studies is a catalytic 
phenomenon and not the result of some form of enzyme degradation e. g. loss of 
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the enzyme bound zinc ion. Clearly, the binding of the inhibitor is affected by just 
one ionisation at low pH whereas catalytic activity is controlled by two ionisations. 
The pH dependence of V, for both substrates, show sirnilar pH inflections to those 
observed in the P-lactamase 11 catalysed hydrolysis of substrates. The calculated 
pK. values of 5.66 ± 0.4 and 9.84 ± 0.1, derived from the inhibition studies, are 
sinilar, within error, to those obtained for 
_catalysis 
5.67 :ý0.2 and 9.60 ± 0.3, 
which confirms that the values obtained ftorn the pH dependence studies of the rate 
of hydrolysis of P-lactams are true equilibrium ionisations and not kinetic values. 
The pY.. of the thiol group of N(2-mercaptoethyl)phenylacetamide (1) was 
determined by spectrophotometric titration to be 9.5 ± 0.1; so, the predominant 
species at neutral pH is the undissociated RSH. - 
The thiol of (1) is most likely to be a figand for the zinc ion in the enzyme active 
site. Assuming that there is displacement of the zinc-bound water by the thiol when 
inhibition occurs"', many binding possibilities arise as a function of the zinc-bound 
water pK.. The activity of the enzyme is linked to the ionisation of three essential 
groups in the active site, with two pY... values of 5.6 -and one of 9.5., each of which 
could be assigned to the zinc-bound water. Models (1), (2) and (3) represent. the 
different modes of binding possible. 
EZn-OH+RSH, -, -,, ýr---%m- EZn-SR+H20 
model (1) 
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EZn. 0112 + RSH -- EZn. SR + 
H30+ 
model (2) 
EZrLOH2 + M' ., EZn. SR + 
H20 
model (3) 
However, only one mode of binding, model, (1), can explain the observed 
invariance of Ki with pH between 6 and 9, with the neutral thiol binding to the 
enzyme active site in which the water ligand is deprotonated giving pH independent 
binding between 6 and 9. 
Alternative binding models (2) and (3) would gýperate pH dependency of the 
binding of the thiol. Assuming that the ionisation of the zinc-bound water 
correspond to the high pY.. value of 9.5, then below pH 9 the undissociated form 
would be predominant and binding to the thiol. would, cause the liberation of the 
hydronium ion and therefore be pH dependent (model 2). :,, ý-,, ýI- -ý 
The binding of the thiolate anion to the undissociated zinc-bound water would also 
be pH dependent as the concentration of the thiolate would vary with the pH 
(model 3). 
It is therefore deduced that 'model (1) most probably represents the mode of 
binding of the thiol inhibitor (1) with P-lactamase H, and explains the observed pH 
profile for pKi. The results, of this study thus favour, a low py.. value of 5.6 for the 
zinc-bound water. 
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3.6.3 Structural dependence of thiol inhibition 
The compounds synthesised during this work as potential inhibitors of the 0- 
lactamase II are shown in Table 3-30. It is known that the precursor of penicillin 
synthesis is a tripeptide containing a cysteine residue, L-S-(cc-aminoadipoyl)-L- 
cysteinyl-D-valine (ACV)165. Based on this acyclic structure and by analogy with 
benzy1penicillin itself, various thiol compounds differing in their side chain 
structure have been synthesised and tested as inhibitors of P-lactamase Il. 
H2N Y**'ýý 
C02H 0 
ACV C02H 
In order to determine whether any of the inhibition observed was due to metal 
chelation and depletion, most of the experiments were performed initially without - 
added zinc and repeated with an excess of zinc sulfate, typically 2x 10'4M. The 
inhibition constant, Ki, for each inhibitor was estimated based on the equation 
below assuming competitive inhibition. 
kc&, [E]. [S] Rate = 
[S]+K 
. 
(Ki +[I]), 
The results of this study are summarized in Table 3-30 
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Table 3-30 Inhibitor dissociation constants for the P-lactamase 11 catalysed 
hydrolysis or P-lactams, at 30 oC p1l 7.0 and ionic strength 1.0 M (NaCl) 
Enzvme concentration 0.1 u1%1 
Compounds Ki pM (ZnSO4 
2x 10'6AP 
Kj pM (ZnSO4 
2x]0-4AD 
N(2-mercaptoethyl)phenylacetainide (1) 56.2 ± 11 
N-phenylacetylglycine (2) 1000 ± 150 
N-phenylacetyl-L-cysteine (3) 108 3 285 ±5 
N-phenylacetyl-DL-penicillan-dne (4) 515 38 465 169 
N-carbobenzoxy-L-cysteine (5) 
N-carbobenzoxy-D-cysteine (5) 
97 5 
20.1 1.6 30.8 1.3 
N-carbobenzoxy-L-cysteinyl-glycine (6) 
N-carbobenzoxy-DL-cysteinyl-glycine (6) 
42.2 10 
46.3 0.1 
40.7 ± 10 
N-carbobenzo)cy-L-cysteinyl-DL-alanine (7) 62.0 9.3 81.5 ± 10 
N-carbobenzoxy-L-cysteinyl-DL-vaUne (8) 48.3 2.3 85.5 ± 1.5 
N-carbobenzoVý-L-cysteinyl-L-leucine (9) 135.5 ± 17 173 ±I 
N-carbobenzoxy-L-cysteinyl-DL-serine (10) 
N-carbobenzoxy-DL-cysteinyl-L-serine (10) 
72.5 ± 0.5 
83.8 ±4 
107 ±3 
118 ±3 
N-carbobenzoxy-D-cysteinyl-D-penicillamine (11) no hydrolysis 107 ± 13 
N-carbobenzoxy-L-cysteinyl-DL-phenylalanine (12) 
N-carbobenzoxy-L-cysteinyl-L-phenylalanine (12) 
N-carbobenzoxy-L-cysteinyl-D-phenylalanine (12) 
N-carbobenzoxy-D-cysteinyl-L-phenylalanine (12) 
N-carbobenzoxy-D-cysteinyl-D-phenylalýne (12) 
17.3 ± 0.2 
26.9 ± 0.5 
9.3 ± 0.4 
11.0 ±1 
3.0 ± 0.1 
22.0 ± 1.0 
40.8 ±3 
14.7 ±I 
22.0 ±I 
11.0 0.3 
N-carbobenzoxy-L-cysteinyl-DL-proline (13) 95.0 ± 1.5 140 1 
3-oxoperhydro[I. 3]thiazolo[4.3-b][1.3]thiazole-7a- 
carboxylic acid (15) 
181 
2,, 3-dimercaptosuccinic acid 
2,, 3-dimercapto-I -propane sulfonic acid. 
Sodium hydrogen sulfide 
no hydrolysis activity 
restored 
Enalapril 5.69 x 104 
Captopril 41.6 ±9 88.6 ±. 14 
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The compounds tested exhibited various potencies against D-lactamase 11. The first 
thiol exarnined was N(2-mercaptoethyl)phenylacetamide (1) the inhibitory action of 
which has been previously discussed. The thiol itself is necessary for inhibition, N- 
phenylacetylglycine (2) is a very poor inhibitor. The addition of a carboxylic acid 
residue to the basic neutral thiol structure (1) to give N-phenylacetyl-L-cysteine (3) 
slightly decreases potency, suggesting that a negatively charged carboxylate, anion 
in this position does not facilitate binding. There is an order of magnitude decrease 
in binding when two gern-dimethyl groups are (x-substituted to the thiol, as in N- 
phenylacetyl-DL-peniciflamine (4). This again is indicative of some selectivity and 
suggests that thiol co-ordination is important and can be sterically inhibited. 
There is only a slight difference between the Ki values measured for N- 
carbobenzoxy and N-phenylacetyl side chains. N-phenylacetyl-L-cysteine (3) and 
N-carbobenzoxy-L-cysteine (5) have sinfilar Ki values of 108 pM and 97 plvL 
respectively. 
The effect of substituents on the inhibition by the thiol dipeptides was investigated 
in various N-carbobenzoxy-cysteinyl amino acids. The effect on Ki upon increasing 
the size of the R group from CH3 in N-carbobenzoxy-L-cysteinyl-DL-alanine (7) 
(Ki of 62 gNl) to CH(CH3)2 in N-carbobenzoxy-L-cysteinyl-DL-vahne (8) (Ki of 
42 pM) shows an increase in affinity for the enzyme active site. When the R group 
is CHrPh as in N-carbobenzoxy-L-cysteinyl-DL-phenylalýiie (12), the Ki of 17 
[tM indicates a more potent inhibitor which may be due to the hydrophobic effect 
of the aromatic group. N-Carbobenzoxy L-cysteinyl-serine (10) with a Ki of 72.5 
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pM displays a lower degree of irNbition than N-carbobenzoxy-L-cysteinyl-DL- 
alanine (7), which indicates that increasing the polarity of the side chain does not 
improve the inhibition. N-carbobenzoxy-L-cysteinyl-DL-proline (13) (Ki 95.0 VM) 
was less active than the other dipeptides which is probably due to the restricted 
flexibility of the C-N peptide bound. It seems that the best inhibition is obtained for 
compounds with a hydrophobic side chain. 
Most of the compounds which inhibited P-lactarnase II were not chelating agents, 
as the enzyme activity was not restored upon the addition of zinc ions. However, 
the enzyme was completely inactivated by N-carbobenzoxy-D-cysteinyl-D- 
peniciflamine (11). No hydrolysis of the substrate was observed when the enzyme 
was submitted to different concentrations of this dithiol. The activity was, 
however, mostly recovered upon addition of excess zinc indicating that the dithiol. 
was acting as a chelating agent and removed the zinc ion from the protein. 
Other dithiol compounds have been tested and they exhibit a similar phenomenon 
against P-lactamase H. Such a phenomenon has been observed when testing 2,3- 
dimercaptosuccinic acid, 2,3-dimercapto-l-propanesulfonic acid and also sodium 
hydrogen sulfide against P-lactamase H. These compounds completely inhibited the 
enzyme activity at the concentration of inhibitor used, the activity was however 
restored upon addition of excess zinc. 
Captopril and enalapril are potent inhibitors of the zinc-dependent angiotensin 
converting enzyme (ACE). Any potential medicinal'use of inlfibitors of 0-lactamase 
11 would obviously require the inhibitor to act selectively and, particularly, not to 
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inhibit ACE. It is equally of interest to test whether ACE inhibitors have an effect 
on P-lactamase Il. Captopril was found to be a good inhibitor of P-lactamase II 
with a K, of 41.6 gNI and repeating the assay with excess zinc did not restore the 
enzyme activity (Ki 88.6 gNI). However enalapril w1&h does not contain a thiol 
group, did not inhibit the enzyme. This result highlights the importance of the thiol 
group in the design of P-lactamase 11 inhibitors. This was also Mustrated by the fact 
that N-phenylacetylglycine (2) was not a good inhibitor of P-ladamase II, with a Ki 
of 1 mm. 
whilst attempting to synthesise the compound N-mercaptoacetyl4- 
thiazolidinecarboxylic acid (16), the interesting 3-oxoperhydro[l'-3]thiazolo[4.3- 
b][1.3]thiazole-7a-carboxyhc acid (15) was obtained. This compound was also 
tested against P-lactamase II and found to be a weak inhibitor with an inhibition 
constant of 181 gN1. This compound obviously does not contain an ionisable thiol 
group, but, nonetheless, it is a better inhibitor than the simple carboxylic acid N- 
phenylacetylglycine (2) K- I mM). 
There are two asymmetric centres in the dipeptides synthesised and the effect of 
the stereochernistry at each centre on inhibition was independently varied. For 
example, for the D-enantiomer of the N-carbobenzoxy-cysteine (5) was five times 
more potent than the L-enantiorner. N-Carbobenzoxy-L-cysteinyl-glycine (6) 
displays the same degree of inhibition as its racernic mixture (DL)., Similar 
inhibitory potencies were obtained with N-carbobenzoxy-L-cysteinyl-DL-serine 
(10) and N-carbobenzoxy-DL-cysteinyl-L-serine (10). N-carbobenzoxy-L- 
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cysteinyl-L-leucine (9) with a Ki 135 gNI was the poorest inhibitor compared with 
the other dipeptides. 
Four diastereoisomers of N-carbobenzoxy-cysteinyl-phenylaianine (12) were 
synthesised and tested as inhibitors of P-lactamase II. The N-carbobenzoxy-L- 
cysteinyl-D-phenylalanine (12) and N-carbobenzoxy-D-cysteinyl-L-phenylalanine 
(12), showed the same degree of inhibifion whUst N-carbobenzoxy-D-cysteinyl-D- 
phenylalanine (12) isomer, was three times more effective. It was found that the N- 
carbobenzoxy-L-cysteinyl-L-phenylalanine is the weaker inhibitor of the four 
isomers. 
From these results, we can state that thiol compounds effectively inhibit 0- 
lactamase II. It can be concluded that the best interactions with the enzyme are 
obtained with compounds with a thiol residue and a hydrophobic side chain such as 
N-carbobenzoxy-<, -ysteinyl-phenylalanine (12). Furthermore, they exhibit some 
selective stereochemistry, as the D, D isomers of N-carbobenzoxy-cysteinyl-amino 
acids exhibit the highest potency. N-Carbobenzoxy-D-cysteinyl-D-phenylalanine 
(12) with a K, of 3.0 W is the most efficient in vitro inhibitor of P-lactamase 11 
synthesised during this work. 
These results indicate that - P-lactamase 11 requires aD configuration at the 
cysteinyl amino acid centre, as shown by comparing the inhibitory effect of N- 
carbobenzoxy-L-cysteine (5) K- = 97 pM) with N-carbobenzoxy-D-cysteine (Ki = 
20 gM). Good inhibition also requires aD configuration at the second amino acid 
centre as the best inhibition was obtained with the DD isomer of N-carbobenzoxy- 
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cysteinyl-phenylalanine (12) (Ki 3.0 [M). However, the enzyme does tolerate an L 
configuration at both centres when combined with aD configuration. Scheme 3-17 
shows the stereochemistry of the two asymmetric centres of a D, D isomer of N- 
carbobenzoxy-cysteinyl amino acid and a comparison made with the 
stereochemistry of benzylpenicUlin as a substrate. 
PhCH2CONH 
Hw- -R 
H 
(S) -D- cysteinyl residue is 
preferred inhibitor 
PhCH2CONH 0 
Hww' 
4H 
(R)- D-amino acid is 
N-ýr preferred at C-terminus 
HS H C02H 
Compare with benzylpeniciUin 
PhCH2CONH 
s 
L 
): 
jNý 
4: ý 
0D t%H 
(R) Icysteine at C6 
D-centre at C3 
Scheme 3-17 
Since the enzyme stereoselectively hydrolyses the substrate benzylpeniciUin which 
has three asymmetric centres, it is expected that the inhibitor has to have the right 
stereocheýnistry in order to be effective. Jhe proposed docking of the N- 
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carbobenzoxy-D-cysteinyl-D-anýno acid inhibitor in the active site is shown in 
Scheme 3-18. The result of the inhibition study shows that there is discrimination in 
the binding of inhibitors and is further evidence that binding occurs to the zinc ion 
of the active site The case of the inhibition of a binuclear zinc P-lactarnase II has 
also to be considered where the thiol could be coordinated to both zinc ions. 
PhCH20CONH 0 
H 
N 
H 
0s C., 
zir 00 ýH3+ 
I 
LYS171 
Scheme 3-18 Proposed model for the binding of the thiol dipeptides to the 
active site of P-lactamase H 
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3.7 Mechanism of catalysis of P-lactamase H 
As stated in the introduction, the mechanistic studies on carboxypeptidase A 
usually serve as models for other metallo-enzymes89,90. Many pathways for the 
mechanism of catalysis of this enzyme have been proposed93, such as the anhydride 
pathWay&6'87'88 where Glu270 acts as a nucleophile and attacks the carbonyl 
function of the peptide substrate. The other mechanism proposed involves Glu270 
acting as a general base, deprotonating an external water molecule or a zinc-bound 
water molecule concerted with attack on the substrate89,90 
Similar to carboxypeptidase A, an anhydride pathway is possible for P-lactamase II 
action, where Asp90 would act as a nucleophile attacking the carbonyl function of 
the P-lactam ring, leading to the formation of an anhydride intermediate (Scheme 
3-4, page 143). This pathway is, however, probably ruled out by the methanolysis 
studies. There was no effect of the methanol on the enzyme catalysis, and no 
methyl ester product was detected, whereas such effect could have been expected 
if an anhydride intennediate was involved. 
Earlier studies of the mechanism of action of P-lactamase Il'9, suggested a 
mechanism involving Asp 90 acting as a general base to promote nucleophilic 
attack of a zinc-bound water (Scheme 3-19) or, as for carboxypeptidase, of an 
external water molecule on the substrate (and Scheme 3-20). The activated water 
attacks the carbonyl carbon of the P-lactam ring to form a tetrahedral intermediate. 
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The intennediate then collapses when a proton is donated to the nitrogen by Asp9o 
which is acting as a general acid. 
N 
P 
all H 
N---irý + -- 0"" 
10/ "1 * \H Asp 90 
Nýý 
i 
fl; H 0 
Of ý 
H 
0-ýý-`-Asp 90 
'Po 
++ HO 
Asp 90 
Scheme 3-19 
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Alsp790 
Scheme 3-20 
However, the pH dependence studies of catalysis for the P-lactamase 11 conducted 
during this work, have shown that the enzyme activity was linked to the ionisation 
of at least three essential groups in the active site, two of which have a pY... value 
of 5.6 and were attributed to the zinc-bound water and Asp90. Thus at 
physiological pH we would expect these two residues to be unprotonated. Kinetic 
solvent isotope experiments revealed that. k,. /K. H'o /(kt/K M) 
D20 
was 1.82 for the 
hydrolysis of benzylpenicillin, 0.85 for cephaloridine and 1.23 for cefuroxime and 
k,. t 
H20 
/kat D20 was 1.5 ±'O. I for all three substrates. These are relatively small 
kinetic solvent isotope effects, whereas the mechanisms proposed in Scheme 3-19 
and Scheme 3-20 involve rate-limiting proton transfer from the zinc-bound water, 
which should generate significant kinetic isotope effects of 2 to 3. 
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Finally, from the results of the mechanistic study of the O-lactamase II, the 
mechanisms which meet the above considerations, the pK. of 5.6 for the zinc- 
bound water and Asp90 residue and relatively small kinetic solvent isotope effects, 
is shown in Scheme 3-21 when the enzyme binds only one zinc ion and in Scheme 
3-22 when the enzyme binds two zinc ions. 
When considering the case of the mononuclear P-lactamase II (Scheme 3-21), the 
enzyme activity requires the two catalytically important groups, the zinc-bound 
water and Asp90, to be in their deprotonated fonn. The zinc-bound hydroxide ion 
attacks the carbonyl of the P-lactam ring to form a tetrahedral intermediate. 
Fonnation of the tetrahedral intermediate results in a significant build up of 
negative charge on both oxygens, which would be stabilised by the zinc ion. Ring 
opening of the P-lactam is not an easy process and the reaction will probably be 
reversible regenerating the P-lactam. The collapse of the tetrahedral intermediate 
needs therefore to be assisted by protonation of the nitrogen of the P-lactam. Ring 
opening will also be facilitated if the tetrahedral intermediate is deprotonated 
during the process"", therefore creating a dianionic species. Asp90 could act as a 
base and deprotonates the tetrahedral intermediate. The newly protonated Asp90 
will then assist the breakdown of the intennediate by general acid-catalysis, 
donating a proton to the 0-lactam nitrogen. Asp90 in the mononuclear enzyme 
would therefore function as a proton ShUttlep, 
167 
. Either k2or 
k3 in Scheme 3-21 
could be rate-limiting. 
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The small kinetic solvent isotope effects observed are compatible with the 
proposed mechanism: in the first step, where the zinc-bound hydroxide attacks the 
carbonyl function of the P-lactam ring and as OD' is a stronger nucleophile than 
we expect an inverse kinetic solvent isotope effect whereas the k2 and k3 
steps would be associated with a primary kinetic solvent isotope effects. 
N ki 
11 
p 
%% 11 -0 
k -i 
0-H 
ýN 0-11'AspW 
9 HN*. 
II 
_0 
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N 
-10/F"- \ 
'Hn 
0 
. d, o# 
%%% wý, Asp90 
1 
k2 
N 
k3 
0 
01ý--ý"-Asp 90 
Scheme 3-21 
However, when considering the case of the enzyme binding two zinc ions, Asp90 is 
one of the five ligands of the second zinc ion along with Waterl, Cys16% 11is 210 
and another water molecule' and therefore cannot perform its role as a proton 
shuttle. A possible mechanism in this case is shown in Scheme 3-22. The zinc- 
bound hydroxide acts as the nucleophile and attacks the P-lactam carbonyl. The 
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tetrahedral intermediate formed would then collapse upon protonation of the 
nitrogen of the P-lactarn by the Water molecule bound to the second zinc ion. 
JALV90 obviously cannot perform this role as it is bound to the second zinc. It has 
been previously suggested that water co-ordinated to zinc is a good general acid 
catalyst". 
0H2 
,, 
p 
0', 'YS168 
His149»---ZIIý-- OH-' t '9S210 
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Scheme 3-22 
Such a mechanism is in accord with the recent crystallography studies of the 
af 67 lactarnase II by Fabiane el. As previously reported the enzyme active site 
contains two zinc ions, one of high affinity and the other one of low affinity. A 
water molecule is reported to bridge the two zinc ions in series with Asp90 but 
unlike binuclear zinc peptidase whose bridging water is at equal distance between 
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the two zinc ions, Waterl in P-lactamase 11 lies very much closer to zincl. than 
zinc2 and this distance is not affected by the positioning of zinc2. 
The zinc-bound hydroxide (at neutral pH), which is polarized and positioned by the 
two zinc ions in a binuclear zinc enzyme or one zinc ion in a mono zinc form, 
performs the attack on the carbonyl of the P-lactam ring. However, the hydroxide 
when co-ordinated to two zinc ions would be expected to be a very weak 
nucleophile. The zincl is also found to have a stabilising action on the oxyanion 
intermediate formed during the catalysis. The role of the second zinc is not exactly 
understood although its binding to the enzyme at low pH seems to help restore the 
enzyme activity. 
Bacillus cereus P-lactamase II seems to be able to function as a mono nuclear zinc 
enzyme as well as a binuclear zinc enzyme. Such flexibility and adaptability may 
well be the explanation for the large substrate profile displayed by P-lactamase II. 
It would be interesting to continue these studies in order to distinguish between the 
mononuclear and the binuclear zinc enzyme, and to investigate further the 
dissociation of zinc ions at low pH. 
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